https://bostonlifesciencestimes.com/2022/03/k2-scientific-launches-new-giveaway-program-to-bolster-healthcare-access-in-underserved-communities/ 2022-03-15T15:26:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Art-Henson.jpg https://bostonlifesciencestimes.com/2022/03/limflow-completes-enrollment-in-promise-ii-u-s-pivotal-trial-of-breakthrough-device-designed-to-prevent-amputations-in-no-option-patients-with-chronic-limb-threatening-ischemia/ 2022-03-15T15:36:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/LimFlow.png https://bostonlifesciencestimes.com/2022/03/arima-genomics-closes-series-b-financing-to-support-growing-portfolio-of-3d-genomics-solutions-for-biomedical-research-and-translational-applications/ 2022-03-15T15:38:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Darlene-Solomon-Ph.D..jpg https://bostonlifesciencestimes.com/2022/03/jsr-life-sciences-amsphere-a3-integrated-into-the-commercial-manufacturing-of-fda-approved-antibody-therapy/ 2022-03-15T15:42:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Hideaki-Nomura.jpg https://bostonlifesciencestimes.com/2022/03/bear-robotics-raises-81m-series-b-to-scale-up-mobile-robots-in-the-hospitality-market/ 2022-03-15T15:49:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Servi-and-Servi-Mini.jpg https://bostonlifesciencestimes.com/2022/03/linkinvax-announces-a-collaboration-with-gtp-bioways-for-the-development-and-production-of-its-second-generation-vaccine-against-sars-cov-2/ 2022-03-15T15:52:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/LinKinVax.webp https://bostonlifesciencestimes.com/2022/03/vivasure-medical-announces-first-patient-treated-in-u-s-early-feasibility-study-evaluating-perqseal/ 2022-03-15T16:03:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/William-Gray-M.D..jpg https://bostonlifesciencestimes.com/2022/03/life-spine-announces-first-surgical-cases-of-dyna-link-titanium-with-barb-fixation/ 2022-03-15T16:05:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Life-Spine.jpg https://bostonlifesciencestimes.com/2022/03/metame-health-raises-2-2-million-to-bring-its-ibs-solution-to-market/ 2022-03-15T16:17:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/metaMe-Health.webp https://bostonlifesciencestimes.com/2022/03/amazon-commits-124-million-to-create-more-than-1000-affordable-homes-near-transit-stations-in-washington-states-puget-sound-region-and-the-arlington-virginia-region/ 2022-03-15T16:21:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/The-Margaux.jpg https://bostonlifesciencestimes.com/2022/03/nextgen-healthcare-teams-up-with-paralympic-medalist-amy-purdy-to-champion-whole-person-care/ 2022-03-15T16:32:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Amy-Purdy.jpg https://bostonlifesciencestimes.com/2022/03/bruker-appoints-philip-ma-to-its-board-of-directors/ 2022-03-16T14:19:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Dr.-Philip-Ma.jpg https://bostonlifesciencestimes.com/2022/03/biocoach-reaches-100-million-valuation-for-its-innovative-approach-to-digital-health-solutions/ 2022-03-16T14:29:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/LOGAN-DELGADO.webp https://bostonlifesciencestimes.com/2022/03/kayothera-inc-raises-8-million-in-series-a-financing-led-by-accelerator-life-science-partners-to-develop-novel-cancer-immunotherapeutics/ 2022-03-16T14:39:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/KayoThera.jpg https://bostonlifesciencestimes.com/2022/03/propanc-biopharmas-ceo-believes-proenzyme-therapy-may-become-the-healthcare-solution-of-choice-for-treating-cancerous-solid-tumors/ 2022-03-16T14:48:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Propanc-Biopharma.jpg https://bostonlifesciencestimes.com/2022/03/new-fully-customizable-electroporation-system-enables-large-scale-cell-therapy-development-and-clinical-manufacturing/ 2022-03-16T14:50:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Gibco-CTS-Xenon-Electroporation-System.jpg https://bostonlifesciencestimes.com/2022/03/orthofix-announces-fda-clearance-and-first-patient-cases-with-the-truelok-evo-ring-fixation-system/ 2022-03-16T14:52:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/The-TrueLok-EVO-system.jpg https://bostonlifesciencestimes.com/2022/03/frazier-life-sciences-closes-987-million-venture-fund-to-invest-in-companies-developing-novel-biopharmaceuticals/ 2022-03-16T14:58:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Patrick-Heron.jpg https://bostonlifesciencestimes.com/2022/03/jimmy-joy-eternal-to-launch-a-first-of-its-kind-fungi-based-complete-meal/ 2022-03-16T15:02:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Jimmy-Joy-Eternal.jpg https://bostonlifesciencestimes.com/2022/03/exactech-powers-new-ways-for-surgeons-to-connect-with-patients-through-exaccoach/ 2022-03-16T15:06:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/exacCoach.jpg https://bostonlifesciencestimes.com/2022/03/ge-healthcare-alivecor-partnership-aims-to-increase-convenience-for-patients-and-help-reduce-cardiac-related-hospitalizations-by-improving-the-quality-and-integration-of-patient-data/ 2022-03-16T15:10:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Patient-Data.jpg https://bostonlifesciencestimes.com/2022/03/minute-moleculars-dash-point-of-care-covid-19-rapid-pcr-test-gains-fda-emergency-use-authorization/ 2022-03-16T15:15:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/The-DASH-SARS.jpg https://bostonlifesciencestimes.com/2022/03/nj-biopharmaceuticals-llc-and-jeol-ltd-are-excited-to-announce-their-collaboration-to-bring-innovative-drug-discovery-platform-solutions-using-jeols-800-mhz-nmr/ 2022-03-17T15:02:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/JEOLs-800-MHz-NMR.jpg https://bostonlifesciencestimes.com/2022/03/physiq-and-cellcarta-collaborate-to-accelerate-a-more-precise-personalized-approach-to-vaccine-development/ 2022-03-17T15:04:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/physIQ.jpg https://bostonlifesciencestimes.com/2022/03/deepcell-raises-73-million-series-b-round-to-advance-its-ai-powered-single-cell-analysis-platform/ 2022-03-17T15:21:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Maddison-Masaeli.jpg https://bostonlifesciencestimes.com/2022/03/new-labcorp-offering-makes-detecting-measuring-unintentional-gluten-consumption-simple-and-effective/ 2022-03-17T15:23:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/LabCorp.jpg https://bostonlifesciencestimes.com/2022/03/cytovale-intellisep-test-demonstrates-potential-to-rapidly-risk-stratify-suspected-covid-19-patients-in-new-study/ 2022-03-17T15:27:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Screenshot-2022-03-17-at-11-25-14-Cytovale%E2%84%A2-IntelliSep%E2%84%A2-Test-Demonstrates-Potential-to-Rapidly-Risk-Stratify-Suspected-COVI...-e1647530805490.png https://bostonlifesciencestimes.com/2022/03/puretech-founded-entity-akili-appoints-game-industry-veteran-behind-bejeweled-plants-vs-zombies-as-chief-product-officer/ 2022-03-17T15:29:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Jon-David.jpg https://bostonlifesciencestimes.com/2022/03/biomind-labs-opens-a-new-clinical-psychedelic-research-facility/ 2022-03-17T15:32:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Biomind.jpg https://bostonlifesciencestimes.com/2022/03/medtex-ventures-raises-50-million-to-back-early-stage-medical-devices/ 2022-03-17T15:35:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/MedTex.jpg https://bostonlifesciencestimes.com/2022/03/pavmed-announces-successful-first-in-human-implantations-of-its-portio-intraosseous-infusion-system/ 2022-03-17T15:37:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/PAVmed.jpg https://bostonlifesciencestimes.com/2022/03/u-s-fda-approves-foundationonecdx-as-a-companion-diagnostic-for-egfr-therapeutics-targeting-exon-19-deletions-or-exon-21-substitutions-in-non-small-cell-lung-cancer/ 2022-03-17T15:41:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Screenshot-2022-03-17-at-11-39-48-Mia-Levy-Foundation-Medicine.png https://bostonlifesciencestimes.com/2022/03/m-booth-health-taps-creative-strategist-peter-matheson-gay-as-agencys-first-chief-impact-officer/ 2022-03-17T15:44:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Peter-Matheson-Gay.jpg https://bostonlifesciencestimes.com/2022/03/epistemix-releases-data-in-partnership-with-convene-on-covid-19-safety-for-in-person-meetings-and-events/ 2022-03-17T15:46:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Convene.jpg https://bostonlifesciencestimes.com/2022/03/heru-achieves-clinical-milestone-of-10000-patient-eyes-examined-with-award-winning-wearable-ar-vr-vision-diagnostic-platform/ 2022-03-18T16:13:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Heru-Inc..jpg https://bostonlifesciencestimes.com/2022/03/covid-19-vaccinations-remain-necessary-for-successful-organ-transplants/ 2022-03-18T16:17:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Dr.-Lewis-W.-Teperman.jpg https://bostonlifesciencestimes.com/2022/03/cellchorus-publishes-data-demonstrating-the-importance-of-t-cell-immunity-in-sars-cov-2/ 2022-03-21T14:49:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/CellChorus.jpg https://bostonlifesciencestimes.com/2022/03/integrated-dna-technologies-adds-mll-munich-leukemia-laboratory-to-align-program/ 2022-03-21T14:56:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Align-Program.jpg https://bostonlifesciencestimes.com/2022/03/maryland-tech-council-receives-2-45-million-in-federal-funds-to-propel-tech-life-sciences-innovation-in-maryland-with-biohub-maryland/ 2022-03-21T15:04:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Senator-Van-Hollen.jpg https://bostonlifesciencestimes.com/2022/03/34-of-doctors-worldwide-observed-increased-medical-errors-due-to-staffing-shortages-as-their-mental-health-suffers-says-survey-healthcare-global-report/ 2022-03-21T15:14:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Survey-Healthcare-Global.webp https://bostonlifesciencestimes.com/2022/03/the-conrad-prebys-foundation-to-support-the-discovery-and-development-of-personalized-aso-medicines-for-nano-rare-patients/ 2022-03-21T15:24:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Stanley-T.-Crooke.jpg https://bostonlifesciencestimes.com/2022/03/avacta-appoints-dr-christina-coughlin-as-non-executive-director/ 2022-03-21T15:41:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Dr-Christina-Coughlin.png https://bostonlifesciencestimes.com/2022/03/with-a-new-healthcare-brand-and-iso-certified-site-techmer-pm-has-much-to-discuss-at-mdm-west/ 2022-03-21T15:53:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/TechmerVision.jpg https://bostonlifesciencestimes.com/2022/03/whitney-dailey-joins-allisonpartners-as-executive-vice-president-purpose/ 2022-03-21T16:08:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Whitney-Dailey.jpg https://bostonlifesciencestimes.com/2022/03/virpax-completes-all-fda-required-pre-clinical-studies-for-epoladerm/ 2022-03-22T14:24:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Virpax%C2%AE-Pharmaceuticals.jpg https://bostonlifesciencestimes.com/2022/03/itm-receives-eur-33-million-equity-investment-to-advance-precision-oncology-pipeline-of-targeted-radiopharmaceuticals/ 2022-03-22T15:02:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/ITM-Isotope-Technologies.png https://bostonlifesciencestimes.com/2022/03/tae-technologies-announces-appointment-of-chief-science-officer-to-international-union-of-pure-and-applied-physics/ 2022-03-22T15:07:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Dr.-Toshi-Tajima.jpg https://bostonlifesciencestimes.com/2022/03/waters-introduces-faster-reliable-and-automated-solution-for-mass-and-purity-analysis-of-biomolecules/ 2022-03-22T15:11:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Waters-BioAccord-LC-MS.jpg https://bostonlifesciencestimes.com/2022/03/temperpack-accelerates-growth-with-140-million-in-new-funding-led-by-goldman-sachs-asset-management/ 2022-03-22T15:13:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/TemperPack.jpg https://bostonlifesciencestimes.com/2022/03/in-a-world-first-yokogawa-and-jsr-use-ai-to-autonomously-control-a-chemical-plant-for-35-consecutive-days/ 2022-03-22T15:16:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/JSR-chemical-plant.jpg https://bostonlifesciencestimes.com/2022/03/augmented-reality-medical-technology-company-immersivetouch-announces-strategic-collaboration-with-mayo-clinic/ 2022-03-22T15:22:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/ImmersiveTouch.jpg https://bostonlifesciencestimes.com/2022/03/livermultiscan-detected-earlier-stages-of-treatable-disease-in-patients-with-autoimmune-hepatitis-to-allow-tailored-treatment/ 2022-03-22T15:34:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Matt-Kelly-Chief-Innovation-Officer.jpg https://bostonlifesciencestimes.com/2022/03/medcase-offers-immediate-medical-assistance-to-ukrainian-refugees-across-neighboring-countries/ 2022-03-22T15:38:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Medcase-doctors.jpg https://bostonlifesciencestimes.com/2022/03/paige-launches-ai-software-to-enable-accurate-and-efficient-detection-of-breast-cancer-metastases-in-lymph-nodes/ 2022-03-22T15:49:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Paige-Breast-Lymph-Node.jpg https://bostonlifesciencestimes.com/2022/03/wellair-launches-a-new-advanced-air-cleaning-device-in-europe-with-independently-tested-industry-leading-99-9-effectiveness-against-airborne-pathogens/ 2022-03-22T15:54:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Screenshot-2022-03-22-at-11-53-02-WellAir-Launches-a-New-Advanced-Air-Cleaning-Device-in-Europe-with-Independently-Tested-Industry-Leading-99.9-Effectiveness-Against-Airborne-Pathogens.png https://bostonlifesciencestimes.com/2022/03/ecolab-celebrates-new-water-stewardship-certifications-on-world-water-day/ 2022-03-22T15:57:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Ecolab.jpg https://bostonlifesciencestimes.com/2022/03/cyclica-and-arctoris-to-expand-partnership-to-advance-drug-discovery-programs-for-alzheimers-disease/ 2022-03-23T14:50:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Cyclica.jpg https://bostonlifesciencestimes.com/2022/03/medx-health-appoints-new-ceo/ 2022-03-23T14:52:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/MedX-Health.jpg https://bostonlifesciencestimes.com/2022/03/eikon-therapeutics-announces-the-appointment-of-dr-roy-d-baynes-as-executive-vice-president-and-chief-medical-officer/ 2022-03-23T14:53:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Dr.-Roy-D.-Baynes.jpg https://bostonlifesciencestimes.com/2022/03/silence-therapeutics-and-mallinckrodt-announce-submission-of-clinical-trial-application-for-sln501/ 2022-03-23T14:57:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Silence-Therapeutics.jpg https://bostonlifesciencestimes.com/2022/03/thermo-fisher-scientific-to-support-national-program-to-accelerate-sars-cov-2-variant-identification/ 2022-03-23T15:00:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Thermo-Fisher.jpg https://bostonlifesciencestimes.com/2022/03/dubai-on-the-brain-neurovigils-philip-low-assembles-dream-team-to-launch-modern-neurotechnology-industry-expands-conglomerate-in-montreal-canada/ 2022-03-23T15:14:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Stephen-Hawking.jpg https://bostonlifesciencestimes.com/2022/03/ocelot-bio-closes-36-million-series-a-financing-appoints-katherine-vega-stultz-as-president-and-chief-executive-officer/ 2022-03-23T15:47:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Ocelot-Bio.jpg https://bostonlifesciencestimes.com/2022/03/vaxxas-licenses-hexapro-spike-glycoprotein-from-university-of-texas-at-austin-for-use-on-its-needle-free-vaccine-patches/ 2022-03-23T16:09:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Vaxxas-scaled-e1648051725314.jpg https://bostonlifesciencestimes.com/2022/03/covid-clinic-celebrates-three-months-of-helping-people-safely-attend-events-at-the-forum/ 2022-03-23T16:31:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Covid-Clinic.jpg https://bostonlifesciencestimes.com/2022/03/motorola-solutions-acquires-tetra-ireland-communications-the-provider-of-irelands-national-digital-radio-service/ 2022-03-23T16:37:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Motorola-Solutions.jpg https://bostonlifesciencestimes.com/2022/03/st-louis-county-missouri-leverages-bamboo-healths-prescription-drug-monitoring-program-for-safer-controlled-substance-prescriptions-and-dispensations/ 2022-03-23T16:39:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Bamboo-Health.jpg https://bostonlifesciencestimes.com/2022/03/bristol-myers-squibb-announces-new-prescription-drug-user-fee-act-goal-date-for-reblozyl-luspatercept-aamt-supplemental-biologics-license-application/ 2022-03-25T14:17:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Bristol-Myers-Squibb.jpg https://bostonlifesciencestimes.com/2022/03/angelini-pharma-a-new-partner-in-epilepsy/ 2022-03-25T14:21:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Angelini-Pharma.jpg https://bostonlifesciencestimes.com/2022/03/schrocken-strengthens-the-executive-team-and-board-as-it-gears-up-for-us-launch-and-raise-series-a-funding-round/ 2022-03-25T14:25:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Schrocken-Inc.png https://bostonlifesciencestimes.com/2022/03/scientists-identify-overgrowth-of-key-brain-structure-in-babies-who-later-develop-autism/ 2022-03-25T14:27:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Infants.jpg https://bostonlifesciencestimes.com/2022/03/34-of-doctors-worldwide-observed-increased-medical-errors-due-to-staffing-shortages-as-their-mental-health-suffers-says-survey-healthcare-global-report-2/ 2022-03-25T14:33:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Survey-Healthcare-Global.webp https://bostonlifesciencestimes.com/2022/03/orcosa-comments-on-positive-results-of-nyu-langones-phase-1-2-clinical-trial-utilizing-oravexx/ 2022-03-25T14:39:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Orcosa.jpg https://bostonlifesciencestimes.com/2022/03/ipsen-receives-positive-chmp-opinion-for-cabometyx-in-radioactive-iodine-refractory-differentiated-thyroid-cancer/ 2022-03-25T14:53:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Ipsen.jpg https://bostonlifesciencestimes.com/2022/03/carvykti-ciltacabtagene-autoleucel-receives-positive-chmp-opinion-for-the-treatment-of-patients-with-relapsed-and-refractory-multiple-myeloma/ 2022-03-25T14:58:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Legend-Biotech.jpg https://bostonlifesciencestimes.com/2022/03/lazurites-arthrofree-wireless-camera-system-for-minimally-invasive-surgery-receives-fda-market-clearance/ 2022-03-25T15:08:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/ArthroFree%E2%84%A2-System.jpg https://bostonlifesciencestimes.com/2022/03/renovacor-announces-the-appointment-of-fred-driscoll-as-chief-financial-officer/ 2022-03-28T13:19:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Renovacor.jpg https://bostonlifesciencestimes.com/2022/03/first-patient-dosed-in-can106-phase-1b-2-trial-for-treatment-of-paroxysmal-nocturnal-hemoglobinuria-pnh-in-china/ 2022-03-28T13:21:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/CANbridge-Pharmaceuticals.jpg https://bostonlifesciencestimes.com/2022/03/eckuity-moves-to-disrupt-manufacturing-in-the-300-billion-biologics-market-with-an-investment-in-mobius-biomedical/ 2022-03-28T13:28:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Eckuity.jpg https://bostonlifesciencestimes.com/2022/03/charles-river-laboratories-to-appoint-flavia-h-pease-as-chief-financial-officer/ 2022-03-28T13:32:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Charles-River-Laboratories.jpg https://bostonlifesciencestimes.com/2022/03/alzamend-neuro-announces-full-data-set-from-phase-1-first-in-human-clinical-trial-for-al001-treatment-of-dementia-related-to-alzheimers/ 2022-03-28T13:50:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Alzamend-Neuro.png https://bostonlifesciencestimes.com/2022/03/the-medi-globe-group-opens-the-mgg-campus-a-new-training-and-virtual-test-laboratory/ 2022-03-28T13:54:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/MGG-Campus.jpg https://bostonlifesciencestimes.com/2022/03/new-study-finds-that-noninvasive-and-continuous-hemoglobin-improved-transfusion-management-and-outcomes-in-pediatric-patients/ 2022-03-28T13:58:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Masimo-Radical-7.jpg https://bostonlifesciencestimes.com/2022/03/staar-surgical-announces-u-s-fda-approval-of-evo-visian-implantable-collamer-lenses/ 2022-03-28T14:14:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/EVO-Visian-ICL.jpg https://bostonlifesciencestimes.com/2022/03/shorla-oncology-appoints-dennis-purcell-as-chairman-of-the-board-of-directors/ 2022-03-29T13:32:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Dennis-Purcell.jpg https://bostonlifesciencestimes.com/2022/03/urogen-announces-fda-clearance-of-ind-application-for-the-investigational-immunotherapy-ugn-301-zalifrelimab-intravesical-solution-in-recurrent-non-muscle-invasive-bladder-cancer/ 2022-03-29T13:38:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Screenshot-2022-02-03-at-10-23-59-Leadership-Team-UroGen-Pharma.png https://bostonlifesciencestimes.com/2022/03/appili-therapeutics-announces-non-convertible-secured-loan-of-us3-6-million-and-license-and-distribution-agreement-with-long-zone-holdings/ 2022-03-29T13:45:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Appili-Therapeutics.jpg https://bostonlifesciencestimes.com/2022/03/mercator-data-shows-netherlands-best-base-for-international-pharmaceutical-companies/ 2022-03-29T14:17:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Kariem-Abdellatif.jpg https://bostonlifesciencestimes.com/2022/03/thermo-fisher-scientific-launches-ce-ivd-marked-next-generation-sequencing-instrument-for-use-in-clinical-labs/ 2022-03-29T14:38:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Thermo-Fisher-1.jpg https://bostonlifesciencestimes.com/2022/03/scientist-com-expands-science-as-a-service-platform-with-acquisition-of-notch8/ 2022-03-29T14:51:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Rob-Kaufman.png https://bostonlifesciencestimes.com/2022/03/curi-bio-acquires-cartox-technology-from-stembiosys-announces-launch-of-nautilus-optical-mapping-system/ 2022-03-29T14:58:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Baseline-Human-Atrial-hiPSC-CMs.gif https://bostonlifesciencestimes.com/2022/03/fda-grants-orphan-drug-designation-to-noxopharm-for-sarcoma-treatment/ 2022-03-29T15:02:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Noxopharm.png https://bostonlifesciencestimes.com/2022/03/small-healthcare-practices-are-at-greater-risk-of-cyberattacks-according-to-software-advice-research/ 2022-03-29T15:11:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Software-Advice.jpg https://bostonlifesciencestimes.com/2022/03/blue-bird-receives-largest-single-order-of-electric-school-buses-in-its-history/ 2022-03-29T15:14:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Blue-Bird.jpg https://bostonlifesciencestimes.com/2022/03/pfizer-and-biontech-receive-expanded-u-s-emergency-use-authorization-for-an-additional-covid-19-vaccine-booster-in-individuals-aged-50-years-and-older/ 2022-03-29T15:15:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Pfizer.jpg https://bostonlifesciencestimes.com/2022/03/onehsn-delivers-the-easiest-way-for-parents-to-find-child-care-in-ontario-with-launch-of-mobile-app/ 2022-03-29T15:17:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/OneHSN.jpg https://bostonlifesciencestimes.com/2022/03/prestige-biopharma-enters-mou-with-vaxine-for-supply-of-covid-19-vaccine-and-co-development-of-covid-19-influenza-combo-vaccine/ 2022-03-29T15:20:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Prestige-Biopharma.jpg https://bostonlifesciencestimes.com/2022/03/voxneuro-announces-significant-milestones-as-it-embarks-on-its-mission-to-become-the-brain-company/ 2022-03-30T13:36:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Jason-Flowerday.jpg https://bostonlifesciencestimes.com/2022/03/vivosense-announces-closing-of-25m-series-a-financing/ 2022-03-30T13:38:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/VivoSense.jpg https://bostonlifesciencestimes.com/2022/03/linus-health-announces-acquisition-of-kinesis-health-technologies/ 2022-03-30T13:41:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/David-Bates-PhD.jpg https://bostonlifesciencestimes.com/2022/03/thermo-fisher-scientifics-ppd-clinical-research-business-earns-topra-award-for-regulatory-affairs-excellence-in-supporting-novavaxs-covid-19-vaccine-approval/ 2022-03-30T13:44:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Thermo-Fisher.jpg https://bostonlifesciencestimes.com/2022/03/fda-clears-realta-life-sciences-phase-2-star-trial-of-rls-0071-in-neonates-with-hypoxic-ischemic-encephalopathy/ 2022-03-30T13:46:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Ulrich-Thienel-M.D.-Ph.D..jpg https://bostonlifesciencestimes.com/2022/03/x-chems-noor-shaker-awarded-for-achievements-in-ai-for-drug-discovery/ 2022-03-30T13:51:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Noor-Shaker.jpg https://bostonlifesciencestimes.com/2022/03/namsa-to-acquire-european-based-medanex-clinic-to-expand-early-stage-preclinical-research-capabilities/ 2022-03-30T13:55:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/NAMSA.png https://bostonlifesciencestimes.com/2022/03/altoida-upsizes-its-series-a-round-to-20-3m-to-advance-its-first-in-class-ai-powered-neurocognitive-assessment-platform/ 2022-03-30T13:58:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Altoida.jpg https://bostonlifesciencestimes.com/2022/03/contraline-appoints-medical-device-industry-leader-dr-yelena-tropsha-as-chief-technology-officer/ 2022-03-30T14:22:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Dr.-Yelena-Tropsha.jpg https://bostonlifesciencestimes.com/2022/03/mojo-vision-reaches-significant-development-milestone-for-smart-contact-lens/ 2022-03-30T14:31:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/New-Mojo-Lens-prototype.jpg https://bostonlifesciencestimes.com/2022/03/sonoma-pharmaceuticals-launches-new-urinary-tract-infection-product-through-distributors-in-new-zealand-australia-and-south-africa/ 2022-03-30T14:35:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Sonoma-Pharmaceuticals.jpg https://bostonlifesciencestimes.com/2022/03/eikon-therapeutics-announces-the-election-of-kenneth-c-frazier-to-its-board-of-directors/ 2022-03-31T14:17:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Kenneth-C.-Frazier.jpg https://bostonlifesciencestimes.com/2022/03/waters-introduces-xevo-tq-absolute-the-most-sensitive-and-compact-benchtop-tandem-quadrupole-mass-spectrometer/ 2022-03-31T14:24:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Waters-Xevo-TQ-Absolute.jpg https://bostonlifesciencestimes.com/2022/03/neospectra-by-si-ware-and-nutricontrol-to-provide-customers-with-improved-solutions-for-accurate-in-field-materials-analysis/ 2022-03-31T14:26:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/NeoSpectra-Scanner.jpg https://bostonlifesciencestimes.com/2022/03/thomas-h-lee-partners-acquires-intelligent-medical-objects/ 2022-03-31T14:29:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Intelligent-Medical-Objects.jpg https://bostonlifesciencestimes.com/2022/03/exactech-celebrates-15-years-of-clinical-use-equinoxe-reverse-shoulder/ 2022-03-31T14:33:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Equinoxe%C2%AE-Reverse-Shoulder.jpg https://bostonlifesciencestimes.com/2022/03/freudenberg-medical-operations-worldwide-now-iso-14001-certified/ 2022-03-31T14:37:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Visual-inspection.jpg https://bostonlifesciencestimes.com/2022/03/cybin-announces-initiation-of-kernel-flow-feasibility-study-measuring-psychedelic-effects-on-the-brain/ 2022-03-31T14:41:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Doug-Drysdale.png https://bostonlifesciencestimes.com/2022/03/exactech-announces-key-leadership-changes/ 2022-03-31T15:16:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Jeffrey-R.-Binder.jpg https://bostonlifesciencestimes.com/2022/03/vizient-medical-device-tech-watch-provides-trends-in-transcatheter-valve-replacement-and-a-model-for-assessing-new-technology-in-musculoskeletal-care/ 2022-03-31T15:19:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Vizient-Medical-Device-Tech-Watch.jpg https://bostonlifesciencestimes.com/2022/03/athenahealth-addresses-the-needs-of-transgender-and-gender-diverse-patients-with-improved-gender-affirming-care-product-functionality/ 2022-03-31T15:21:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/athenahealth.png https://bostonlifesciencestimes.com/2022/03/fort-bend-isd-partners-with-r-zero-to-deploy-sustainable-uv-c-technology-across-the-district-protecting-over-90000-students-and-staff/ 2022-03-31T15:25:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/R-Zero-Arc.jpg https://bostonlifesciencestimes.com/2022/03/videahealth-raises-20-million-to-expand-ai-in-the-dentists-chair-for-millions-of-patients/ 2022-03-31T15:28:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/VideaHealth.jpg https://bostonlifesciencestimes.com/2022/04/cenobamate-ontozry-for-the-treatment-of-drug-resistant-focal-onset-seizures-in-adults-is-now-available-in-the-netherlands/ 2022-04-01T14:26:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Angelini-Pharma.jpg https://bostonlifesciencestimes.com/2022/04/bayer-set-to-drive-breakthrough-innovations-in-the-life-sciences/ 2022-04-01T14:28:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Bayer.jpg https://bostonlifesciencestimes.com/2022/04/assure-wearable-cardioverter-defibrillator-wcd-system-demonstrates-low-false-alarm-rates-high-patient-compliance-in-clinical-study/ 2022-04-01T14:31:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/The-ASSURE-Wearable-Defibrillator.jpg https://bostonlifesciencestimes.com/2022/04/spacelabs-healthcare-showcases-new-products-at-upcoming-american-college-of-cardiology-scientific-sessions-and-expo/ 2022-04-01T14:34:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Shalabh-Chandra.jpg https://bostonlifesciencestimes.com/2022/04/henry-schein-promotes-jennifer-ferrero-to-corporate-secretary/ 2022-04-01T14:36:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Jennifer-Ferrero.jpg https://bostonlifesciencestimes.com/2022/04/mednow-closes-previously-announced-acquisition-of-pharmacy-in-toronto/ 2022-04-01T14:38:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Mednow.jpg https://bostonlifesciencestimes.com/2022/04/ventus-therapeutics-appoints-victor-lobanov-phd-as-head-of-computational-sciences/ 2022-04-04T13:56:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Victor-Lobanov-PhD.jpg https://bostonlifesciencestimes.com/2022/04/genialis-responderid-to-use-xerna-tme-panel-to-improve-targeted-therapy-selection/ 2022-04-04T14:00:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Rafael-Rosengarten-Ph.D..jpg https://bostonlifesciencestimes.com/2022/04/bruker-expands-dia-pasef-on-the-timstof-4d-proteomics-and-epiproteomics-platform-to-identify-up-to-13000-protein-groups-with-1-fdr/ 2022-04-04T14:04:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Bruker.jpg https://bostonlifesciencestimes.com/2022/04/adaptive-phage-therapeutics-extends-series-b-to-61-million-with-addition-of-the-amr-action-fund/ 2022-04-04T14:11:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Adaptive-Phage-Therapeutics.jpg https://bostonlifesciencestimes.com/2022/04/venatorx-pharmaceuticals-raises-series-c-financing-led-by-the-amr-action-fund/ 2022-04-04T14:17:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Christopher-J.-Burns-Ph.D..jpg https://bostonlifesciencestimes.com/2022/04/biomed-realty-acquires-largest-life-science-and-office-campus-in-boulder-colorado/ 2022-04-04T14:23:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/5505-CENTRAL-AVE.jpg https://bostonlifesciencestimes.com/2022/04/new-trace-level-online-silica-analyzer-improves-reliability-of-process-water-monitoring/ 2022-04-04T14:26:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Orion-8030cX-Silica-Analyzer.jpg https://bostonlifesciencestimes.com/2022/04/realta-life-sciences-rls-0071-demonstrates-excellent-safety-profile-and-confirmed-target-engagement-in-first-in-human-phase-1-clinical-trial/ 2022-04-04T14:29:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Ulrich-Thienel-M.D.-Ph.D..jpg https://bostonlifesciencestimes.com/2022/04/perkinelmer-introduces-first-ready-to-use-htrf-and-alphalisa-assay-kits-for-cho-hcp-impurities-detection-and-quantification/ 2022-04-04T14:32:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/1200px-PerkinElmer_logo.svg_.png https://bostonlifesciencestimes.com/2022/04/blade-therapeutics-announces-feedback-from-fda-on-end-of-phase-1-data-package/ 2022-04-04T14:34:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Wendye-Robbins-M.D.jpg https://bostonlifesciencestimes.com/2022/04/rallybio-appoints-christine-a-nash-and-hui-liu-ph-d-to-its-board-of-directors/ 2022-04-04T14:39:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Rallybio.jpg https://bostonlifesciencestimes.com/2022/04/alzamend-neuro-appoints-dr-terri-hunter-to-its-scientific-advisory-board/ 2022-04-04T14:44:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Dr.-Terri-Hunter.jpg https://bostonlifesciencestimes.com/2022/04/alnylam-announces-3-month-extension-of-review-period-for-new-drug-application-for-vutrisiran/ 2022-04-04T14:46:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Alnylam-Ranks.jpg https://bostonlifesciencestimes.com/2022/04/medx-health-corp-signs-commercial-distribution-agreement-with-vitamed-biomedical-to-launch-medxs-teledermatology-screening-platform-in-italy/ 2022-04-04T14:50:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/MedX-Health-Corp.jpg https://bostonlifesciencestimes.com/2022/04/techmer-pm-targeting-the-medical-device-sector-with-its-proven-trusted-materials-design-expertise/ 2022-04-04T14:54:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/TechmerVision.jpg https://bostonlifesciencestimes.com/2022/04/caire-celebrates-20th-anniversary-of-launch-of-the-first-portable-oxygen-concentrator/ 2022-04-04T14:55:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/CAIRE.jpg https://bostonlifesciencestimes.com/2022/04/feops-heartguide-receives-fda-clearance-for-laao-planning-capabilities/ 2022-04-04T14:57:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Dr-Devi-Nair-Director-of-the-Electrophysiology.jpg https://bostonlifesciencestimes.com/2022/04/henry-schein-announces-retirement-of-chief-administrative-officer-and-appoints-chief-operating-officer/ 2022-04-04T15:06:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Gerald-A.-Benjamin.jpg https://bostonlifesciencestimes.com/2022/04/alira-health-strengthens-clinical-operations-with-the-acquisition-of-sourcia/ 2022-04-05T14:04:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Benjamin-Chambon.jpg https://bostonlifesciencestimes.com/2022/04/newamsterdam-pharma-doses-first-patient-in-phase-2-trial-of-obicetrapib-in-combination-with-ezetimibe-as-an-adjunct-to-high-intensity-statin-therapy/ 2022-04-05T14:10:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Screenshot-2022-04-05-at-10-08-23-About-Us-%E2%80%94-New-Amsterdam-Pharma.png https://bostonlifesciencestimes.com/2022/04/bruker-acquires-optimal-companies-for-pharma-pat-software-and-biopharma-manufacturing-automation-expertise-and-technologies/ 2022-04-05T14:16:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Optimal-PAT.jpg https://bostonlifesciencestimes.com/2022/04/micreos-pharmaceuticals-welcomes-trine-ahlgreen-and-carsten-edwards-to-its-executive-team-to-accelerate-its-next-phase-of-development/ 2022-04-05T14:28:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Trine-Ahlgreen-and-Carsten-Edwards.jpg https://bostonlifesciencestimes.com/2022/04/clarify-health-closes-150m-series-d-funding-to-unlock-the-promise-of-value-based-care-with-end-to-end-intelligence-on-every-patient-journey/ 2022-04-05T14:35:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Todd-Gottula.jpg https://bostonlifesciencestimes.com/2022/04/christina-hughes-joins-reverba-as-chief-operating-officer/ 2022-04-05T14:38:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Reverba.jpg https://bostonlifesciencestimes.com/2022/04/portal-innovations-expands-venture-development-platform-to-atlanta/ 2022-04-05T15:27:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/John-Flavin.jpg https://bostonlifesciencestimes.com/2022/04/binx-health-appoints-life-sciences-veteran-jack-crowley-as-chief-financial-officer/ 2022-04-05T15:45:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Jack-Crowley.webp https://bostonlifesciencestimes.com/2022/04/thermo-fisher-scientific-launches-user-friendly-raman-spectroscopic-analyzer/ 2022-04-05T15:48:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Ramina-Process-Analyzer.jpg https://bostonlifesciencestimes.com/2022/04/fda-clears-instrusafe-instrument-protection-system-for-use-in-sterizone-vp4-sterilization-cycle-i/ 2022-04-05T16:34:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/InstruSafe.png https://bostonlifesciencestimes.com/2022/04/baxter-announces-u-s-fda-clearance-of-st-set-used-to-help-treat-acute-kidney-injury-patients-in-the-hospital/ 2022-04-05T16:35:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Baxter.jpg https://bostonlifesciencestimes.com/2022/04/ra-medical-systems-granted-u-s-patent-for-laser-ablation-catheters-with-expanded-ablation-area/ 2022-04-05T16:39:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Will-McGuire.jpg https://bostonlifesciencestimes.com/2022/04/minnesota-commits-25-million-for-als-research-and-caregiving/ 2022-04-05T16:59:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/ALS-Association.png https://bostonlifesciencestimes.com/2022/04/aizon-partners-with-tetrascience-to-help-pharmaceutical-customers-increase-the-speed-and-efficiency-of-drug-manufacturing/ 2022-04-06T13:58:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Aizon.jpg https://bostonlifesciencestimes.com/2022/04/ultomiris-ravulizumab-cwvz-demonstrated-sustained-improvements-in-functional-activities-and-quality-of-life-in-adults-with-generalized-myasthenia-gravis-through-60-weeks/ 2022-04-06T14:00:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/AstraZeneca-India.jpg https://bostonlifesciencestimes.com/2022/04/microba-appoints-therapeutics-head/ 2022-04-06T14:04:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Professor-Trent-Munro.jpg https://bostonlifesciencestimes.com/2022/04/third-harmonic-bio-strengthens-management-team-with-addition-of-adrian-s-ray-ph-d-as-chief-scientific-officer/ 2022-04-06T14:30:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Third-Harmonic-Bio.jpg https://bostonlifesciencestimes.com/2022/04/tegmine-therapeutics-announces-collaboration-with-alloy-therapeutics-to-advance-solid-tumor-treatment/ 2022-04-06T14:43:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Tegmine-Therapeutics.jpg https://bostonlifesciencestimes.com/2022/04/usound-introduces-patient-safe-mems-loudspeaker-for-mri-compatible-headphones/ 2022-04-06T14:55:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/USound-MEMS.jpg https://bostonlifesciencestimes.com/2022/04/paige-earns-ce-ivd-and-ukca-marks-for-clinical-ai-application-to-detect-breast-cancer-metastases-in-lymph-nodes/ 2022-04-06T14:58:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Paige.jpg https://bostonlifesciencestimes.com/2022/04/lendlease-partners-with-ameresco-for-102-million-clean-energy-modernization-project-at-hickam-communities/ 2022-04-06T15:06:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Ameresco-Inc.jpeg https://bostonlifesciencestimes.com/2022/04/covid-clinic-surpasses-6-8-million-covid-tests-administered-across-the-us/ 2022-04-06T15:09:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Covid-Clinic.jpg https://bostonlifesciencestimes.com/2022/04/swedens-bluewater-merges-with-denver-based-flowater-creating-global-powerhouse-in-drinking-water-purification/ 2022-04-06T15:12:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/FloWater-Refill-Station.jpg https://bostonlifesciencestimes.com/2022/04/pregistry-shares-lessons-learned-with-the-international-registry-of-coronavirus-exposure-in-pregnancy/ 2022-04-06T15:15:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Pregistry.jpg https://bostonlifesciencestimes.com/2022/04/happify-health-research-shows-impact-of-digital-interventions-to-improve-anxiety-symptoms-well-being-in-psoriasis-patients/ 2022-04-07T13:56:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Happify-Health.jpg https://bostonlifesciencestimes.com/2022/04/meiji-seika-pharma-first-patient-dosed-in-phase-ii-study-of-me3183-a-selective-pde4-inhibitor-in-patients-with-plaque-psoriasis-in-the-united-states-and-canada/ 2022-04-07T13:59:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Meiji-Seika-Pharma.jpg https://bostonlifesciencestimes.com/2022/04/medable-names-veteran-saas-finance-executive-mike-kourey-to-its-board-of-directors/ 2022-04-07T14:04:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Mike-Kourey.jpg https://bostonlifesciencestimes.com/2022/04/codetta-biosciences-announces-15-million-in-series-a-financing/ 2022-04-07T14:06:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Codetta-Biosciences.jpg https://bostonlifesciencestimes.com/2022/04/receptor-life-sciences-secures-9-7-million-financing-to-advance-rls103-inhaled-dry-powder-cbd-into-clinical-trials/ 2022-04-07T14:10:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Mark-Theeuwes.jpg https://bostonlifesciencestimes.com/2022/04/andera-partners-to-sell-its-life-sciences-portfolio-company-reviral-to-pfizer/ 2022-04-07T14:12:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Andera-Partners.jpg https://bostonlifesciencestimes.com/2022/04/onxeo-appoints-dr-shefali-agarwal-as-president-and-chief-executive-officer/ 2022-04-07T14:15:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Dr.-Shefali-Agarwal.jpg https://bostonlifesciencestimes.com/2022/04/vein-visualization-leader-sponsors-symposium-at-the-american-organization-for-nursing-leadership/ 2022-04-07T14:19:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Vein-Visualization.jpg https://bostonlifesciencestimes.com/2022/04/semtechs-blueriver-platform-provides-near-zero-latency-video-for-jam-labs-surgical-displays/ 2022-04-07T14:21:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Semtechs-BlueRiver.jpg https://bostonlifesciencestimes.com/2022/04/jadak-launches-thingmagic-m7e-pico-smallest-uhf-rfid-module-on-the-market-using-impinj-e310-rain-rfid-reader-chip/ 2022-04-07T14:22:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/ThingMagic-M7e-Pico-UHF-RAIN-RFID-Module.jpg https://bostonlifesciencestimes.com/2022/04/aatru-medical-announces-latin-america-distribution-agreement-for-their-innovative-npsims-negative-pressure-surgical-incision-management-system/ 2022-04-07T14:24:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/NPSIMS-Surgical-Incision-Management-System.jpg https://bostonlifesciencestimes.com/2022/04/kinnos-highlight-product-achieves-global-biorisk-prevention-accreditation/ 2022-04-07T14:27:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Kinnos.jpg https://bostonlifesciencestimes.com/2022/04/additional-100-million-investment-in-housing-bolsters-unitedhealth-groups-efforts-to-address-social-determinants-and-achieve-better-health-outcomes/ 2022-04-07T14:28:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/UnitedHealth-Group.png https://bostonlifesciencestimes.com/2022/04/nikang-therapeutics-presents-preclinical-data-highlighting-nkt2152s-therapeutic-potential-in-clear-cell-renal-cell-carcinoma-ccrcc-and-solid-tumors-beyond-ccrcc/ 2022-04-08T14:41:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/NiKang-Therapeutics.jpg https://bostonlifesciencestimes.com/2022/04/i-vasc-srl-announces-achievement-of-18m-e-series-a-investment-to-launch-its-product-velex-a-device-for-the-treatment-of-chronic-venous-insufficiency-cvi/ 2022-04-08T14:48:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Mario-Salerno.jpg https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/VELEX.jpg https://bostonlifesciencestimes.com/2022/04/orthofix-announces-new-business-unit-president/ 2022-04-08T14:51:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Kimberly-Elting.jpg https://bostonlifesciencestimes.com/2022/04/lucy-therapeutics-receives-4-9-million-grant-from-michael-j-fox-foundation/ 2022-04-11T13:55:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Amy-Ripka-PhD.webp https://bostonlifesciencestimes.com/2022/04/vesigen-therapeutics-appoints-paulash-mohsen-as-chief-executive-officer/ 2022-04-11T13:57:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Vesigen-Therapeutics.png https://bostonlifesciencestimes.com/2022/04/spruce-biosciences-appoints-libbie-mansell-ph-d-m-b-a-r-a-c-as-chief-regulatory-and-quality-officer/ 2022-04-11T14:03:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Libbie-Mansell-Ph.D.-M.B.A.-R.A.C..jpg https://bostonlifesciencestimes.com/2022/04/checkerspot-and-dic-corporation-announce-joint-development-agreement-to-bring-the-power-of-microalgae-to-skin-care-using-the-wing-platform/ 2022-04-11T14:18:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/large-oil-droplets.jpg https://bostonlifesciencestimes.com/2022/04/ansa-biotechnologies-closes-oversubscribed-68-million-series-a-financing-to-power-the-next-era-of-dna-enabled-industries/ 2022-04-11T14:22:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Daniel-Lin-Arlow-Ph.D..jpg https://bostonlifesciencestimes.com/2022/04/the-access-to-advanced-health-institute-receives-26-million-donation-from-the-chan-soon-shiong-family-foundation-to-further-develop-immune-enhancing-platform-technology/ 2022-04-11T14:26:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Corey-Casper-MD-MPH.jpg https://bostonlifesciencestimes.com/2022/04/omnivision-launches-ready-to-go-reference-designs-for-high-definition-video-single-use-laryngoscopes/ 2022-04-11T14:31:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Laryngoscopes.jpg https://bostonlifesciencestimes.com/2022/04/phablecare-raises-inr-187-cr-usd-25-m-in-series-b-funding/ 2022-04-11T14:35:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Sumit-Sinha-and-Mukesh-Bansa.jpg https://bostonlifesciencestimes.com/2022/04/wallbox-enters-first-phase-of-build-out-for-its-u-s-ev-charger-manufacturing-facility/ 2022-04-11T14:39:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Wallbox.png https://bostonlifesciencestimes.com/2022/04/healthcare-venture-fund-wavemaker-three-sixty-health-announces-new-venture-partner-monica-jain-m-d/ 2022-04-12T14:39:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Monica-Jain-M.D..jpg https://bostonlifesciencestimes.com/2022/04/design-pharmaceuticals-closes-5-million-pre-series-a-round-to-accelerate-commercialization-of-ultrahigh-throughput-drug-discovery-platform/ 2022-04-12T14:43:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Dirk-Loeffert.jpg https://bostonlifesciencestimes.com/2022/04/aurion-biotech-raises-120-million-from-deerfield-management-petrichor-flying-l-partners-falcon-vision-kkr-and-visionary-ventures/ 2022-04-12T15:00:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Andrew-ElBardissi-M.D.webp https://bostonlifesciencestimes.com/2022/04/ascellahealths-hub-solutions-for-life-sciences-ensures-specialty-product-access-and-market-entry-optimizes-outcomes-for-rare-disease-patients/ 2022-04-12T15:35:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Dea-Belazi.jpg https://bostonlifesciencestimes.com/2022/04/assure-wearable-cardioverter-defibrillator-wcd-system-earns-2022-medical-design-excellence-award/ 2022-04-12T15:48:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/ASSURE-Wearable-Cardioverter-Defibrillator.jpg https://bostonlifesciencestimes.com/2022/04/governor-deval-patrick-to-speak-at-massbios-annual-state-of-possible-conference/ 2022-04-12T15:54:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Deval-Patrick.jpg https://bostonlifesciencestimes.com/2022/04/atricure-launches-encompass-clamp-a-part-of-isolator-synergy-ablation-system/ 2022-04-12T16:05:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/AtriCure.jpg https://bostonlifesciencestimes.com/2022/04/alucent-biomedical-announces-first-patient-enrolled-in-first-in-human-natural-vascular-scaffolding-clinical-trial/ 2022-04-12T16:07:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Alucent-Biomedical.jpg https://bostonlifesciencestimes.com/2022/04/vistagen-and-affamed-complete-key-regulatory-submissions-for-palisade-global-phase-3-clinical-trial-for-ph94b/ 2022-04-12T16:15:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/VistaGen.jpg https://bostonlifesciencestimes.com/2022/04/richard-green-joins-dorseys-salt-lake-city-office/ 2022-04-12T16:19:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Richard-Green.jpg https://bostonlifesciencestimes.com/2022/04/professional-golfer-james-hahn-partners-with-ibsa-pharma-inc-to-promote-licart/ 2022-04-13T14:21:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/James-Hahn.jpg https://bostonlifesciencestimes.com/2022/04/qpiai-and-quantrolox-sign-a-mou-to-jointly-develop-indias-first-25-qubit-quantum-computing-testbed-and-offerings-for-the-european-and-indian-markets/ 2022-04-13T14:24:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Dr-Nagendra-Nagaraja.jpg https://bostonlifesciencestimes.com/2022/04/spikimm-a-biotech-company-founded-by-truffle-capital-and-institut-pasteur-announces-that-its-monoclonal-antibody-neutralises-all-sars-cov-2-variants-of-concern/ 2022-04-13T14:29:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Philippe-Pouletty-MD.webp https://bostonlifesciencestimes.com/2022/04/seismic-therapeutic-appoints-eric-larson-as-senior-vice-president-of-finance-and-heather-vital-as-vice-president-of-rd-strategy/ 2022-04-13T14:34:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Eric-Larson.png https://bostonlifesciencestimes.com/2022/04/syneurx-reaches-target-enrollment-in-phase-2-clinical-trial-of-covid-19-oral-antiviral-candidate-pentarlandir/ 2022-04-13T14:37:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/SyneuRx.webp https://bostonlifesciencestimes.com/2022/04/pharmacyte-biotech-to-accelerate-preparations-for-start-of-pancreatic-cancer-clinical-trial/ 2022-04-13T14:38:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/PharmaCyte-Biotech.jpg https://bostonlifesciencestimes.com/2022/04/sampling-human-raises-2-million-to-support-the-development-of-engineered-cells-for-single-cell-analysis/ 2022-04-13T14:48:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Screenshot-2022-04-13-at-10-47-13-About-Us-Sampling-Human.png https://bostonlifesciencestimes.com/2022/04/bolstered-by-investment-pictor-partners-with-mobility-health-to-offer-pictarray-sars-cov-2-antibody-test-indicating-whether-patients-require-covid-19-booster/ 2022-04-13T14:52:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/pictor-biotech.webp https://bostonlifesciencestimes.com/2022/04/jeito-capital-co-leads-76-million-series-a-financing-for-cdr-life-its-10th-investment-since-its-launch/ 2022-04-13T14:55:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Screenshot-2022-04-13-at-10-54-33-The-team-Jeito.png https://bostonlifesciencestimes.com/2022/04/lazurite-announces-agreement-with-champs-group-purchasing/ 2022-04-13T15:09:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/The-Center-for-Health-Affairs.jpg https://bostonlifesciencestimes.com/2022/04/wave-neuroscience-partners-with-arkos-health-to-expand-bring-braincare-optimization-services-to-arizona-residents/ 2022-04-13T15:22:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Arkos-Health.jpg https://bostonlifesciencestimes.com/2022/04/pear-therapeutics-receives-safer-technologies-program-step-designation-from-fda-for-product-candidate-to-treat-acute-and-chronic-pain/ 2022-04-13T15:26:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Screenshot-2022-04-13-at-11-25-09-Yuri-Maricich-Pear-Therapeutics.png https://bostonlifesciencestimes.com/2022/04/chargepoint-and-colorado-energy-office-announce-the-completion-of-fast-charging-corridor-along-highway-40/ 2022-04-13T15:28:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/ChargePoint.jpg https://bostonlifesciencestimes.com/2022/04/gsk-reaches-agreement-to-acquire-late-stage-biopharmaceutical-company-sierra-oncology-for-1-9bn/ 2022-04-13T15:31:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Sierra-Oncology.jpg https://bostonlifesciencestimes.com/2022/04/pfizer-and-biontech-announce-data-demonstrating-high-immune-response-following-a-booster-dose-of-their-covid-19-vaccine-in-children-5-through-11-years-of-age/ 2022-04-14T14:34:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Pfizer.jpg https://bostonlifesciencestimes.com/2022/04/upstream-moves-to-the-innovaccer-health-cloud-to-accelerate-transformation-of-u-s-healthcare/ 2022-04-14T14:53:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Lucas-Sahm.png https://bostonlifesciencestimes.com/2022/04/moderna-and-thermo-fisher-scientific-honored-for-covid-19-vaccine-efforts/ 2022-04-14T14:59:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Moderna.jpg https://bostonlifesciencestimes.com/2022/04/be-bio-closes-130-million-financing-to-pioneer-engineered-b-cells-a-new-class-of-cellular-medicines/ 2022-04-14T15:24:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Be-Biopharma.jpg https://bostonlifesciencestimes.com/2022/04/alzheon-appoints-susan-flint-as-vice-president-of-clinical-operations-patrick-kesslak-phd-as-vice-president-of-clinical-development-medical-affairs-and-erwan-de-naurois-as-vice-president-of-fina/ 2022-04-14T15:36:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Susan-Flint.jpg https://bostonlifesciencestimes.com/2022/04/purigen-biosystems-expands-commercial-presence-in-european-union-with-gc-biotech-distribution-agreement/ 2022-04-14T15:54:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/The-Ionic%C2%AE-Purification-System.jpg https://bostonlifesciencestimes.com/2022/04/rheos-medicines-appoints-katerina-leftheris-ph-d-as-svp-of-drug-discovery-and-nabil-uddin-pharm-d-as-vp-of-strategy-and-business-development/ 2022-04-14T16:10:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Katerina-Leftheris-Ph.D..jpg https://bostonlifesciencestimes.com/2022/04/new-study-shows-no-revisions-and-a-low-complication-rate-for-exactechs-vantage-total-ankle-fixed-bearing-system/ 2022-04-14T16:23:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Vantage-Total-Ankle.jpg https://bostonlifesciencestimes.com/2022/04/ir-med-announces-3-2-million-private-placement/ 2022-04-14T16:32:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/IR-Med.jpg https://bostonlifesciencestimes.com/2022/04/with-firearm-deaths-at-record-levels-national-academy-of-medicine-to-host-gun-violence-prevention-workshop/ 2022-04-14T16:38:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Michael-Dowling.jpg https://bostonlifesciencestimes.com/2022/04/psychiatrist-laura-erickson-schroth-joins-the-jed-foundation-as-chief-medical-officer/ 2022-04-14T16:52:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/The-Jed-Foundation.png https://bostonlifesciencestimes.com/2022/04/nomi-health-partners-with-tava-health-to-deliver-1-million-in-free-easy-to-access-mental-health-support-for-frontline-healthcare-workers/ 2022-04-14T16:59:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Nomi-Health.jpg https://bostonlifesciencestimes.com/2022/04/biovectra-starts-construction-on-its-charlottetown-mrna-biomanufacturing-centre/ 2022-04-15T13:43:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/BIOVECTRA.jpg https://bostonlifesciencestimes.com/2022/04/fore-biotherapeutics-appoints-matthew-e-ros-as-chief-executive-officer/ 2022-04-18T14:07:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Matthew-E.-Ros.jpg https://bostonlifesciencestimes.com/2022/04/new-gmp-manufactured-cas9-protein-enables-clinical-genome-editing-research/ 2022-04-18T14:10:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Gibco-CTS-TrueCut-Cas9-Protei.jpg https://bostonlifesciencestimes.com/2022/04/comera-life-sciences-and-otr-acquisition-corp-announce-effectiveness-of-registration-statement-for-proposed-business-combination/ 2022-04-18T14:20:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Comera-Life-Sciences.jpg https://bostonlifesciencestimes.com/2022/04/blue-spark-technologies-raises-40-million-in-growth-funding-led-by-ghost-tree-partners-to-advance-ai-based-remote-patient-monitoring/ 2022-04-18T14:32:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Blue-Spark-Technologies.jpg https://bostonlifesciencestimes.com/2022/04/smart-c-worlds-first-hyper-portable-surgical-imaging-system-receives-prestigious-medical-device-design-award/ 2022-04-18T14:41:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Smart-C.jpg https://bostonlifesciencestimes.com/2022/04/halo-a-universal-fluorescence-reader-based-threat-agent-detection-platform-a-proof-of-concept-study-using-sars-cov-2-assays/ 2022-04-18T14:47:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Halo.jpg https://bostonlifesciencestimes.com/2022/04/new-jama-article-highlights-the-outcome-and-safety-benefits-of-remote-patient-monitoring-during-the-pandemic-and-beyond/ 2022-04-18T14:49:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/JAMA.jpg https://bostonlifesciencestimes.com/2022/04/kite-receives-u-s-fda-approval-of-new-state-of-the-art-car-t-cell-therapy-manufacturing-facility-in-maryland/ 2022-04-19T15:31:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Kite.jpg https://bostonlifesciencestimes.com/2022/04/unlearn-closes-50-million-series-b-funding-to-advance-the-use-of-its-machine-learning-powered-twinrcts-in-clinical-trials/ 2022-04-19T15:34:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Charles-Fisher-Ph.D..jpeg https://bostonlifesciencestimes.com/2022/04/pharma-pioneer-longtime-patient-advocate-gail-trauco-receives-top-100-women-to-know-in-north-america-award/ 2022-04-19T15:36:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Gail-Trauco.jpg https://bostonlifesciencestimes.com/2022/04/urovant-sciences-announces-publication-of-empowur-trial-subgroup-analysis-showing-similar-efficacy-for-gemtesa-in-dry-and-wet-overactive-bladder-populations/ 2022-04-19T15:44:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Urovant-Sciences.jpg https://bostonlifesciencestimes.com/2022/04/clarion-partners-real-estate-income-fund-inc-cpreif-enters-san-diego-life-sciences-market-with-new-acquisition-in-carlsbad-ca/ 2022-04-19T16:00:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Fusion-Life-Science-HQ.jpg https://bostonlifesciencestimes.com/2022/04/tessera-therapeutics-announces-over-300m-series-c-financing-to-advance-its-gene-writing-platform/ 2022-04-19T16:03:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Screenshot-2022-04-19-at-12-02-31-GeoffvonMaltzahn-new_200608_151429.jpg-AVIF-Image-400-%C3%97-400-pixels.png https://bostonlifesciencestimes.com/2022/04/miroculus-appoints-mark-lewis-as-executive-chairman/ 2022-04-19T16:06:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Miroculus.jpg https://bostonlifesciencestimes.com/2022/04/captivate-bio-expands-cell-culture-media-focus-and-small-molecule-kits-for-stem-cell-research-and-emerging-markets/ 2022-04-19T16:11:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Tanya-Potcova.jpg https://bostonlifesciencestimes.com/2022/04/maryland-tech-council-secures-2-5-million-for-life-science-workforce-development-through-biohub-maryland/ 2022-04-19T16:13:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Marty-Rosendale.jpg https://bostonlifesciencestimes.com/2022/04/neuraly-announces-completion-of-enrollment-in-phase-2-clinical-trial-of-nly01-in-patients-with-parkinsons-disease/ 2022-04-19T16:15:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Screenshot-2022-04-19-at-12-14-24-Team-%E2%80%94-Neuraly.png https://bostonlifesciencestimes.com/2022/04/omniose-announces-expanded-leadership-team-to-develop-bioconjugate-vaccines-against-serious-bacterial-threats/ 2022-04-19T16:17:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Omniose.jpg https://bostonlifesciencestimes.com/2022/04/carlsmed-raises-30m-in-series-b-funding-to-scale-personalized-spine-surgery/ 2022-04-19T16:19:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Carlsmed.png https://bostonlifesciencestimes.com/2022/04/virtual-incision-announces-approval-to-complete-clinical-study-enrollment-for-its-mira-platform/ 2022-04-19T16:21:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Virtual-Incisions-MIRA-Platform.jpg https://bostonlifesciencestimes.com/2022/04/ntt-research-names-dr-al-emondi-head-of-partner-strategy/ 2022-04-19T16:23:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Dr.-Al-Emond.jpg https://bostonlifesciencestimes.com/2022/04/paragon-28-launches-r3act-stabilization-system-for-ankle-injuries/ 2022-04-19T16:25:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/R3ACT.jpg https://bostonlifesciencestimes.com/2022/04/denver-colorado-expands-reach-of-everbridge-platform-to-enhance-citizen-safety-amid-increased-risk-of-wildfires/ 2022-04-19T16:29:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/everbridge.jpg https://bostonlifesciencestimes.com/2022/04/genialis-releases-improved-version-of-expressions-for-faster-more-secure-multi-omics-processing-and-data-management/ 2022-04-20T14:27:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Genialis.jpg https://bostonlifesciencestimes.com/2022/04/life-sciences-networking-event-developing-the-next-generation-for-burgeoning-industry/ 2022-04-20T14:29:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Robert-K.-Coughlin.webp https://bostonlifesciencestimes.com/2022/04/amy-dirks-stevens-joins-innovaccer-leadership-team/ 2022-04-20T14:31:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Amy-Dirks.jpg https://bostonlifesciencestimes.com/2022/04/thermo-fisher-scientific-opens-bioprocessing-manufacturing-site-in-ogden-utah/ 2022-04-20T14:34:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Bioprocessing-Manufacturing-Site-in-Ogden.jpg https://bostonlifesciencestimes.com/2022/04/d-matrix-announces-44-million-in-funding-to-build-a-one-of-a-kind-compute-platform-targeted-for-at-scale-transformer-ai-datacenter-inference/ 2022-04-20T14:35:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/d-Matrix.png https://bostonlifesciencestimes.com/2022/04/satellite-bio-reveals-pioneering-tissue-therapeutics-bioengineered-tissues-that-restore-organ-function-bringing-hope-across-diseases/ 2022-04-20T14:37:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Screenshot-2022-04-20-at-10-37-10-Our-Team.png https://bostonlifesciencestimes.com/2022/04/seagen-announces-plans-to-expand-pacific-northwest-biomanufacturing-capacity-to-support-growing-portfolio-of-transformative-cancer-medicines/ 2022-04-20T14:40:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Seagen-Everett-biomanufacturing-facility.jpg https://bostonlifesciencestimes.com/2022/04/butterfly-network-names-heather-getz-as-chief-financial-officer/ 2022-04-20T14:43:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Butterfly-Network.jpg https://bostonlifesciencestimes.com/2022/04/simple-and-streamlined-garmin-vivosmart-5-fitness-tracker-is-the-effortless-way-to-take-charge-of-your-everyday-health-wellness-and-activity/ 2022-04-20T14:50:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Garmin-vivosmart-5.jpg https://bostonlifesciencestimes.com/2022/04/levels-38m-series-a-driven-by-member-and-community-alignment-to-solve-metabolic-health-crisis/ 2022-04-20T14:54:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Levels.jpg https://bostonlifesciencestimes.com/2022/04/maxwell-biosciences-announces-the-appointment-of-edward-rudnic-ph-d-as-chief-operating-officer/ 2022-04-21T13:16:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Edward-Rudnic-Ph.D..jpg https://bostonlifesciencestimes.com/2022/04/lauren-oschman-appointed-ceo-of-vestia-personal-wealth-advisors/ 2022-04-21T13:19:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Lauren-Oschman.jpg https://bostonlifesciencestimes.com/2022/04/reify-health-raises-220m-series-d-to-bridge-the-diversity-gap-in-clinical-trials/ 2022-04-21T13:21:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Reify-Health.png https://bostonlifesciencestimes.com/2022/04/octant-raises-80-million-series-b-round-to-support-expansion-of-next-generation-drug-discovery-platform-announces-collaboration-with-bristol-myers-squibb-and-key-appointments/ 2022-04-21T13:23:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Octant-Inc.png https://bostonlifesciencestimes.com/2022/04/neospectra-by-si-ware-partners-with-ab-vistas-aunir-to-offer-customers-affordable-nir-calibration-choices-for-in-field-analysis/ 2022-04-21T13:24:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/NeoSpectra-Scanner.jpg https://bostonlifesciencestimes.com/2022/04/li-cycle-completes-commercial-agreements-with-lg-chem-and-lg-energy-solution-who-have-recognized-li-cycle-as-their-preferred-lithium-ion-battery-recycling-partner/ 2022-04-21T13:27:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Ajay-Kochhar.jpg https://bostonlifesciencestimes.com/2022/04/showa-group-receives-fda-510k-approval-for-industrys-first-biodegradable-medical-grade-nitrile-glove/ 2022-04-21T13:30:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Nitrile-Glove.jpg https://bostonlifesciencestimes.com/2022/04/rachel-winokur-joins-valtruis-as-executive-advisor/ 2022-04-21T13:32:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Rachel-Winokur.jpg https://bostonlifesciencestimes.com/2022/04/patientpop-becomes-a-massachusetts-medical-society-preferred-provider-for-practice-growth/ 2022-04-21T14:39:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Luke-Kervin.jpg https://bostonlifesciencestimes.com/2022/04/bruker-launches-unique-liquidarray-multiplex-pcr-assays/ 2022-04-22T14:21:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/FluoroCycler.jpg https://bostonlifesciencestimes.com/2022/04/responsible-flushing-alliance-publishes-new-infographic-educating-the-public-on-the-strangest-items-found-in-california-catch-basins/ 2022-04-22T14:35:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Responsible-Flushing-Alliance.jpg https://bostonlifesciencestimes.com/2022/04/takeda-presents-new-exploratory-analysis-showing-patients-treated-with-livtencity-maribavir-had-reductions-in-hospitalization-rates-and-length-of-hospital-stay/ 2022-04-22T14:37:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Takeda.jpg https://bostonlifesciencestimes.com/2022/04/bruker-demonstrates-novel-and-unique-compact-1-0-ghz-nmr-magnet/ 2022-04-25T14:02:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Bruker-Ascend-Evo-1.0-GHz.jpg https://bostonlifesciencestimes.com/2022/04/silence-therapeutics-achieves-2-million-research-milestone-in-hansoh-pharma-collaboration/ 2022-04-25T14:04:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Silence-Therapeutics.jpg https://bostonlifesciencestimes.com/2022/04/new-labvantage-forensic-navigator-seamlessly-manages-vast-data-flows-over-the-entire-forensic-life-cycle/ 2022-04-25T14:08:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/LabVantage-Forensic-Navigator.jpg https://bostonlifesciencestimes.com/2022/04/alice-l-foundation-and-washington-regional-medical-system-form-partnership-to-create-a-transformative-health-care-system-in-northwest-arkansas/ 2022-04-25T14:11:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Alice-L.-Walton-Foundation.jpg https://bostonlifesciencestimes.com/2022/04/immunitybio-announces-first-participants-have-been-enrolled-in-lung-map-trial-studying-anktiva-to-activate-nk-and-t-cells-in-non-small-cell-lung-cancer/ 2022-04-25T14:15:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Patrick-Soon-Shiong-M.D..jpg https://bostonlifesciencestimes.com/2022/04/dalrada-healths-cervia-test-kit-enables-immediate-results-with-second-cervical-cancer-screening-study-amid-covid-19-restrictions/ 2022-04-25T14:18:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Dalrada-Health.jpg https://bostonlifesciencestimes.com/2022/04/selina-secures-147-5-million-convertible-note-financing-in-connection-with-its-planned-business-combination-with-boa-acquisition-corp/ 2022-04-25T14:20:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Selina-Hospitality.png https://bostonlifesciencestimes.com/2022/04/several-new-studies-presented-at-eccmic-2022-confirm-veklury-remdesivir-activity-in-treating-covid-19/ 2022-04-25T14:22:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Gilead-Sciences.png https://bostonlifesciencestimes.com/2022/04/cyteir-therapeutics-names-adam-veness-general-counsel/ 2022-04-25T15:42:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Cyteir-Therapeutics.jpg https://bostonlifesciencestimes.com/2022/04/establishment-labs-enters-into-225-million-credit-facility-with-oaktree/ 2022-04-26T14:12:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Establishment-Labs.webp https://bostonlifesciencestimes.com/2022/04/spotsee-launches-new-temperature-indicator-freezesafe/ 2022-04-26T14:19:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/SpotSee.jpg https://bostonlifesciencestimes.com/2022/04/flare-capital-partners-announces-close-of-its-third-fund-with-350-million-in-commitments/ 2022-04-26T14:35:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Flare-Capital-Partners.jpg https://bostonlifesciencestimes.com/2022/04/essential-utilities-underscores-environmental-commitment-with-earth-day-events-and-donations/ 2022-04-26T14:46:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Essential-Utilities.jpg https://bostonlifesciencestimes.com/2022/04/virpax-successfully-completes-initial-preclinical-studies-for-vrp324/ 2022-04-26T14:50:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Virpax%C2%AE-Pharmaceuticals.jpg https://bostonlifesciencestimes.com/2022/04/evaxion-to-utilize-personalis-immunoid-next-platform-to-evaluate-efficacy-of-combination-therapy-for-late-stage-melanoma/ 2022-04-26T14:59:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Lars-Wegner.png https://bostonlifesciencestimes.com/2022/04/deepcure-appoints-dr-han-lim-as-chief-business-officer/ 2022-04-26T15:01:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Dr.-Han-Lim.jpg https://bostonlifesciencestimes.com/2022/04/mispro-announces-new-location-in-waltham-biopharma-cluster/ 2022-04-26T15:03:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Philippe-Lamarre.jpg https://bostonlifesciencestimes.com/2022/04/qosina-expands-pinch-clamp-product-line-more-than-125-options-available/ 2022-04-26T15:05:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Qosina.jpg https://bostonlifesciencestimes.com/2022/04/spencer-health-solutions-partners-with-ganse-apothecary-to-expand-in-home-support-to-specialty-pharmacy-patients/ 2022-04-26T15:12:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Greg-Ganse.jpg https://bostonlifesciencestimes.com/2022/04/circassia-inc-significantly-expands-reach-of-niox-feno-asthma-testing-and-management-device-with-national-primary-care-distributor-agreements/ 2022-04-26T15:17:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Circassia-Inc.jpg https://bostonlifesciencestimes.com/2022/04/healthcare-thought-leaders-dan-morhaim-m-d-and-rich-feifer-m-d-named-senior-advisors-for-advault/ 2022-04-26T15:33:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Dan-Morhaim.jpg https://bostonlifesciencestimes.com/2022/04/claritin-teams-up-with-nate-berkus-and-jeremiah-brent-to-inspire-families-to-spend-more-time-outside-and-embrace-their-outdoor-space/ 2022-04-26T15:36:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Claritin.jpg https://bostonlifesciencestimes.com/2022/04/valneva-and-pfizer-report-positive-phase-2-pediatric-data-for-lyme-disease-vaccine-candidate/ 2022-04-26T15:43:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Pfizer.jpg https://bostonlifesciencestimes.com/2022/04/sonarsource-the-leading-platform-for-clean-code-raises-412-million-in-new-investment/ 2022-04-26T15:44:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/SonarSource.png https://bostonlifesciencestimes.com/2022/04/acurex-therapeutics-receives-grant-funding-from-the-michael-j-fox-foundation-for-parkinsons-research/ 2022-04-27T13:34:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/AcureX-Therapeutics.jpg https://bostonlifesciencestimes.com/2022/04/highland-therapeutics-announces-appointment-of-stephanie-c-read-as-president-ceo-changes-to-board-of-directors/ 2022-04-27T13:37:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Highland-Therapeutics.png https://bostonlifesciencestimes.com/2022/04/catamaran-bio-appoints-cherry-thomas-md-as-chief-medical-officer/ 2022-04-27T13:39:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Cherry-Thomas.jpg https://bostonlifesciencestimes.com/2022/04/paragon-28-launches-paratrooper-plantar-plate-system-for-hammertoe-and-soft-tissue-repair/ 2022-04-27T13:42:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Paratrooper%E2%84%A2-Plantar-Plate-System.jpg https://bostonlifesciencestimes.com/2022/04/insulet-presents-new-omnipod-5-system-data-for-type-1-and-type-2-diabetes/ 2022-04-27T13:45:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Insulet-Corporation.jpg https://bostonlifesciencestimes.com/2022/04/mattel-announces-goal-to-reduce-plastic-packaging-by-25-per-product-by-2030-and-publishes-latest-citizenship-report/ 2022-04-27T13:48:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Mattel.jpg https://bostonlifesciencestimes.com/2022/04/impact-com-announces-secondary-investment-from-w-capital-and-providence-public-of-approximately-100-million/ 2022-04-27T13:53:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/David-A.-Yovanno.webp https://bostonlifesciencestimes.com/2022/04/wynd-airbydesign-and-carmel-cares-announce-groundbreaking-indoor-air-quality-initiative-in-carmel-by-the-seas-restaurants/ 2022-04-27T13:57:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Mission-Bistro.jpg https://bostonlifesciencestimes.com/2022/04/swtch-raises-13-million-to-provide-equitable-access-to-electric-vehicle-charging-infrastructure-in-communities-across-north-america/ 2022-04-27T14:02:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/SWTCH-Energy.jpg https://bostonlifesciencestimes.com/2022/04/tapestry-inc-appoints-david-l-casey-as-chief-inclusion-and-social-impact-officer/ 2022-04-27T14:04:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/David-L.-Casey.jpg https://bostonlifesciencestimes.com/2022/04/fda-grants-510k-clearance-to-onera-sts-a-system-for-at-home-and-in-lab-polysomnography-studies/ 2022-04-28T14:24:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Onera-STS.jpg https://bostonlifesciencestimes.com/2022/04/appliedvr-and-komodo-health-partner-to-validate-power-of-virtual-reality-as-effective-digital-therapy-for-chronic-pain/ 2022-04-28T14:30:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Komodo-Health-Partner.jpg https://bostonlifesciencestimes.com/2022/04/cytotronics-launches-with-9-25-million-in-seed-funding-to-revolutionize-drug-discovery-and-phenotypic-screening/ 2022-04-28T14:42:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/CytoTronics.jpg https://bostonlifesciencestimes.com/2022/04/twinstrand-biosciences-expands-executive-team-with-appointment-of-goran-pljevaljcic-as-chief-commercial-officer/ 2022-04-28T15:53:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Goran-Pljevaljcic.jpg https://bostonlifesciencestimes.com/2022/04/ultomiris-ravulizumab-cwvz-approved-in-the-us-for-adults-with-generalized-myasthenia-gravis/ 2022-04-28T15:55:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/AstraZeneca-Building.jpg https://bostonlifesciencestimes.com/2022/04/phc-holdings-corporation-appoints-shoji-miyazaki-as-chief-executive-officer/ 2022-04-28T15:58:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Shoji-Miyazaki.jpg https://bostonlifesciencestimes.com/2022/04/ross-prize-awarded-to-mrna-technology-covid-19-vaccine-innovators/ 2022-04-28T16:00:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Drs.-Drew-Weissman.jpg https://bostonlifesciencestimes.com/2022/04/turner-innovations-awarded-air-force-sbir-phase-ii-contract/ 2022-04-28T16:03:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Turner-Innovations.jpg https://bostonlifesciencestimes.com/2022/04/paragonix-technologies-sherpapak-improves-1-year-survival-in-heart-transplant-patients-in-real-world-study/ 2022-04-28T16:12:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/The-Paragonix-SherpaPak-Cardiac-Transport-system.jpg https://bostonlifesciencestimes.com/2022/04/commonspirit-names-wright-l-lassiter-iii-to-succeed-lloyd-h-dean-as-ceo/ 2022-04-28T16:53:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Wright-L.-Lassiter-III.jpg https://bostonlifesciencestimes.com/2022/04/volta-partners-with-the-state-of-michigan-and-dte-energy/ 2022-04-28T16:58:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Volta-Partners.jpg https://bostonlifesciencestimes.com/2022/04/amrotec-is-solving-the-need-for-bacteria-free-us-monies-in-circulation/ 2022-04-28T17:01:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/AMROTEC.jpg https://bostonlifesciencestimes.com/2022/04/stevanato-group-s-p-a-and-bexson-biomedical-inc-expand-collaboration-to-treat-a-range-of-mental-health-conditions-with-an-on-body-device/ 2022-04-29T15:25:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/The-SG-EZ-be-Pod.jpg https://bostonlifesciencestimes.com/2022/04/ictero-medical-closes-6m-series-a-financing/ 2022-04-29T15:49:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Ictero-Medical.jpg https://bostonlifesciencestimes.com/2022/04/thermal-custom-packaging-maintains-proper-preservation-of-law-enforcement-evidence-with-pc-21-phase-change-material-case/ 2022-04-29T15:52:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/PC-21-Phase-Change-Material-Case.jpg https://bostonlifesciencestimes.com/2022/05/voxeleron-launches-inebula-a-cloud-based-platform-for-optimized-ophthalmic-clinical-trial-workflow/ 2022-05-02T14:05:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Daniel-Russakoff.jpg https://bostonlifesciencestimes.com/2022/05/propanc-biopharma-purchases-pharma-grade-raw-materials-for-prp-manufacture-in-preparation-for-phase-i-first-in-human-study/ 2022-05-02T14:08:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Propanc-Biopharma.jpg https://bostonlifesciencestimes.com/2022/05/horizon-therapeutics-plc-receives-european-commission-ec-approval-of-uplizna-inebilizumab-for-the-treatment-of-adults-with-neuromyelitis-optica-spectrum-disorder-nmosd/ 2022-05-02T14:28:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Vikram-Karnani.jpg https://bostonlifesciencestimes.com/2022/05/amber-l-southwell-ph-d-awarded-sensory-sentineltm-grant-by-turner-scientific/ 2022-05-02T14:31:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Amber-L.-Southwell-Ph.D..jpg https://bostonlifesciencestimes.com/2022/05/redshift-bioanalytics-announces-launch-of-next-generation-apollo-for-ultra-sensitive-biophysical-characterization-of-biomolecules/ 2022-05-02T14:34:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Apollo.jpg https://bostonlifesciencestimes.com/2022/05/tia-opens-flagship-clinic-in-san-francisco-and-teams-with-ucsf-health-to-scale-comprehensive-womens-healthcare-to-40000-bay-area-women/ 2022-05-02T14:40:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Carolyn-Witte-co-founder-and-CEO-of-Tia.jpg https://bostonlifesciencestimes.com/2022/05/nexel-earns-the-first-iso-iec-170252017-accreditation-for-ipsc-derived-cardiomyocyte-based-cardiac-safety-testing/ 2022-05-02T14:42:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/NEXEL.jpg https://bostonlifesciencestimes.com/2022/05/gordon-robert-alton-phd-joins-briori-biotech-as-coo-to-develop-patented-topical-formulation-of-vioxx-providing-those-suffering-with-osteoarthritis-a-long-lasting-non-opioid-option-for-pain-reli/ 2022-05-02T14:46:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Gordon-Robert-Alton-PhD.webp https://bostonlifesciencestimes.com/2022/05/medical-monitoring-pioneer-announces-the-limited-market-release-of-the-masimo-w1-watch-for-consumers/ 2022-05-02T14:50:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Masimo-W1.jpg https://bostonlifesciencestimes.com/2022/05/lawson-health-research-institute-selects-cubresas-brainpet-system-to-support-neurological-research-studies/ 2022-05-02T14:52:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Cubresa-BrainPET.jpg https://bostonlifesciencestimes.com/2022/05/rhinostic-automated-nasal-swab-earns-health-canada-covid-19-interim-order-no-2-medical-device-authorization/ 2022-05-02T14:59:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/RHINOstic.jpg https://bostonlifesciencestimes.com/2022/05/skyway-capital-markets-advises-spac-on-85-million-medical-technology-merger/ 2022-05-02T15:01:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Skyway-Capital-Markets.jpg https://bostonlifesciencestimes.com/2022/05/headspace-health-expands-executive-team-with-addition-of-new-chief-social-impact-diversity-officer-and-chief-commercial-officer/ 2022-05-02T15:03:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Dr.-Wizdom-Powell-Chief-Social-Impact-Diversity-Officer-Headspace-Health-and-Jodi-Bryant.jpg https://bostonlifesciencestimes.com/2022/05/worldwide-clinical-trials-names-rosemarie-corrigan-executive-vice-president-global-quality/ 2022-05-03T14:01:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Rosemarie-Corrigan.jpg https://bostonlifesciencestimes.com/2022/05/alentis-therapeutics-appoints-dr-andrea-pellacani-as-chief-medical-officer/ 2022-05-03T14:02:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Dr.-Pellacani.jpg https://bostonlifesciencestimes.com/2022/05/tubulis-closes-e60-million-series-b-financing-to-accelerate-its-adc-pipeline-and-expand-its-breadth-of-platform-technologies/ 2022-05-03T14:09:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Tubulis.jpg https://bostonlifesciencestimes.com/2022/05/catalio-capital-management-raises-381-million-for-oversubscribed-third-life-sciences-fund/ 2022-05-03T14:13:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Brandon-Matz-e1651587175400.jpg https://bostonlifesciencestimes.com/2022/05/revolutionizing-quat-pesticide-determination-and-quantitation-workflows-to-protect-food-supply/ 2022-05-03T14:20:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Dionex-IonPac-CS21-Fast-4%C2%B5m-ion-exchange-column.jpg https://bostonlifesciencestimes.com/2022/05/tevogen-bio-expands-research-and-development-capacity-at-cic-philadelphia-to-accommodate-its-expanding-product-portfolio/ 2022-05-03T14:22:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Tevogen-Bio.jpg https://bostonlifesciencestimes.com/2022/05/matica-bio-opens-new-cell-and-gene-therapy-gmp-facility-in-texas/ 2022-05-03T14:26:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Matica-Bio.jpg https://bostonlifesciencestimes.com/2022/05/fulgent-genetics-announces-opening-of-new-state-of-the-art-oncology-laboratory-in-el-monte-california/ 2022-05-03T14:32:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Fulgent-Genetics.png https://bostonlifesciencestimes.com/2022/05/robotics-ai-industry-leader-fady-saad-and-automation-sensor-industry-executive-mark-martin-launch-first-of-its-kind-50-million-fund-for-early-stage-robotics-automation-and-ai-companies/ 2022-05-03T14:34:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Cybernetix-Ventures-General-Partners.jpg https://bostonlifesciencestimes.com/2022/05/wireless-surgical-camera-maker-lazurite-selected-to-participate-in-medtech-innovator-pitch-event-in-boston/ 2022-05-03T14:35:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Wireless-Surgical-Camera-Maker-Lazurite.jpg https://bostonlifesciencestimes.com/2022/05/x-therma-receives-fda-breakthrough-device-designation-for-xt-vivo-preservation-solution-and-timeseal-organ-transport-device/ 2022-05-03T14:38:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Dr.-Xiaoxi-Wei.jpg https://bostonlifesciencestimes.com/2022/05/tectraum-announces-completion-of-multisite-clinical-trial-using-pro2cool-device-for-the-treatment-of-concussions/ 2022-05-03T14:39:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/pro2cool.jpg https://bostonlifesciencestimes.com/2022/05/orthofix-and-mtf-biologics-expand-partnership-agreement/ 2022-05-03T14:43:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/The-Legacy.jpg https://bostonlifesciencestimes.com/2022/05/digital-screening-for-covid-19-and-infectious-disease-could-prevent-8-million-infections-according-to-study-at-risk-communities-may-benefit-most/ 2022-05-03T14:46:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Praduman-PJ-Jain.webp https://bostonlifesciencestimes.com/2022/05/center-for-health-innovation-coming-to-dallas/ 2022-05-03T14:52:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Capital-Factory.jpg https://bostonlifesciencestimes.com/2022/05/viecure-announces-new-appointments-to-its-board-of-directors-michael-mentesana-and-brad-prechtl-bring-industry-knowledge-and-expertise-to-the-growing-cancer-care-company/ 2022-05-04T14:29:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Michael-Mentesana.jpg https://bostonlifesciencestimes.com/2022/05/julianne-averill-and-kristen-richardson-join-anji-pharma-to-ready-company-for-next-stage-of-growth/ 2022-05-04T14:31:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Julianne-Averill.jpg https://bostonlifesciencestimes.com/2022/05/gwynedd-mercy-university-announces-10-million-gift-to-develop-the-frances-m-maguire-healthcare-innovation-campus/ 2022-05-04T14:34:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Gwynedd-Mercy-University.jpg https://bostonlifesciencestimes.com/2022/05/stevanato-group-and-owen-mumford-sign-exclusive-collaboration-agreement-for-the-innovative-aidaptus-auto-injector/ 2022-05-04T14:38:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Stevanato-Group-and-Owen-Mumford.jpg https://bostonlifesciencestimes.com/2022/05/integrated-medical-professionals-a-multi-specialty-physician-group-and-affiliate-of-solaris-health-adopts-ambus-single-use-cystoscopy/ 2022-05-04T14:41:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/aScope%E2%84%A2-4-Cysto.jpg https://bostonlifesciencestimes.com/2022/05/fda-grants-pma-for-the-accelstim-bone-growth-stimulation-device-expanding-orthofixs-portfolio-of-market-leading-bone-healing-therapy-solutions/ 2022-05-04T14:43:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/The-Orthofix-AccelStim.jpg https://bostonlifesciencestimes.com/2022/05/clinical-data-presented-at-the-european-congress-on-obesity-2022-demonstrates-weight-loss-with-gs200-in-adults-with-prediabetes-and-type-2-diabetes/ 2022-05-04T14:49:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/GS200.jpg https://bostonlifesciencestimes.com/2022/05/p360-launches-zing-engagement-suite-to-help-pharma-sales-teams-improve-hcp-engagement/ 2022-05-05T13:26:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/P360.jpg https://bostonlifesciencestimes.com/2022/05/medicago-announces-publication-of-phase-3-covid-19-vaccine-study-results-in-new-england-journal-of-medicine/ 2022-05-05T13:35:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Marc-Andre-DAoust.jpg https://bostonlifesciencestimes.com/2022/05/multiply-labs-adds-thermo-fisher-scientific-and-charles-river-laboratories-to-its-robotic-manufacturing-consortium/ 2022-05-05T13:39:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Multiply-Labs-Robotic-Cluster.jpg https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Multiply-Labs-Robotic-Cluster.gif https://bostonlifesciencestimes.com/2022/05/gary-druckenmiller-jr-joins-innovaccer-management-team/ 2022-05-05T13:42:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Gary-Druckenmiller-Jr.jpg https://bostonlifesciencestimes.com/2022/05/waters-and-university-of-delaware-announce-official-opening-of-immerse-delaware-lab/ 2022-05-05T13:47:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Immerse-Delaware-Lab.jpg https://bostonlifesciencestimes.com/2022/05/energy-vault-atlas-renewable-and-china-tianying-begin-construction-of-first-chinese-deployment-of-evx-gravity-based-energy-storage-system/ 2022-05-05T13:50:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Energy-Vault-Resiliency-Center.jpg https://bostonlifesciencestimes.com/2022/05/sqz-biotechnologies-announces-first-data-presentation-on-non-clinical-studies-of-point-of-care-manufacturing-system-and-collaboration-with-stemcell-technologies/ 2022-05-05T13:58:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Armon-Sharei-PhD.jpg https://bostonlifesciencestimes.com/2022/05/alzamend-neuro-announces-initiation-of-phase-iia-multiple-ascending-dose-clinical-trial-for-al001-treatment-of-dementia-related-to-alzheimers/ 2022-05-05T14:02:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Stephan-Jackman.jpg https://bostonlifesciencestimes.com/2022/05/artiva-biotherapeutics-appoints-edith-a-perez-m-d-to-its-board-of-directors-and-clinical-advisory-board/ 2022-05-05T14:05:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Edith-A.-Perez-M.D..jpg https://bostonlifesciencestimes.com/2022/05/clarius-receives-ce-mark-certification-for-seven-new-ultra-portable-wireless-ultrasound-scanners-for-apple-and-android-devices/ 2022-05-05T14:08:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Clarius-HD3.jpg https://bostonlifesciencestimes.com/2022/05/anthem-inc-completes-acquisition-of-integra-managed-care/ 2022-05-05T14:17:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Anthem-Inc.jpg https://bostonlifesciencestimes.com/2022/05/door-handle-that-sanitizes-with-every-touch-to-debut-on-world-hand-hygiene-day-may-5/ 2022-05-05T14:20:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Door-Handle-That-Sanitizes.jpg https://bostonlifesciencestimes.com/2022/05/comera-life-sciences-announces-research-collaboration-with-top-10-pharmaceutical-company-to-develop-subcutaneous-formulation/ 2022-05-09T14:04:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Comera-Life-Sciences.jpg https://bostonlifesciencestimes.com/2022/05/emulate-announces-launch-of-immune-cell-recruitment-application-for-the-colon-intestine-chip-to-aid-in-the-study-of-inflammatory-bowel-disease/ 2022-05-09T14:09:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Lorna-Ewart-PhD.jpg https://bostonlifesciencestimes.com/2022/05/twist-bioscience-enters-into-research-exclusive-option-and-license-agreement-with-astellas-for-antibodies-to-reduce-tumor-microenvironment-mediated-immunosuppression/ 2022-05-09T14:26:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Emily-M.-Leproust-Ph.D..webp https://bostonlifesciencestimes.com/2022/05/ventus-therapeutics-awarded-grant-by-the-u-s-department-of-defense-to-study-the-role-of-cgas-in-lupus/ 2022-05-09T14:32:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Michael-Crackower-Ph.D..jpg https://bostonlifesciencestimes.com/2022/05/legend-biotech-appoints-lori-macomber-as-chief-financial-officer/ 2022-05-09T14:35:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Lori-Macomber.jpg https://bostonlifesciencestimes.com/2022/05/bit-bios-new-huntingtons-disease-human-cell-model-set-to-accelerate-drug-discovery-and-screening/ 2022-05-09T14:37:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/bit.bio_.jpg https://bostonlifesciencestimes.com/2022/05/arrowhead-breaks-ground-on-new-manufacturing-facility-with-wisconsin-governor-tony-evers-and-announces-receipt-of-incentives/ 2022-05-09T14:38:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Verona-Facility-Concept-Drawing.jpg https://bostonlifesciencestimes.com/2022/05/cybin-and-kernel-announce-results-from-kernel-flow-piloting-of-feasibility-study-measuring-ketamines-effects-on-the-brain/ 2022-05-09T14:40:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Johnson.jpg https://bostonlifesciencestimes.com/2022/05/adc-therapeutics-announces-ceo-transition/ 2022-05-09T14:41:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Ameet-Mallik.jpg https://bostonlifesciencestimes.com/2022/05/onward-announces-first-patient-enrollment-in-hemon-study-and-first-in-human-use-of-its-arcim-implantable-neurostimulator/ 2022-05-09T14:43:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Neurosurgeon-Dr.-Jocelyne-Bloch.jpg https://bostonlifesciencestimes.com/2022/05/ick-its-officially-peak-tick-season/ 2022-05-09T14:45:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/National-Pest-Management-Association.jpg https://bostonlifesciencestimes.com/2022/05/straus-dairy-farms-carbon-neutral-goal-draws-near-as-cdfa-approves-first-ever-red-seaweed-supplement-to-reduce-methane-emissions/ 2022-05-09T14:48:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Straus-Dairy-Farm.jpg https://bostonlifesciencestimes.com/2022/05/the-beauty-health-company-appoints-amy-juaristi-as-head-of-corporate-affairs/ 2022-05-09T14:55:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Amy-Juaristi.jpg https://bostonlifesciencestimes.com/2022/05/an2-therapeutics-appoints-maggie-fitzpatrick-to-its-board-of-directors/ 2022-05-09T14:56:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Maggie-FitzPatrick.jpg https://bostonlifesciencestimes.com/2022/05/boston-pharmaceuticals-appoints-dr-sophie-kornowski-as-chair-of-its-board-of-directors-and-acting-chief-executive/ 2022-05-10T13:43:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Dr.-Sophie-Kornowski.jpg https://bostonlifesciencestimes.com/2022/05/labtician-thea-announces-successful-completion-of-joint-venture-resulting-in-a-stronger-labtician-ophthalmics-and-launch-of-thea-pharma-canada/ 2022-05-10T13:49:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Fiona-McCloskey.jpg https://bostonlifesciencestimes.com/2022/05/bruker-and-tofwerk-form-strategic-partnership-in-high-speed-ultra-sensitive-solutions-for-applied-and-industrial-markets/ 2022-05-10T13:51:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/TOFWERK-Vocus-Eiger.jpg https://bostonlifesciencestimes.com/2022/05/related-beal-jamestown-lease-260000-sf-to-multiple-life-sciences-firms-at-bostons-innovation-and-design-building/ 2022-05-10T13:57:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Innovation-and-Design-Building.webp https://bostonlifesciencestimes.com/2022/05/193-76-million-construction-loan-secured-for-the-development-of-new-262468-sf-life-sciences-campus-in-bostons-seaport-district/ 2022-05-10T13:59:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Rendering.webp https://bostonlifesciencestimes.com/2022/05/clarify-health-announces-launch-of-institute-to-democratize-healthcare-research-and-insights-that-fuel-improvements-for-better-care/ 2022-05-10T14:02:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Jean-Drouin.jpg https://bostonlifesciencestimes.com/2022/05/seasoned-chicago-based-c-level-law-firm-executive-thomas-gaughan-named-honigmans-new-chief-operating-officer/ 2022-05-10T14:04:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Thomas-Gaughan.jpg https://bostonlifesciencestimes.com/2022/05/thermo-fisher-scientific-introduces-qualtrak-biopharma-qpcr-solutions-to-streamline-biologics-development-and-compliance/ 2022-05-10T14:06:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/TaqPath-BactoPure.jpg https://bostonlifesciencestimes.com/2022/05/dna-script-appoints-chris-barbazette-as-chief-commercial-officer/ 2022-05-10T14:08:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Chris-Barbazette.jpg https://bostonlifesciencestimes.com/2022/05/fsd-pharma-closes-cad16-4-million-sale-of-non-core-assets/ 2022-05-10T14:10:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/FSD-Pharma2.jpg https://bostonlifesciencestimes.com/2022/05/domain-therapeutics-raises-42m-series-a-financing/ 2022-05-10T14:12:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Domain-Therapeutics.png https://bostonlifesciencestimes.com/2022/05/massbio-state-of-possible-conference-honored-governor-deval-patrick-with-its-innovative-leadership-award/ 2022-05-10T14:14:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Deval-Patrick.jpg https://bostonlifesciencestimes.com/2022/05/rockley-photonics-announces-results-of-preliminary-human-study-measuring-hydration-and-introduces-a-novel-hydration-index/ 2022-05-10T14:18:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Rockley-Hydration-Index.jpg https://bostonlifesciencestimes.com/2022/05/mawi-dna-technologies-launches-nextswab-for-accurate-more-reliable-covid-19-test-results/ 2022-05-10T14:26:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Dr.-Bassam-El-Fahmawi.png https://bostonlifesciencestimes.com/2022/05/alira-health-acquires-redcrow-an-equity-crowdfunding-platform-for-healthcare-startups/ 2022-05-11T14:32:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Gabriele-Brambilla.jpg https://bostonlifesciencestimes.com/2022/05/new-meta-analysis-in-european-heart-journals-cardiovascular-pharmacotherapy-examines-cholesterol-ester-transfer-protein-cetp-inhibitors-role-in-reduction-of-diabetes-risk/ 2022-05-11T14:44:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Screenshot-2022-05-11-at-10-42-25-About-Us-%E2%80%94-New-Amsterdam-Pharma.png https://bostonlifesciencestimes.com/2022/05/mdclone-launches-the-only-synthetic-data-platform-for-life-science-rwe-project-collaboration/ 2022-05-11T15:16:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Robi-Wartenfeld.png https://bostonlifesciencestimes.com/2022/05/nuvig-launches-to-develop-novel-immune-therapeutics-for-chronic-inflammatory-and-autoimmune-diseases/ 2022-05-11T15:28:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Nuvig-Therapeutics.jpg https://bostonlifesciencestimes.com/2022/05/verisim-life-announces-acquisition-of-molomics-biotech/ 2022-05-11T15:39:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Screenshot-2022-05-11-at-11-38-26-About-us-VeriSIM.png https://bostonlifesciencestimes.com/2022/05/carmell-therapeutics-announces-the-appointment-of-sebastian-sebby-borriello-to-chief-business-officer/ 2022-05-11T15:42:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Sebastian-Sebby-Borriello.jpg https://bostonlifesciencestimes.com/2022/05/biotech-partnership-to-accelerate-understanding-of-genetics-of-long-covid-and-help-identify-new-treatments/ 2022-05-11T15:45:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Dr-Patrick-Short.jpg https://bostonlifesciencestimes.com/2022/05/qosina-announces-launch-of-new-bioprocess-resource-center/ 2022-05-11T16:29:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Qosina.jpg https://bostonlifesciencestimes.com/2022/05/first-simulated-patient-treatment-carried-out-in-the-first-hospital-based-bnct-facility-in-europe/ 2022-05-11T16:31:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Dr.-Elizabeth-Reczek.jpg https://bostonlifesciencestimes.com/2022/05/mitsubishi-electric-expands-silicon-carbide-power-device-lineup-with-industry-standard-package-dual-device/ 2022-05-11T16:33:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/FMF400DY-24B-SiC-module.jpg https://bostonlifesciencestimes.com/2022/05/introducing-mood-a-new-mobile-app-that-lets-users-track-how-they-feel-with-one-tap-a-day/ 2022-05-11T16:42:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/The-Mood.jpg https://bostonlifesciencestimes.com/2022/05/relex-solutions-acquires-formulate-to-advance-promotional-planning-solutions-as-part-of-unified-platform/ 2022-05-12T14:24:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Mikko-Karkkainen.jpg https://bostonlifesciencestimes.com/2022/05/unlearn-receives-draft-qualification-opinion-from-european-medicines-agency-for-using-the-procova-framework-to-implement-twinrcts/ 2022-05-12T14:26:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Charles-Fisher-PhD.jpeg https://bostonlifesciencestimes.com/2022/05/tellius-and-indegene-partner-to-help-life-sciences-companies-enhance-patient-journeys-with-faster-data-backed-decision-making/ 2022-05-12T14:31:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Ajay-Khanna.jpg https://bostonlifesciencestimes.com/2022/05/thermo-fisher-scientifics-clinical-research-business-named-a-leader-in-decentralized-clinical-trial-solutions-by-isg/ 2022-05-12T14:33:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Thermo-Fisher.jpg https://bostonlifesciencestimes.com/2022/05/isomorphic-labs-announces-first-phase-of-management-team/ 2022-05-12T14:36:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Demis-Hassabis-PhD.jpeg https://bostonlifesciencestimes.com/2022/05/maternal-health-startup-mahmee-raises-9-2m-series-a-led-by-goldman-sachs-asset-management/ 2022-05-12T15:27:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Linda-Hanna.jpg https://bostonlifesciencestimes.com/2022/05/brainlab-announces-the-majority-acquisition-of-medphoton/ 2022-05-12T15:30:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Stefan-Vilsmeier.jpg https://bostonlifesciencestimes.com/2022/05/wysa-receives-fda-breakthrough-device-designation-for-ai-led-mental-health-conversational-agent/ 2022-05-12T15:33:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Wysa.jpg https://bostonlifesciencestimes.com/2022/05/dexlevo-first-in-asia-to-win-best-injectable-award-at-amwc-the-worlds-largest-congress-for-aesthetic-anti-aging/ 2022-05-12T15:38:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/DEXLEVO.jpg https://bostonlifesciencestimes.com/2022/05/henry-schein-donates-200000-to-howard-and-meharry-dental-schools-to-support-care-for-the-underserved/ 2022-05-12T15:44:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Henry-Schein.jpg https://bostonlifesciencestimes.com/2022/05/harvard-medtech-appoints-anita-breedlove-vice-president-of-market-partnerships/ 2022-05-12T15:47:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Harvard-MedTech.jpg https://bostonlifesciencestimes.com/2022/05/kriya-announces-270-million-series-c-financing-to-advance-fully-integrated-gene-therapy-engine/ 2022-05-16T14:50:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Shankar-Ramaswamy-M.D..jpg https://bostonlifesciencestimes.com/2022/05/trinity-life-sciences-announces-the-opening-of-state-of-the-art-office-in-india/ 2022-05-16T14:52:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Trinity-Life-Sciences.jpg https://bostonlifesciencestimes.com/2022/05/genoa-ventures-promotes-vikram-chaudhery-ph-d-to-partner/ 2022-05-16T14:54:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Vikram-Chaudhery-Ph.D..jpg https://bostonlifesciencestimes.com/2022/05/quebecs-life-sciences-strategy-2022-2025-a-promising-plan-for-bioquebecs-members-and-quebecs-life-sciences-industry/ 2022-05-16T14:57:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/BIOQuebec.jpg https://bostonlifesciencestimes.com/2022/05/axion-biosystems-welcomes-biotech-industry-leader-kevin-gould-as-new-ceo/ 2022-05-16T14:59:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Kevin-Gould.jpg https://bostonlifesciencestimes.com/2022/05/lg-chem-develops-advanced-plastic-product-to-prevent-thermal-runaway-in-ev-batteries/ 2022-05-16T15:01:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/LG-Chem.jpg https://bostonlifesciencestimes.com/2022/05/blade-therapeutics-presents-data-from-phase-1-and-preclinical-studies-of-cudetaxestat-at-the-american-thoracic-society-2022-international-conference/ 2022-05-16T15:06:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Blade-Therapeutics-Inc.jpg https://bostonlifesciencestimes.com/2022/05/eikon-therapeutics-announces-the-election-of-robin-l-washington-to-its-board-of-directors/ 2022-05-16T15:07:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Robin-L.-Washington.jpg https://bostonlifesciencestimes.com/2022/05/innovative-ai-software-for-the-detection-of-pancreatic-diseases-first-in-human-application-successful/ 2022-05-16T15:10:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/AI-software.jpg https://bostonlifesciencestimes.com/2022/05/saint-gobain-announces-100-million-expansion-of-its-certainteed-roofing-facility-in-peachtree-city-georgia-more-than-doubling-production-capacity-and-reducing-co2-emissions/ 2022-05-16T15:23:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Saint-Gobain.jpg https://bostonlifesciencestimes.com/2022/05/fidelity-releases-2022-retiree-health-care-cost-estimate-65-year-old-couple-retiring-today-will-need-an-average-of-315000-for-medical-expenses/ 2022-05-16T15:26:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Hope-Manion.jpg https://bostonlifesciencestimes.com/2022/05/altoida-joins-digital-medicine-societys-dime-alzheimers-disease-and-related-dementias-project-to-advance-next-generation-predictive-biomarkers/ 2022-05-16T15:29:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Travis-Bond.png https://bostonlifesciencestimes.com/2022/05/bioohio-launches-gene-and-cell-therapy-gct-industry-council/ 2022-05-17T14:35:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Eddie-Pauline.png https://bostonlifesciencestimes.com/2022/05/nuritas-announces-north-american-headquarters-ceo-to-relocate-to-us/ 2022-05-17T14:40:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Dr.-Nora-Khaldi.jpg https://bostonlifesciencestimes.com/2022/05/civetta-therapeutics-appoints-jesse-smith-ph-d-as-cso-and-susan-ashwell-ph-d-as-svp-of-chemistry/ 2022-05-17T14:47:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Jesse-Smith-Ph.D.-1.png https://bostonlifesciencestimes.com/2022/05/optomec-announces-delivery-of-600th-industrial-printer-for-additive-manufacturing/ 2022-05-17T15:02:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Optomec-CS-250-DED-machine.jpg https://bostonlifesciencestimes.com/2022/05/julien-bradley-joins-cellchorus-as-advisor/ 2022-05-17T15:05:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Julien-Bradley.jpg https://bostonlifesciencestimes.com/2022/05/new-milestone-clinical-study-shows-postbiotic-urolithin-a-mitopure-improves-muscle-strength-and-exercise-performance-in-middle-aged-adults/ 2022-05-17T15:17:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Amazentis.jpg https://bostonlifesciencestimes.com/2022/05/arieca-announces-6-5m-series-a-funding-round/ 2022-05-17T15:34:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Arieca.jpg https://bostonlifesciencestimes.com/2022/05/university-of-nebraska-medical-center-and-ananda-scientific-announce-fda-approval-of-the-ind-for-a-clinical-trial-exploring-treatment-for-post-traumatic-stress-disorder/ 2022-05-17T15:47:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Ananda.jpg https://bostonlifesciencestimes.com/2022/05/proscia-introduces-ai-powered-quality-control-to-accelerate-data-driven-drug-development/ 2022-05-17T15:49:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Proscia.jpg https://bostonlifesciencestimes.com/2022/05/forensic-laboratories-gain-unique-flexibility-with-spectrum-ce-system/ 2022-05-17T15:51:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/The-Spectrum-CE-System.jpg https://bostonlifesciencestimes.com/2022/05/alzamend-neuro-announces-pre-ind-submission-for-al001-as-a-treatment-of-bipolar-disorder-major-depressive-disorder-and-post-traumatic-stress-disorder/ 2022-05-17T15:54:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Stephan-Jackman.jpg https://bostonlifesciencestimes.com/2022/05/vertex-announces-further-expansion-in-the-boston-seaport-at-dedication-of-the-jeffrey-leiden-center-for-cell-and-genetic-therapies/ 2022-05-17T15:57:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Reshma-Kewalramani-M.D..jpg https://bostonlifesciencestimes.com/2022/05/vivasure-medical-announces-series-d-financing-to-advance-portfolio-of-perqseal-vessel-closure-devices/ 2022-05-17T15:59:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Andrew-Glass.png https://bostonlifesciencestimes.com/2022/05/exactech-announces-fda-breakthrough-device-designation-for-jointmedicas-polymotion-hip-resurfacing-system/ 2022-05-17T16:07:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/JointMedicas-Polymotion%C2%AE-Hip-Resurfacing-System.jpg https://bostonlifesciencestimes.com/2022/05/appliedvr-partners-with-kernel-to-measure-brain-activity-changes-before-during-and-after-virtual-reality-vr-treatment-of-chronic-pain/ 2022-05-17T16:08:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Kernel-FlowVR-Neuroimaging-Technology.jpg https://bostonlifesciencestimes.com/2022/05/paragon-28-expands-soft-tissue-portfolio-with-grappler-suture-anchor-system-launch/ 2022-05-17T16:10:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/he-Grappler%E2%84%A2-Suture-Anchor-System.jpg https://bostonlifesciencestimes.com/2022/05/linear-health-sciences-announces-u-s-fda-clearance-and-health-canada-approval-of-its-orchid-safety-release-valve-srv/ 2022-05-17T16:13:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Nancy-Moureau-PhD.png https://bostonlifesciencestimes.com/2022/05/jabil-healthcare-announces-the-launch-of-the-qfinity-autoinjector-platform-a-reusable-drug-delivery-device-with-broad-applicability/ 2022-05-18T13:51:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Jabil-Healthcare.jpg https://bostonlifesciencestimes.com/2022/05/anji-pharma-completes-patient-enrollment-in-phase-2-study-of-pradigastat-in-functional-constipation/ 2022-05-18T13:58:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Anji-Pharma.jpg https://bostonlifesciencestimes.com/2022/05/freudenberg-medical-launches-helixflex-tpe-tubing-for-bioprocessing-applications-at-pharmapack-2022/ 2022-05-18T14:11:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/HelixFlex%E2%84%A2-TPE-tubing.jpg https://bostonlifesciencestimes.com/2022/05/labcorp-receives-emergency-use-authorization-for-first-non-prescription-at-home-collection-kit-for-combined-covid-19-flu-and-rsv-detection/ 2022-05-18T14:16:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Labcorp.jpg https://bostonlifesciencestimes.com/2022/05/article-reviews-the-evolution-of-arthroscopy-from-its-invention-in-1912-to-the-dawn-of-the-wireless-arthrofree-era/ 2022-05-18T15:09:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Lazurites-ArthroFree.jpg https://bostonlifesciencestimes.com/2022/05/scai-2022-scientific-sessions-highlight-impella-research-advancements-to-improve-cardiogenic-shock-outcomes/ 2022-05-18T15:12:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Impella-RP.jpg https://bostonlifesciencestimes.com/2022/05/anchor-line-partners-topps-off-cambridge-building-100-leased-with-two-life-sciences-tenants/ 2022-05-18T17:10:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/60-first-st.webp https://bostonlifesciencestimes.com/2022/05/vertex-pharmaceuticals-to-occupy-related-beals-planned-development-of-22-drydock-avenue/ 2022-05-18T17:19:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/22-drydock.webp https://bostonlifesciencestimes.com/2022/05/rocket-pharmaceuticals-presents-positive-top-line-data-from-severe-leukocyte-adhesion-deficiency-i-program-at-the-25th-annual-meeting-of-the-american-society-of-gene-and-cell-therapy/ 2022-05-19T15:32:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Rocket-Pharma.webp https://bostonlifesciencestimes.com/2022/05/chemistry-shorts-releases-new-film-about-water-and-future-water-supply-plans-additional-chemistry-productions/ 2022-05-19T15:44:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Untapped-Potentia.jpg https://bostonlifesciencestimes.com/2022/05/thermo-fisher-scientific-and-labshares-partner-to-support-emerging-boston-biotechs/ 2022-05-19T15:49:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Thermo-Fisher.jpg https://bostonlifesciencestimes.com/2022/05/biognosys-announces-appointment-of-beat-luthi-ph-d-as-independent-board-director/ 2022-05-19T16:07:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Dr.-Luthi.jpg https://bostonlifesciencestimes.com/2022/05/labcorp-launches-new-test-for-people-with-skin-cancer/ 2022-05-19T16:15:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Labcorp-1.jpg https://bostonlifesciencestimes.com/2022/05/myrtelle-enters-into-a-worldwide-exclusive-license-agreement-with-rescue-hearing-to-develop-and-commercialize-gene-therapy-for-the-treatment-of-hearing-loss/ 2022-05-19T16:22:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Mark-Pykett.jpg https://bostonlifesciencestimes.com/2022/05/veranex-announces-strategic-investments-from-accelmed-partners-and-lauxera-capital-partners/ 2022-05-19T17:00:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/David-Dockhorn.jpg https://bostonlifesciencestimes.com/2022/05/suketu-upadhyay-elected-to-vertex-board-of-directors/ 2022-05-19T17:03:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Suketu-Upadhyay.jpg https://bostonlifesciencestimes.com/2022/05/milestone-scientific-expands-access-to-safe-more-comfortable-and-effective-epidural-for-expecting-parents-during-womens-health-month/ 2022-05-19T17:05:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Arjan-Haverhals.png https://bostonlifesciencestimes.com/2022/05/lumendi-files-for-510k-clearance-for-two-new-products/ 2022-05-19T17:07:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/DiLumen-EZ%C2%B9.jpg https://bostonlifesciencestimes.com/2022/05/paragon-28-launches-tenotac-2-0-soft-tissue-stabilization-system-for-hammertoe-and-soft-tissue-repair/ 2022-05-19T17:08:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/TenoTac.jpg https://bostonlifesciencestimes.com/2022/05/henry-schein-announces-participation-in-william-blair-emerging-technologies-in-dental-care-virtual-investor-conference/ 2022-05-19T17:12:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Henry-Schein-1.jpg https://bostonlifesciencestimes.com/2022/05/comera-life-sciences-debuts-as-publicly-traded-company-focused-on-transforming-biologics/ 2022-05-20T14:39:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Jeff-Hackman.png https://bostonlifesciencestimes.com/2022/05/booz-allen-hamilton-names-kristine-martin-anderson-as-chief-operating-officer/ 2022-05-20T14:44:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Booz-Allen-Hamilton.png https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Kristine-Martin-Anderson.jpeg https://bostonlifesciencestimes.com/2022/05/award-winning-orthodontics-startup-klowen-nabs-10-5m-series-a-for-custom-braces-system/ 2022-05-20T14:45:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/KLOwen.jpg https://bostonlifesciencestimes.com/2022/05/align-technology-introduces-invisalign-outcome-simulator-pro-next-generation-patient-communication-tool/ 2022-05-20T14:55:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/ligns-Invisalign-Outcome-Simulator-Pro.jpg https://bostonlifesciencestimes.com/2022/05/precision-biosciences-appoints-juli-blanche-as-chief-people-officer/ 2022-05-23T14:48:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Juli-Blanche.jpg https://bostonlifesciencestimes.com/2022/05/pfizer-biontech-covid-19-vaccine-demonstrates-strong-immune-response-high-efficacy-and-favorable-safety-in-children-6-months-to-under-5-years-of-age-following-third-dose/ 2022-05-23T14:56:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Pfizer.jpg https://bostonlifesciencestimes.com/2022/05/pharmacyte-biotech-initiates-studies-to-confirm-its-pancreatic-cancer-therapy-can-treat-malignant-ascites/ 2022-05-23T14:58:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Kenneth-L.-Waggoner.jpg https://bostonlifesciencestimes.com/2022/05/the-art-of-the-brick-and-enchroma-offer-color-blind-dads-a-memorable-colorful-fathers-day-experience/ 2022-05-23T15:00:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/EnChroma.jpg https://bostonlifesciencestimes.com/2022/05/vectorious-announces-vector-hf-i-study-confirms-safety-and-accuracy-of-v-lap-in-heart-sensor-for-left-atrial-pressure-management-of-heart-failure/ 2022-05-23T15:06:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Eyal-Orion.jpg https://bostonlifesciencestimes.com/2022/05/alnylam-presents-new-18-month-results-from-exploratory-cardiac-endpoints-in-helios-a-phase-3-study-of-investigational-vutrisiran/ 2022-05-23T15:23:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Alnylam-Pharmaceuticals.png https://bostonlifesciencestimes.com/2022/05/micro-tech-endoscopy-partners-with-wision-a-i-to-distribute-its-ai-assisted-polyp-detection-software-in-the-u-s/ 2022-05-23T15:41:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Micro-Tech.jpg https://bostonlifesciencestimes.com/2022/05/health-care-service-corporation-joins-civicascript-to-make-lower-cost-generic-medicines-available-to-its-members/ 2022-05-23T15:55:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/CivicaScript.jpg https://bostonlifesciencestimes.com/2022/05/chemours-announces-process-innovation-with-new-viton-fluoroelastomers-advanced-polymer-architecture-apa-offering/ 2022-05-23T15:59:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Denise-Dignam.jpg https://bostonlifesciencestimes.com/2022/05/cosette-pharmaceuticals-and-alembic-pharmaceuticals-limited-announce-the-approval-and-launch-of-a-national-brand-equivalent-nbe-of-abreva/ 2022-05-24T12:27:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Apurva-Saraf.jpg https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Abreva.jpg https://bostonlifesciencestimes.com/2022/05/miravo-healthcare-announces-appointment-of-dale-maccandlish-weil-to-its-board-of-directors/ 2022-05-24T12:29:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Dale-MacCandlish-Weil.jpg https://bostonlifesciencestimes.com/2022/05/microbiology-students-using-labster-virtual-labs-see-19-test-score-improvements-over-traditional-reading-materials/ 2022-05-24T12:50:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Dr.-Manuela-Tripepi.jpg https://bostonlifesciencestimes.com/2022/05/fda-approves-dermavants-vtama-tapinarof-cream-1-first-topical-novel-chemical-entity-launched-for-psoriasis-in-the-u-s-in-25-years/ 2022-05-24T12:53:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/VTAMA.jpg https://bostonlifesciencestimes.com/2022/05/alithea-genomics-raises-chf-1-million-in-seed-financing-round-led-by-novalis-biotech/ 2022-05-24T13:05:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Riccardo-Dainese.webp https://bostonlifesciencestimes.com/2022/05/galapagos-in-licenses-novel-drug-targets-for-inflammatory-bowel-disease-discovered-by-scipher-medicines-spectra-platform/ 2022-05-24T13:13:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Alif-Saleh-e1653397982299.png https://bostonlifesciencestimes.com/2022/05/zz-biotechs-stroke-drug-moves-closer-to-pivotal-phase-3-clinical-trial-as-the-nih-awards-first-tranche-of-30-million-grant-to-the-keck-school-of-medicine-of-usc/ 2022-05-24T13:19:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Kent-Pryor-PhD.jpg https://bostonlifesciencestimes.com/2022/05/medexecwomen-third-annual-conference-in-boston-june-14-2022/ 2022-05-24T13:22:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/MedExecWomen.jpg https://bostonlifesciencestimes.com/2022/05/shoulder-surgeons-perform-first-u-s-surgeries-using-exactechs-next-generation-cage-glenoid/ 2022-05-24T13:25:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/The-Equinoxe.jpg https://bostonlifesciencestimes.com/2022/05/upstream-peripheral-technologies-partners-with-red-one-medical-to-facilitate-access-of-the-goback-catheter-to-the-va-health-system/ 2022-05-24T13:43:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/GoBack.jpg https://bostonlifesciencestimes.com/2022/05/moves-raises-5-million-to-empower-gig-workers-to-own-the-gig-economy/ 2022-05-24T13:45:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Moves.jpg https://bostonlifesciencestimes.com/2022/05/peter-sanborn-joins-arbor-ventures-as-general-partner/ 2022-05-24T13:49:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Peter-Sanborn.jpg https://bostonlifesciencestimes.com/2022/05/pfizer-presents-elevate-pivotal-findings-demonstrating-etrasimods-potentially-best-in-class-profile-in-ulcerative-colitis/ 2022-05-24T13:50:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Pfizer.jpg https://bostonlifesciencestimes.com/2022/05/napoli-shkolnik-files-a-class-action-complaint-against-the-long-island-veterans-home/ 2022-05-24T13:52:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Joseph-L.-Ciaccio.jpg https://bostonlifesciencestimes.com/2022/05/foot-levelers-momentous-endowment-creates-chair-in-biomechanics-and-human-performance-supports-research-education-for-evidence-based-patient-centered-outcomes/ 2022-05-25T16:22:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Foot-Levelers.jpg https://bostonlifesciencestimes.com/2022/05/lg-chem-life-sciences-innovation-center-and-labcentral-announce-the-2022-golden-ticket-winner/ 2022-05-25T16:26:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/LG-Chem-Life-Sciences.jpg https://bostonlifesciencestimes.com/2022/05/terremoto-biosciences-launches-with-75-million-series-a-financing-and-mission-to-discover-and-develop-groundbreaking-covalent-medicines/ 2022-05-25T16:29:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/usd.jpg https://bostonlifesciencestimes.com/2022/05/targan-secures-35m-series-c-financing-led-by-mountain-group-partners-and-novaquest-capital-management-to-commercialize-novel-vaccine-delivery-system-for-poultry-industry/ 2022-05-25T16:39:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/TARGAN.jpg https://bostonlifesciencestimes.com/2022/05/good-meat-partners-with-industry-leader-to-build-the-worlds-first-large-scale-cultivated-meat-facility/ 2022-05-25T16:42:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/GOOD-Meat.jpg https://bostonlifesciencestimes.com/2022/05/multi-omics-startup-pleno-inc-announces-15-million-in-pre-series-a-funding/ 2022-05-25T16:46:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Pieter-van-Rooyen.webp https://bostonlifesciencestimes.com/2022/05/lumenis-optilight-wins-2022-medtech-breakthrough-award-best-new-technology-solution-for-ophthalmology/ 2022-05-25T16:50:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/OptiLight.jpg https://bostonlifesciencestimes.com/2022/05/healthcare-technology-veteran-greg-nagy-joins-mdisrupt-as-chief-operating-officer/ 2022-05-25T16:54:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Greg-Nagy.png https://bostonlifesciencestimes.com/2022/05/arrivo-bioventures-closes-enrollment-in-large-phase-2-clinical-trial-for-major-depressive-disorder/ 2022-05-26T15:46:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Arrivo-BioVentures.png https://bostonlifesciencestimes.com/2022/05/element-biosciences-debuts-new-headquarters-in-san-diego/ 2022-05-26T15:53:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Element-Biosciences.jpg https://bostonlifesciencestimes.com/2022/05/the-phadia-2500-instrument-family-now-available-in-the-u-s-for-autoimmune-testing/ 2022-05-26T15:55:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Thermo-Fisher-1.jpg https://bostonlifesciencestimes.com/2022/05/biosynth-carbosynth-further-expands-life-sciences-platform-with-acquisition-of-aalto-bio-reagents/ 2022-05-26T15:58:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Dr.-Urs-Spitz.png https://bostonlifesciencestimes.com/2022/05/alchemab-appoints-young-t-kwon-as-chief-executive-officer/ 2022-05-26T16:05:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Young-T.-Kwon.jpeg https://bostonlifesciencestimes.com/2022/05/virtamed-and-medical-microinstruments-partner-to-advance-the-skills-of-surgeons-performing-complex-robotic-microsurgeries/ 2022-05-26T16:09:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Stefan-Tuchschmid.jpg https://bostonlifesciencestimes.com/2022/05/nexus-medical-labs-receives-fda-emergency-use-authorization-for-sars-cov-2-test-using-the-rhinostic-automated-nasal-swab-from-rhinostics/ 2022-05-26T16:13:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/RHINOstic-1.jpg https://bostonlifesciencestimes.com/2022/05/visual-system-brain-development-implicated-in-infants-who-develop-autism/ 2022-05-26T16:31:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Baby-falling-asleep.jpg https://bostonlifesciencestimes.com/2022/05/castle-biosciences-decisiondx-melanoma-test-receives-2022-medtech-breakthrough-award/ 2022-05-27T16:49:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Castle-Biosciences.png https://bostonlifesciencestimes.com/2022/05/dtx-pharma-appoints-michael-huang-md-as-chief-medical-officer/ 2022-05-31T13:44:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Michael-Huang-MD.jpg https://bostonlifesciencestimes.com/2022/05/pai-life-sciences-doses-first-healthy-volunteer-in-schistosomiasis-vaccine-clinical-trial/ 2022-05-31T13:53:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/SchistoShield.jpg https://bostonlifesciencestimes.com/2022/05/astorg-to-acquire-global-medical-communications-and-market-access-platform-open-health-from-amulet-capital-partners/ 2022-05-31T14:05:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Rob-Barker.jpg https://bostonlifesciencestimes.com/2022/05/u-s-hospitals-could-save-2-28-billion-by-maximizing-use-of-reprocessed-single-use-devices/ 2022-05-31T14:10:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Daniel-J.-Vukelich-e1654006243241.jpg https://bostonlifesciencestimes.com/2022/05/altoida-appoints-neuroscience-pioneer-dr-antontella-santuccione-chadha-as-chief-medical-officer/ 2022-05-31T14:14:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Altoida.jpg https://bostonlifesciencestimes.com/2022/05/orthofix-m6-c-artificial-cervical-disc-ide-study-data-to-be-presented-at-isass-demonstrates-continued-statistically-significant-benefits-at-five-years/ 2022-05-31T14:18:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/M6-C-artificial-cervical-disc.jpg https://bostonlifesciencestimes.com/2022/05/axonics-files-pma-supplement-with-fda-for-fourth-generation-rechargeable-neurostimulator/ 2022-05-31T14:30:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Axonics.jpg https://bostonlifesciencestimes.com/2022/05/infineon-and-pmdtechnologies-develop-3d-depth-sensing-technology-for-magic-leap-2/ 2022-05-31T14:32:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Magic-Leap-2.jpg https://bostonlifesciencestimes.com/2022/05/fuel-this-global-running-day-with-potatoes/ 2022-05-31T14:38:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Runners-fueling-with-potaotes.jpg https://bostonlifesciencestimes.com/2022/05/allegion-announces-ceo-succession/ 2022-05-31T14:40:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/John-H.-Stone.jpg https://bostonlifesciencestimes.com/2022/05/mana-capital-acquisition-corp-and-cardio-diagnostics-inc-announce-definitive-business-combination-agreement-to-create-publicly-listed-company/ 2022-05-31T14:44:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Meesha-Dogan-Ph.D.webp https://bostonlifesciencestimes.com/2022/06/massbio-releases-study-identifying-workforce-needs-and-challenges-within-massachusetts-life-sciences-industry/ 2022-06-01T14:17:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Joe-Boncore.jpg https://bostonlifesciencestimes.com/2022/06/realta-life-sciences-inc-doses-first-patient-in-phase-1b-inhaled-lps-challenge-clinical-trial-to-support-development-of-rls-0071-in-severe-asthma/ 2022-06-01T14:28:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Kenji-Cunnion-M.D.-M.P.H..jpg https://bostonlifesciencestimes.com/2022/06/moxe-health-raises-30m-series-b-to-further-advance-interoperability/ 2022-06-01T14:52:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Dan-Wilson.png https://bostonlifesciencestimes.com/2022/06/perimeter-medical-imaging-ai-appoints-experienced-medtech-executive-chris-scott-as-chief-financial-officer/ 2022-06-01T15:15:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Perimeter-Medical-Imaging-AI.jpg https://bostonlifesciencestimes.com/2022/06/atricure-announces-the-appointment-of-deborah-yount-as-chief-human-resources-officer/ 2022-06-01T15:21:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/AtriCure.jpg https://bostonlifesciencestimes.com/2022/06/transcat-strengthens-central-region-presence-with-acquisition-of-alliance-calibration/ 2022-06-01T15:38:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Transcat.jpg https://bostonlifesciencestimes.com/2022/06/launch-of-art-fixation-system-from-ngmedical-germany/ 2022-06-01T15:39:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/ART%C2%AE-Fixation-System.jpg https://bostonlifesciencestimes.com/2022/06/dr-terry-wahls-joins-levels-as-advisor/ 2022-06-01T15:43:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Dr.-Terry-Wahls.jpg https://bostonlifesciencestimes.com/2022/06/paradigm-convergence-technologies-corporations-hydrolyte-can-be-used-to-kill-monkeypox-virus/ 2022-06-01T15:45:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Paradigm-Convergence-Technologies-Corporation.png https://bostonlifesciencestimes.com/2022/06/prince-edward-island-becomes-a-national-leader-in-providing-coverage-for-dexcom-g6-continuous-glucose-monitoring-system-for-canadians-with-diabetes/ 2022-06-01T15:47:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/The-Dexcom-G6-CGM-System.jpg https://bostonlifesciencestimes.com/2022/06/harborone-bancorp-names-anne-margulies-to-board-of-directors/ 2022-06-01T15:49:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Anne-Margulies.jpg https://bostonlifesciencestimes.com/2022/06/massive-bio-raises-9-million-to-scale-growth-and-fuel-global-expansion-of-its-ai-enabled-oncology-clinical-trial-platform/ 2022-06-02T14:18:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Massive-Bio.jpg https://bostonlifesciencestimes.com/2022/06/tellius-appoints-hardik-chheda-to-chief-product-officer-and-john-aven-to-head-of-engineering/ 2022-06-02T14:21:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Hardik-Chheda-e1654179657108.jpg https://bostonlifesciencestimes.com/2022/06/bigbear-ai-announces-key-leadership-appointments-in-finance-and-corporate-development/ 2022-06-02T14:22:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Julie-Peffer.jpg https://bostonlifesciencestimes.com/2022/06/childrens-hospital-los-angeles-awarded-3-million-to-study-opioid-use-in-hospitalized-infants/ 2022-06-02T14:26:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Childrens-Hospital-Los-Angeles.jpg https://bostonlifesciencestimes.com/2022/06/bayer-appoints-two-new-members-to-u-s-country-leadership-team/ 2022-06-02T17:11:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Brian-Branca.jpg https://bostonlifesciencestimes.com/2022/06/mabxience-continues-manufacturing-capacity-expansion-with-abec-single-use-bioreactor-technology/ 2022-06-02T17:13:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/mAbxience.jpg https://bostonlifesciencestimes.com/2022/06/endpoint-health-raises-52-million-in-financing-to-expand-and-progress-precision-immunology-pipeline/ 2022-06-02T17:15:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Jason-Springs.webp https://bostonlifesciencestimes.com/2022/06/u-s-cdc-endorses-the-use-of-digital-pcr-technology-for-wastewater-surveillance-of-infectious-diseases-including-covid-19-outbreaks/ 2022-06-02T17:19:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Dr.-Thomas-Schweins.jpg https://bostonlifesciencestimes.com/2022/06/upstream-bio-launches-with-200m-series-a-financing-to-advance-novel-therapeutics-for-allergic-and-inflammatory-diseases/ 2022-06-02T17:21:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Aaron-Deykin-MD.png https://bostonlifesciencestimes.com/2022/06/spectrumai-announces-9-million-in-seed-funding-to-innovate-autism-care/ 2022-06-02T17:27:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/SpectrumAi.jpg https://bostonlifesciencestimes.com/2022/06/study-data-show-premia-spines-tops-spinal-arthroplasty-system-is-cost-effective-compared-with-tlif-becomes-dominant-strategy-over-time/ 2022-06-02T17:34:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/TOPS%E2%84%A2-Spinal-Arthroplasty-System.jpg https://bostonlifesciencestimes.com/2022/06/igentify-announces-new-hires/ 2022-06-02T17:40:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Igentify.jpg https://bostonlifesciencestimes.com/2022/06/curia-adopts-the-berkeley-lights-platform-to-expand-its-antibody-discovery-capabilities/ 2022-06-06T14:33:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Berkeley-Lights.jpg https://bostonlifesciencestimes.com/2022/06/covid-19-patients-with-both-type-2-diabetes-and-heart-disease-have-greater-risk-of-death/ 2022-06-06T14:36:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/03/covid3.jpg https://bostonlifesciencestimes.com/2022/06/thermo-fisher-scientific-collaborates-with-transmit-gmbh-on-a-high-performance-orbitrap-mass-spectrometry-imaging-platform/ 2022-06-06T14:37:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Thermo-Fisher.jpg https://bostonlifesciencestimes.com/2022/06/bruker-announces-key-innovations-for-highly-multiplexed-spatial-proteomics-and-multiomic-tissue-imaging-at-large-field-of-view/ 2022-06-06T14:39:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/MALDI-HiPLEX-IHC.jpg https://bostonlifesciencestimes.com/2022/06/bruker-introduces-novel-point-of-need-applied-mass-spectrometry-tools-for-accelerated-measurements-without-chromatography/ 2022-06-06T14:41:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/DART-EVOQ-PoN-Mass-Spec.jpg https://bostonlifesciencestimes.com/2022/06/bruker-launches-timstof-ht-with-greater-dynamic-range-for-further-enhancing-unbiased-high-confidence-4d-proteomics/ 2022-06-06T14:55:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Six-timsTOF-Pro-2-systems.jpg https://bostonlifesciencestimes.com/2022/06/prominent-litigation-partner-christopher-j-sullivan-joins-nutter-in-new-york/ 2022-06-06T14:57:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Christopher-J.-Sullivan.jpg https://bostonlifesciencestimes.com/2022/06/advanced-hplc-column-delivers-improved-separation-performance-and-protein-identification-in-comprehensive-new-proteomics-workflow/ 2022-06-06T15:00:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Thermo-Scientific-%C2%B5PAC-Neo-HPLC-Column.jpg https://bostonlifesciencestimes.com/2022/06/novel-mass-spectrometry-solution-simplifies-insight-gathering-into-macromolecular-complexes/ 2022-06-06T15:01:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Thermo-Scientific-Q-Exactive-UHMR-Hybrid-Quadrupole-Orbitrap-mass-spectrometers.jpg https://bostonlifesciencestimes.com/2022/06/expanded-liquid-chromatography-mass-spectrometry-platform-provides-all-in-one-toxicology-solution/ 2022-06-06T15:13:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Tox-Explorer-Collection.jpg https://bostonlifesciencestimes.com/2022/06/prometheus-materials-raises-8-million-to-decarbonize-the-building-materials-industry-in-series-a-funding-round-led-by-sofinnova-partners/ 2022-06-06T15:16:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/zero-carbon-blocks.jpg https://bostonlifesciencestimes.com/2022/06/waters-introduces-high-resolution-mass-spectrometry-products-and-software-to-accelerate-drug-development/ 2022-06-06T15:18:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Xevo-G3-QTof.jpg https://bostonlifesciencestimes.com/2022/06/washingtons-litter-prevention-campaign-aims-to-curb-roadside-debris/ 2022-06-06T15:30:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/litter.png https://bostonlifesciencestimes.com/2022/06/the-wellsky-foundation-grants-100000-to-the-american-heart-association-to-provide-stem-scholarships-and-educational-opportunities/ 2022-06-06T15:33:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/WellSky-Foundation.png https://bostonlifesciencestimes.com/2022/06/alpine-immune-sciences-appoints-andrew-s-sandler-m-d-as-chief-medical-officer/ 2022-06-07T13:23:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Andrew-S.-Sandler-M.D..jpg https://bostonlifesciencestimes.com/2022/06/ecp-pharmas-path-forward-clearer-after-fdas-response-to-pre-ind-submission-on-its-neurological-cns-diseases-drug-products/ 2022-06-07T13:26:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/ECP-Pharma.webp https://bostonlifesciencestimes.com/2022/06/entos-pharmaceuticals-expands-rd-operations-into-the-us/ 2022-06-07T13:29:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/The-Muse-at-Torrey-Pines.jpg https://bostonlifesciencestimes.com/2022/06/integrated-dna-technologies-beckman-coulter-life-sciences-ink-distribution-deal/ 2022-06-07T13:34:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Biomek-NGeniuS-Next-Generation-Sequencing-Library-Prep-System.jpg https://bostonlifesciencestimes.com/2022/06/iqvia-appoints-dr-christina-mack-chief-scientific-officer-of-real-world-solutions/ 2022-06-07T13:38:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Dr.-Christina-Mack.jpg https://bostonlifesciencestimes.com/2022/06/thermo-fisher-scientific-updates-applied-biosystems-quantstudio-5-dx-real-time-pcr-system-to-comply-with-ivdr-regulations/ 2022-06-07T13:40:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/The-IVDR-compliant-QuantStudio-5-Dx-System.jpg https://bostonlifesciencestimes.com/2022/06/stratcap-acquires-cleveland-data-center/ 2022-06-07T13:44:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Cleveland-Data-Center.jpg https://bostonlifesciencestimes.com/2022/06/code-biotherapeutics-raises-upsized-and-oversubscribed-75-million-in-series-a-financing-to-develop-therapies-for-debilitating-genetic-diseases/ 2022-06-07T13:52:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Brian-P.-McVeigh.webp https://bostonlifesciencestimes.com/2022/06/rhinostics-announces-first-close-of-its-series-a-2-financing-round-led-by-shadow-capital/ 2022-06-07T13:56:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/The-RHINOstic%C2%AE-Automated-Nasal-Swab.jpg https://bostonlifesciencestimes.com/2022/06/vonco-products-expands-highlights-customer-innovation-experience-greater-capacity-and-new-jobs/ 2022-06-07T14:09:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Vonco.jpg https://bostonlifesciencestimes.com/2022/06/continual-raises-14-5-million-series-a-to-unite-analytics-ai-teams-on-the-modern-data-stack/ 2022-06-08T15:09:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Continual.jpg https://bostonlifesciencestimes.com/2022/06/renewable-sources-now-supplying-over-20-of-promega-global-electricity-use/ 2022-06-08T15:18:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Promega.jpg https://bostonlifesciencestimes.com/2022/06/pillar-biosciences-strengthens-leadership-team-with-appointment-of-vincent-ricci-as-chief-financial-officer/ 2022-06-08T15:23:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Vincent-Ricci.png https://bostonlifesciencestimes.com/2022/06/lazurite-named-one-of-the-industrys-hottest-companies-by-worlds-largest-medtech-accelerator/ 2022-06-08T15:27:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Lazurite-President-Leah-Brownlee-and-CEO-Eugene-Malinskiy.jpg https://bostonlifesciencestimes.com/2022/06/over-100m-procedures-performed-with-nanosonics-trophon-devices-across-north-america-since-2011-protecting-patients-from-ultrasound-probe-cross-contamination/ 2022-06-08T15:31:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Nanosonics.png https://bostonlifesciencestimes.com/2022/06/corvista-health-announces-drs-vallerie-v-mclaughlin-and-mark-g-rabbat-join-medical-advisory-board/ 2022-06-08T15:33:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Dr.-Mark-G.-Rabbat.jpg https://bostonlifesciencestimes.com/2022/06/avellino-welcomes-virginia-gambale-to-its-board-of-directors/ 2022-06-08T15:56:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Virginia-Gambale.jpg https://bostonlifesciencestimes.com/2022/06/gi-partners-acquires-bostons-451-d-street-life-sciences-asset/ 2022-06-08T15:57:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/451-D-Street.webp https://bostonlifesciencestimes.com/2022/06/wavemaker-three-sixty-health-closes-fund-ii-at-64-million/ 2022-06-09T15:49:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/John-Nackel-PhD.webp https://bostonlifesciencestimes.com/2022/06/bayers-vividion-emerging-as-significant-player-in-san-diego-biotech-hub/ 2022-06-09T15:51:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Jeffrey-Hatfield.jpg https://bostonlifesciencestimes.com/2022/06/curia-and-replicate-bioscience-enter-strategic-collaboration-to-create-groundbreaking-development-platform-for-self-replicating-rna-srrna/ 2022-06-09T15:55:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Andrew-Geall-Ph.D..png https://bostonlifesciencestimes.com/2022/06/stada-and-alvotech-broaden-european-patients-options-by-launching-hukyndra-high-concentration-citrate-free-adalimumab/ 2022-06-09T16:02:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Bryan-Kim.webp https://bostonlifesciencestimes.com/2022/06/massachusetts-innovation-network-announces-its-2022-eddies-finalists/ 2022-06-09T16:11:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Massachusetts-Innovation-Network.jpg https://bostonlifesciencestimes.com/2022/06/fda-clears-thermo-scientific-elia-rna-pol-iii-and-elia-rib-p-tests-for-use-in-u-s/ 2022-06-09T16:22:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Thermo-Fisher-1.jpg https://bostonlifesciencestimes.com/2022/06/aurion-biotech-appoints-dr-michael-goldstein-as-president-and-chief-medical-officer/ 2022-06-09T17:11:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Dr.-Michael-Goldstein.jpg https://bostonlifesciencestimes.com/2022/06/binx-health-ceo-jeffrey-luber-announced-as-an-ey-entrepreneur-of-the-year-2022-new-england-award-winner/ 2022-06-09T17:21:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Jeffrey-Luber.jpg https://bostonlifesciencestimes.com/2022/06/paragon-28-launches-monkey-rings-circular-external-fixation-system/ 2022-06-09T17:25:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Monkey-Rings.jpg https://bostonlifesciencestimes.com/2022/06/bright-uro-launches-with-6-million-in-seed-financing-and-grant-from-national-institutes-of-health/ 2022-06-09T17:27:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Bright-Uro.webp https://bostonlifesciencestimes.com/2022/06/applied-uv-announces-international-dealer-awarded-sole-source-provider-contract-for-airocides-fda-class-ii-listed-medical-device/ 2022-06-09T17:31:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Applied-UV.jpg https://bostonlifesciencestimes.com/2022/06/amerihealth-caritas-appoints-loretta-lenko-president-of-its-exchange-business/ 2022-06-09T17:36:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Loretta-Lenko.jpg https://bostonlifesciencestimes.com/2022/06/pfizer-completes-acquisition-of-reviral/ 2022-06-09T17:37:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Pfizer.jpg https://bostonlifesciencestimes.com/2022/06/china-nmpa-approves-tislelizumab-for-recurrent-or-metastatic-nasopharyngeal-cancer/ 2022-06-10T13:32:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/BeiGene.png https://bostonlifesciencestimes.com/2022/06/mei-pharma-and-kyowa-kirin-report-clinical-data-on-zandelisib-at-european-hematology-association-2022-hybrid-congress/ 2022-06-10T13:34:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/MEI-Pharma.jpg https://bostonlifesciencestimes.com/2022/06/adc-therapeutics-announces-results-from-pivotal-phase-2-clinical-trial-of-camidanlumab-tesirine-cami-in-relapsed-or-refractory-hodgkin-lymphoma/ 2022-06-10T13:36:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/ADC-Therapeutics-SA.png https://bostonlifesciencestimes.com/2022/06/elektrofi-raises-40-million-financing-to-establish-gmp-manufacturing-capabilities-for-upcoming-clinical-studies-and-expand-development-pipeline/ 2022-06-13T13:04:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Elektrofi-scaled.jpg https://bostonlifesciencestimes.com/2022/06/adc-therapeutics-names-david-gilman-as-chief-business-strategy-officer/ 2022-06-13T13:12:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/David-Gilman.jpg https://bostonlifesciencestimes.com/2022/06/artiva-biotherapeutics-celebrates-official-opening-of-san-diego-corporate-headquarters-and-rd-lab-facilities/ 2022-06-13T13:15:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Artiva.jpg https://bostonlifesciencestimes.com/2022/06/biotech-firm-tackling-covid-19-and-m-bovis-announces-successful-development-of-rapid-accurate-johnes-disease-assay/ 2022-06-13T13:20:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Pictor-Limited.jpg https://bostonlifesciencestimes.com/2022/06/new-research-reveals-roughly-4-in-5-moderate-to-severe-acne-sufferers-have-missed-moments-in-their-life-due-to-acne/ 2022-06-13T13:24:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/avi-clear.jpg https://bostonlifesciencestimes.com/2022/06/lensar-receives-u-s-fda-clearance-of-ally-adaptive-cataract-treatment-system/ 2022-06-13T13:27:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/LENSAR.webp https://bostonlifesciencestimes.com/2022/06/chevron-completes-acquisition-of-renewable-energy-group/ 2022-06-13T13:36:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Chevron-e1655127354726.png https://bostonlifesciencestimes.com/2022/06/maureen-knott-named-president-of-the-henry-schein-cares-foundation/ 2022-06-13T13:38:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Maureen-Knott.jpg https://bostonlifesciencestimes.com/2022/06/electric-micro-mobility-vehicle-striemo-to-launch-by-end-of-2022/ 2022-06-13T13:41:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Striemo.jpg https://bostonlifesciencestimes.com/2022/06/renovation-cleanroom-expansion-increase-production-capabilities-at-spectrum-plastics-groups-minneapolis-facility/ 2022-06-13T14:10:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Spectrum-Plastics-Group-Minneapolis.jpg https://bostonlifesciencestimes.com/2022/06/happify-health-and-almirall-go-live-with-digital-solution-to-support-psoriasis-patients/ 2022-06-13T14:20:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Happify-Health.jpg https://bostonlifesciencestimes.com/2022/06/gentegra-expands-nucleic-acid-sample-stabilization-product-portfolio-to-include-rna-in-fresh-tissues/ 2022-06-14T13:28:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Robert-Bob-Barrett.png https://bostonlifesciencestimes.com/2022/06/donaldson-company-expands-life-sciences-portfolio-acquires-purilogics/ 2022-06-14T13:42:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Donaldson-Company.png https://bostonlifesciencestimes.com/2022/06/tilt-biotherapeutics-announces-over-10-million-financing-to-advance-oncology-immunotherapy-assets/ 2022-06-14T13:44:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Akseli-Hemminki.jpg https://bostonlifesciencestimes.com/2022/06/cemvita-factory-acquires-biomining-company-solfatara/ 2022-06-14T13:53:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Cemvita-Factory.jpg https://bostonlifesciencestimes.com/2022/06/oragenics-announces-publication-of-positive-data-for-its-nt-cov2-1-intranasal-covid-19-vaccine-candidate-in-scientific-reports/ 2022-06-14T13:55:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Oragenics.jpg https://bostonlifesciencestimes.com/2022/06/xenco-medical-expands-its-ambulatory-surgery-center-device-portfolio-with-fda-clearance-and-launch-of-its-multilevel-cervikit/ 2022-06-14T13:59:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Xenco-Medical.jpg https://bostonlifesciencestimes.com/2022/06/digital-therapeutics-alliance-and-healthware-group-partner-to-build-european-coalition-to-scale-access-to-digital-therapeutics/ 2022-06-14T14:01:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Digital-Therapeutics-Alliance.jpg https://bostonlifesciencestimes.com/2022/06/cardiawave-confirms-the-safety-of-valvosoft-its-non-invasive-ultrasound-treatment-for-aortic-stenosis/ 2022-06-14T14:07:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Benjamin-Bertrand.jpg https://bostonlifesciencestimes.com/2022/06/sga-designed-9-story-life-sciences-lab-building-boynton-yards-celebrates-grand-opening/ 2022-06-14T14:13:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Boynton-Yards.webp https://bostonlifesciencestimes.com/2022/06/new-healthcare-ready-executive-director-brings-more-than-a-decade-of-global-health-readiness-and-response-expertise/ 2022-06-14T14:27:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Tom-Cotter-MPH.jpg https://bostonlifesciencestimes.com/2022/06/boston-cambridge-market-ranks-1-in-life-sciences-talent-report/ 2022-06-14T14:39:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Eric-Smith.webp https://bostonlifesciencestimes.com/2022/06/world-innovation-lab-raises-1-billion-to-bridge-the-innovation-gap-across-the-global-venture-ecosystem/ 2022-06-14T14:54:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/WiLs-US-team.jpg https://bostonlifesciencestimes.com/2022/06/saint-gobain-bioprocess-solutions-business-announces-c-flex-production-capability-in-suwa-japan/ 2022-06-15T14:07:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Saint-Gobain-Life-Sciences.jpg https://bostonlifesciencestimes.com/2022/06/biotechnology-innovation-organization-bio-elects-mike-huckman-to-board-of-directors/ 2022-06-15T14:11:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Mike-Huckman.jpg https://bostonlifesciencestimes.com/2022/06/mit-northpond-program-created-to-advance-innovation-in-engineering-and-life-science/ 2022-06-15T14:14:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Ernest-Fraenkel-PhD.jpg https://bostonlifesciencestimes.com/2022/06/slingshot-biosciences-inc-partners-with-cambridge-bioscience-to-distribute-synthetic-cells-throughout-united-kingdom-and-ireland/ 2022-06-15T14:36:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Screenshot-2022-06-15-at-10-35-27-About-Us-%E2%80%A2-Slingshot-Bio.png https://bostonlifesciencestimes.com/2022/06/oregons-bio-boom-pandemic-ready-industry-surpasses-15-billion-footprint-in-oregon-creating-more-firms/ 2022-06-15T14:42:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Oregon.jpg https://bostonlifesciencestimes.com/2022/06/avilar-therapeutics-appoints-adam-muzikant-phd-as-chief-business-officer/ 2022-06-15T14:48:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Adam-Muzikant-PhD.jpg https://bostonlifesciencestimes.com/2022/06/olix-pharmaceuticals-subsidiary-mcurex-announces-mrna-technology-collaboration-with-toolgen-for-rare-eye-disease/ 2022-06-15T14:55:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/OliX-Pharmaceuticals.jpg https://bostonlifesciencestimes.com/2022/06/third-rock-ventures-raises-1-1-billion-fund-vi/ 2022-06-15T15:05:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Reid-Huber-Ph.D.-scaled-e1655305526788.jpg https://bostonlifesciencestimes.com/2022/06/inflammatix-appoints-purvesh-khatri-as-chief-scientific-officer/ 2022-06-15T15:08:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Purvesh-Khatri.webp https://bostonlifesciencestimes.com/2022/06/humana-healthy-horizons-commits-4-6-million-to-improve-health-of-ohioans/ 2022-06-15T15:16:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Humana-Healthy-Horizons.jpg https://bostonlifesciencestimes.com/2022/06/walgreens-and-greater-than-aids-partner-with-health-departments-and-community-organizations-to-provide-free-hiv-testing-and-information-in-more-than-250-cities-on-national-hiv-testing-day/ 2022-06-15T15:19:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/National-HIV-Testing-Day.jpg https://bostonlifesciencestimes.com/2022/06/koneksa-and-northwestern-university-awarded-a-grant-from-the-michael-j-fox-foundation-to-investigate-speech-symptoms-in-parkinsons-disease/ 2022-06-16T13:51:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Chris-Benko.jpg https://bostonlifesciencestimes.com/2022/06/alvotech-a-global-pureplay-biosimilars-company-to-debut-on-nasdaq-under-the-ticker-alvo-on-june-16/ 2022-06-16T13:53:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Screenshot_2021-05-11-Meet-the-Chairman.png https://bostonlifesciencestimes.com/2022/06/auxilius-raises-10-million-to-help-biopharma-manage-150-billion-in-clinical-rd-spend/ 2022-06-16T14:12:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Auxilius.jpg https://bostonlifesciencestimes.com/2022/06/reltio-appoints-eric-cross-as-chief-revenue-officer/ 2022-06-16T14:16:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Eric-Cross.webp https://bostonlifesciencestimes.com/2022/06/eikon-therapeutics-announces-long-term-lease-with-alexandria-real-estate-equities-inc-for-new-corporate-headquarters-in-the-san-francisco-bay-area/ 2022-06-16T14:20:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Eikon-Therapeutics.jpg https://bostonlifesciencestimes.com/2022/06/comera-life-sciences-appoints-michael-campbell-as-executive-vice-president-and-chief-financial-officer/ 2022-06-16T14:34:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Comera-Life-Sciences.jpg https://bostonlifesciencestimes.com/2022/06/aerin-medical-secures-60-million-in-equity-financing/ 2022-06-16T14:49:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Aerin-Medical.jpg https://bostonlifesciencestimes.com/2022/06/tandem-diabetes-care-welcomes-two-new-members-to-board-of-directors/ 2022-06-16T15:03:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Joao-Malagueira.jpg https://bostonlifesciencestimes.com/2022/06/senseonics-announces-ce-mark-approval-of-the-eversense-e3-continuous-glucose-monitoring-system/ 2022-06-16T15:11:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Timothy-T.-Goodnow-PhD.png https://bostonlifesciencestimes.com/2022/06/u-s-district-court-enters-judgment-of-no-infringement-of-patent-asserted-against-kurin-inc-by-magnolia-medical-technologies-inc/ 2022-06-16T15:20:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Kurin-Inc.jpg https://bostonlifesciencestimes.com/2022/06/nomi-health-contributes-5-million-to-nonprofit-civica-to-address-crisis-of-skyrocketing-insulin-costs-for-americans/ 2022-06-16T15:23:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Screenshot-2022-06-16-at-11-23-12-bWFyay1uZXdtYW5AMngucG5n.avif-AVIF-Image-596-%C3%97-596-pixels.png https://bostonlifesciencestimes.com/2022/06/pfizer-biontech-covid-19-vaccine-receives-fda-emergency-use-authorization-for-children-6-months-through-4-years-of-age/ 2022-06-17T13:30:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Pfizer.jpg https://bostonlifesciencestimes.com/2022/06/the-civic-council-of-greater-kansas-city-announces-dr-dred-scott-as-president/ 2022-06-17T13:33:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Dr.-Dred-Scott.jpg https://bostonlifesciencestimes.com/2022/06/lyndra-therapeutics-president-and-chief-operations-officer-jessica-ballinger-named-to-national-small-business-association-nsba-leadership-council/ 2022-06-17T13:34:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Jessica-Ballinger.jpg https://bostonlifesciencestimes.com/2022/06/onward-awarded-european-innovation-council-grant-to-develop-brain-spine-interface-technology/ 2022-06-17T13:53:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/ONWARD-ARC-Brain-Spine-Interface.jpg https://bostonlifesciencestimes.com/2022/06/the-amerisourcebergen-foundation-commits-150000-to-equitable-vaccination-efforts-across-the-globe/ 2022-06-17T13:57:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/AmerisourceBergen.jpg https://bostonlifesciencestimes.com/2022/06/northstar-medical-technologies-llc-announces-promotion-of-frank-scholz-ph-d-to-president-and-chief-operating-officer/ 2022-06-20T13:25:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Frank-Scholz-Ph.D..jpg https://bostonlifesciencestimes.com/2022/06/with-the-commencement-of-gmp-manufacturing-operations-organabios-cdmo-offers-the-cell-therapy-industry-ready-access-to-flexible-manufacturing-solutions-and-clinical-grade-cellular-raw-materi/ 2022-06-20T13:28:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/OrganaBio.jpg https://bostonlifesciencestimes.com/2022/06/ge-healthcare-introduces-wireless-patient-monitoring-solution-to-help-clinicians-detect-early-patient-deterioration/ 2022-06-20T13:40:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Portrait-Mobile.jpg https://bostonlifesciencestimes.com/2022/06/valneva-and-pfizer-enter-into-an-equity-subscription-agreement-and-update-terms-of-collaboration-agreement-for-lyme-disease-vaccine-candidate-vla15/ 2022-06-20T13:46:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Pfizer.jpg https://bostonlifesciencestimes.com/2022/06/castle-biosciences-announces-support-for-ohsus-war-on-melanoma/ 2022-06-20T13:47:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Castle-Biosciences.png https://bostonlifesciencestimes.com/2022/06/walgreens-now-providing-pfizer-and-moderna-covid-19-vaccines-to-children-ages-3-and-older-at-select-locations-nationwide/ 2022-06-20T13:49:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Children-Ages-3-and-Older.jpg https://bostonlifesciencestimes.com/2022/06/bruker-presents-high-value-life-science-materials-research-and-applied-market-solutions-at-analytica-2022/ 2022-06-21T14:29:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/HYPERION.jpg https://bostonlifesciencestimes.com/2022/06/aizon-launches-gxp-compliant-data-processing-solution-to-accelerate-digital-transformation-for-life-sciences-manufacturing/ 2022-06-21T14:31:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/John-Vitalie.jpg https://bostonlifesciencestimes.com/2022/06/iktos-and-zealand-pharma-to-develop-artificial-intelligence-technology-for-peptide-drug-design/ 2022-06-21T14:36:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Yann-Gaston-Mathe.png https://bostonlifesciencestimes.com/2022/06/labcorp-enhances-clinical-trial-and-drug-development-capabilities-through-real-world-data-collaboration-with-healthverity/ 2022-06-21T14:38:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Labcorp.jpg https://bostonlifesciencestimes.com/2022/06/agilent-laboratory-achieves-green-lab-certification/ 2022-06-21T14:41:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Padraig-McDonnell.jpg https://bostonlifesciencestimes.com/2022/06/carbon-biosciences-launches-with-38-million-series-a-financing-to-advance-novel-gene-therapy-platform-and-pipeline/ 2022-06-21T15:10:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Joel-Schneider-Ph.D..jpg https://bostonlifesciencestimes.com/2022/06/adva-and-ii-vi-incorporated-unveil-industrys-first-100zr-pluggable-coherent-transceiver-for-the-optical-network-edge/ 2022-06-21T15:12:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/ADVAs-new-pluggable-100ZR-transceiver.jpg https://bostonlifesciencestimes.com/2022/06/allied-motion-technologies-adds-precision-linear-and-rotary-motor-technology-with-acquisition-of-airex-llc/ 2022-06-21T15:30:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Allied-Motion-Technologies.jpg https://bostonlifesciencestimes.com/2022/06/city-center-realty-partners-sells-class-a-office-building-in-twin-cities-suburb-to-investment-company-oshaughnessy-holding-company/ 2022-06-21T15:44:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/City-Center-Realty-Partners.jpg https://bostonlifesciencestimes.com/2022/06/envoy-medical-receives-fda-ide-approval-to-begin-early-feasibility-study-of-acclaim-cochlear-implant/ 2022-06-21T16:09:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Envoy-Medical.webp https://bostonlifesciencestimes.com/2022/06/spectrumx-strengthens-senior-leadership/ 2022-06-21T16:20:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/SpectrumX.jpg https://bostonlifesciencestimes.com/2022/06/advault-senior-vp-says-electronic-advance-care-plans-can-reduce-waste-in-us-healthcare-spending-by-honoring-patient-wishes/ 2022-06-21T17:48:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/ADVault.jpg https://bostonlifesciencestimes.com/2022/06/dalrada-financial-corporation-appoints-brian-mcgoff-as-president-and-chief-operating-officer/ 2022-06-21T17:50:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Brian-McGoff.jpg https://bostonlifesciencestimes.com/2022/06/dr-andrew-kolodny-appointed-president-of-physicians-for-responsible-opioid-prescribing/ 2022-06-21T17:52:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Andrew-Kolodny-MD.jpg https://bostonlifesciencestimes.com/2022/06/ellipses-announces-fda-clearance-of-ind-application-for-ep0031-for-patients-with-advanced-ret-altered-malignancies/ 2022-06-22T13:38:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Dr-Rajan-Jethwa.png https://bostonlifesciencestimes.com/2022/06/biogen-and-happify-health-collaborate-to-support-multiple-sclerosis-patients-on-digital-platform/ 2022-06-22T13:55:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Biogen.png https://bostonlifesciencestimes.com/2022/06/gemelli-biotech-completes-19-million-series-a-financing/ 2022-06-22T14:18:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Matt-Mitcho.webp https://bostonlifesciencestimes.com/2022/06/comera-life-sciences-announces-issuance-of-u-s-patent-for-proprietary-excipients-in-sqore-platform/ 2022-06-22T14:30:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Comera-Life-Sciences.jpg https://bostonlifesciencestimes.com/2022/06/biomed-realty-announces-landmark-lease-with-takeda-at-585-kendall-to-accommodate-cambridge-expansion/ 2022-06-22T14:43:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Kendall-Square-innovation-ecosystem.jpg https://bostonlifesciencestimes.com/2022/06/bay-point-advisors-funds-10-million-line-of-credit-to-reveam/ 2022-06-22T14:45:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Bay-Point-Advisors.png https://bostonlifesciencestimes.com/2022/06/john-walter-named-ceo-of-food-allergy-science-initiative/ 2022-06-22T14:50:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/John-Walter.jpg https://bostonlifesciencestimes.com/2022/06/harvard-medtech-to-participate-in-study-on-virtual-reality-therapy-with-johns-hopkins-medicine/ 2022-06-22T14:53:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Harvard-MedTech.jpg https://bostonlifesciencestimes.com/2022/06/zebras-first-healthcare-grade-tablets-deliver-better-patient-and-provider-experience/ 2022-06-22T15:03:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/New-rugged-ET4x-HC-series.jpg https://bostonlifesciencestimes.com/2022/06/vamstar-closes-9-5m-series-a-to-expand-ai-based-global-healthcare-supply-chain-platform/ 2022-06-22T15:08:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Vamstar.jpg https://bostonlifesciencestimes.com/2022/06/transine-therapeutics-poised-for-growth-with-new-cso-hire-and-tripling-of-lab-space/ 2022-06-23T14:17:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Jan-Thirkettle.jpg https://bostonlifesciencestimes.com/2022/06/fujirebio-acquires-adx-neurosciences-and-confirms-its-intentions-to-bring-better-and-earlier-neurodegenerative-disease-diagnostic-solutions-to-the-global-diagnostics-industry/ 2022-06-23T14:19:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Goki-Ishikawa.png https://bostonlifesciencestimes.com/2022/06/usa-fda-grants-fast-track-designation-to-realta-life-sciences-lead-compound-rls-0071-for-the-treatment-of-hypoxic-ischemic-encephalopathy-in-neonates/ 2022-06-23T14:26:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Ulrich-Thienel-MD-PhD.jpg https://bostonlifesciencestimes.com/2022/06/treatment-with-hepcludex-bulevirtide-meets-primary-endpoint-and-achieves-significant-response-in-chronic-hepatitis-delta-virus-at-48-weeks/ 2022-06-23T14:29:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Hepcludex.jpg https://bostonlifesciencestimes.com/2022/06/dalrada-financial-corporation-appoints-professor-elizabeth-winzeler-to-healthcare-advisory-board/ 2022-06-23T14:32:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Brian-Bonar.png https://bostonlifesciencestimes.com/2022/06/ancora-heart-appoints-mark-miles-as-chief-commercial-officer/ 2022-06-23T14:38:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Mark-Miles.jpg https://bostonlifesciencestimes.com/2022/06/stemcell-technologies-receives-iso-14001-certification-of-environmental-management-system/ 2022-06-23T14:43:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/STEMCELL-Technologies.png https://bostonlifesciencestimes.com/2022/06/xentria-announces-initial-findings-showing-novel-biologic-xtmab-16s-potential-to-reduce-sarcoidosis-granuloma/ 2022-06-23T14:46:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Thomas-Shea.jpg https://bostonlifesciencestimes.com/2022/06/carequest-institute-partners-with-journal-of-public-health-dentistry-on-anti-racism-issue/ 2022-06-23T14:50:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/CareQuest.jpg https://bostonlifesciencestimes.com/2022/06/dr-reddys-laboratories-announces-the-acquisition-of-an-injectable-product-portfolio-from-eton-pharma/ 2022-06-24T14:23:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Dr.-Reddy.webp https://bostonlifesciencestimes.com/2022/06/investigational-lenacapavir-receives-positive-chmp-opinion-for-people-with-multi-drug-resistant-hiv/ 2022-06-24T14:24:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Gilead-Sciences.png https://bostonlifesciencestimes.com/2022/06/tigerlily-foundation-and-labcorp-collaborate-to-increase-clinical-trial-diversity-for-women-of-color/ 2022-06-24T14:42:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Tigerlily.jpg https://bostonlifesciencestimes.com/2022/06/biolexis-and-akston-biosciences-announce-encouraging-top-line-results-from-phase-ii-iii-trial-of-their-thermostable-2nd-gen-covid-19-vaccine/ 2022-06-24T15:16:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Akston-Biosciences.jpg https://bostonlifesciencestimes.com/2022/06/entegris-and-cmc-materials-receive-china-antitrust-clearance-for-pending-acquisition/ 2022-06-24T15:27:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Entegris.png https://bostonlifesciencestimes.com/2022/06/denver-health-names-donna-lynne-next-ceo/ 2022-06-24T15:33:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Donna-Lynne.jpg https://bostonlifesciencestimes.com/2022/06/kuria-therapeutics-and-scohia-pharma-announce-strategic-licensing-agreement-for-ophthalmic-and-dermal-rights-to-sco-116-a-novel-nrf2-activator/ 2022-06-27T13:22:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Kuria-Therapeutics.jpg https://bostonlifesciencestimes.com/2022/06/virpax-will-pursue-direct-to-otc-pathway-for-epoladerm-for-pain-associated-with-osteoarthritis/ 2022-06-27T13:31:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Anthony-P.-Mack.jpg https://bostonlifesciencestimes.com/2022/06/landmark-study-reveals-new-technology-from-debogy-molecular-significantly-reduces-the-bacteria-and-deadly-infection-that-can-occur-following-a-surgical-implant/ 2022-06-27T13:39:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Wayne-Gattinella.jpg https://bostonlifesciencestimes.com/2022/06/fda-favorably-concludes-hb4-wheat-food-and-feed-safety-evaluation/ 2022-06-27T13:49:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Bioceres-Crop-Solutions-Corp.png https://bostonlifesciencestimes.com/2022/06/limbach-holdings-inc-expands-technology-focus-and-appoints-christos-ruci-to-chief-information-officer/ 2022-06-27T13:55:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Christos-Ruci.jpg https://bostonlifesciencestimes.com/2022/06/dtx-pharma-appoints-peter-condon-as-chief-business-officer/ 2022-06-28T13:47:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Peter-Condon.jpg https://bostonlifesciencestimes.com/2022/06/swave-a-new-imec-and-vub-spin-off-raises-e7m-to-deliver-truly-realistic-ar-vr-experiences-to-applications-like-the-metaverse/ 2022-06-28T14:01:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Swave-Photonics.jpg https://bostonlifesciencestimes.com/2022/06/cerebral-therapeutics-inc-secures-40-million-series-c-financing/ 2022-06-28T14:06:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Screenshot-2022-06-28-at-10-04-42-Cerebral-Therapeutics-Management-Team-%E2%80%94-Cerebral-Therapeutics.png https://bostonlifesciencestimes.com/2022/06/charles-river-laboratories-announces-opening-of-u-k-manufacturing-facility/ 2022-06-28T14:12:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Charles-Rivers-High-Quality.jpg https://bostonlifesciencestimes.com/2022/06/kites-car-t-cell-therapy-yescarta-granted-european-marketing-authorization-for-the-treatment-of-relapsed-or-refractory-follicular-lymphoma/ 2022-06-28T14:22:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Christi-Shaw.jpg https://bostonlifesciencestimes.com/2022/06/vetters-newest-clinical-manufacturing-site-successfully-completed-its-first-customer-fills/ 2022-06-28T14:44:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Vial-filling-station-at-Vetters-Rankweil-site.jpg https://bostonlifesciencestimes.com/2022/06/palleon-pharmaceuticals-and-henlius-enter-into-strategic-collaboration-to-develop-bifunctional-sialidase-therapies/ 2022-06-28T14:53:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Palleon.jpg https://bostonlifesciencestimes.com/2022/06/athenahealth-expands-mobile-ehr-voice-capabilities-for-healthcare-providers/ 2022-06-28T15:02:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/athenahealth.jpg https://bostonlifesciencestimes.com/2022/06/sanaz-massoumi-joins-patient-safety-movement-foundation-as-new-chief-operating-officer/ 2022-06-28T15:23:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Sanaz-Massoumi.jpg https://bostonlifesciencestimes.com/2022/06/saving-lives-one-mammogram-at-a-time-vna-launches-its-worth-the-squeeze-initiative/ 2022-06-28T15:26:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Mammograms.jpg https://bostonlifesciencestimes.com/2022/06/university-of-hartford-partners-with-mantis-innovation-on-sustainability-initiatives-saving-5m-kwh/ 2022-06-28T15:32:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/University-of-Hartford.jpg https://bostonlifesciencestimes.com/2022/07/catalent-announces-new-operating-structure/ 2022-07-05T13:06:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/ALESSANDRO-MASELLI.png https://bostonlifesciencestimes.com/2022/07/virpax-pursues-otc-medical-device-pathway-for-anqlar/ 2022-07-05T13:07:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Virpax%C2%AE-Pharmaceuticals.jpg https://bostonlifesciencestimes.com/2022/07/syros-to-raise-approximately-190-million-through-merger-with-tyme-technologies-and-concurrent-private-placement/ 2022-07-05T13:09:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Dr.-Simonian.jpg https://bostonlifesciencestimes.com/2022/07/iveric-bio-and-delsitech-enter-exclusive-agreement-for-development-of-sustained-release-zimura/ 2022-07-05T13:13:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Pravin-U.-Dugel-MD.png https://bostonlifesciencestimes.com/2022/07/oxford-quantum-circuits-raises-38-million-series-a-to-accelerate-rd-and-expand-into-apac/ 2022-07-05T13:15:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Ilana-Wisby.jpg https://bostonlifesciencestimes.com/2022/07/applied-uv-announces-medline-places-follow-on-order/ 2022-07-05T13:18:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Scientific-Air-S400.jpg https://bostonlifesciencestimes.com/2022/07/with-its-acquisition-of-california-based-bartel-associates-foster-foster-continues-to-expand-its-national-footprint-as-a-premier-actuarial-firm/ 2022-07-05T13:22:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Foster-Foster.jpg https://bostonlifesciencestimes.com/2022/07/teva-announces-appointment-of-new-global-rd-and-chief-medical-officer/ 2022-07-05T13:29:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Eric-A.-Hughes.jpg https://bostonlifesciencestimes.com/2022/07/bearingpoint-appoints-19-new-partners-across-europe/ 2022-07-05T15:06:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Screenshot-2022-07-05-at-11-05-55-Roberto-Agatini.png https://bostonlifesciencestimes.com/2022/07/bruker-launches-nmr-based-molecular-phenomics-clinical-research-tool-for-long-covid-multi-organ-risk-assessment/ 2022-07-06T13:34:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/ANPC-Molecular-Phenomics-NMR-Lab.jpg https://bostonlifesciencestimes.com/2022/07/kbi-biopharma-and-selexis-hold-joint-ribbon-cutting-of-the-expanded-state-of-the-art-facility-in-geneva-switzerland/ 2022-07-06T13:38:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/KBI-Biopharma.jpg https://bostonlifesciencestimes.com/2022/07/labcorp-first-national-laboratory-to-offer-monkeypox-test/ 2022-07-06T13:45:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Labcorp.jpg https://bostonlifesciencestimes.com/2022/07/proteintech-group-inc-opens-new-singapore-office/ 2022-07-06T13:47:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Proteintech.jpg https://bostonlifesciencestimes.com/2022/07/twist-bioscience-opens-new-twist-boston-location-to-expand-antibody-discovery-capacity/ 2022-07-06T13:50:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Emily-M.-Leproust-Ph.D..webp https://bostonlifesciencestimes.com/2022/07/gnubiotics-sciences-announces-funding-from-the-swiss-innovation-agency-to-accelerate-development-of-glycopeptide-mediated-immunotherapies-against-solid-tumors/ 2022-07-06T13:53:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/GNUBIOTICS.jpg https://bostonlifesciencestimes.com/2022/07/new-12-month-results-from-rhintrac-randomized-controlled-trial-demonstrate-durable-safety-and-efficacy-of-aerin-medicals-rhinaer-for-treatment-of-chronic-rhinitis/ 2022-07-06T13:57:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/RHINTRAC.jpg https://bostonlifesciencestimes.com/2022/07/qhp-capital-acquires-lexitas-pharma-services/ 2022-07-07T14:30:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/George-Magrath-M.D..jpg https://bostonlifesciencestimes.com/2022/07/inficons-ul6000-fab-plus-makes-leak-testing-in-semiconductor-production-even-faster/ 2022-07-07T14:32:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/UL6000-Fab-PLUS-from-INFICON.jpg https://bostonlifesciencestimes.com/2022/07/new-study-shows-urolithin-a-mitopure-improves-mitochondrial-health-reduces-joint-cartilage-damage-and-alleviates-pain-in-osteoarthritis/ 2022-07-07T14:35:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Urolithin-A.jpg https://bostonlifesciencestimes.com/2022/07/burke-neurological-institute-receives-a-45-million-nih-grant-to-study-a-vitamin-b1-precursor-for-treatment-of-alzheimers-disease-in-multi-center-clinical-trial/ 2022-07-07T14:39:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Gary-Gibson-Ph.D.jpg https://bostonlifesciencestimes.com/2022/07/ventus-therapeutics-promotes-daniel-koerwer-to-chief-operating-officer/ 2022-07-07T14:41:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Daniel-Koerwer.jpg https://bostonlifesciencestimes.com/2022/07/henry-schein-completes-acquisition-of-condor-dental/ 2022-07-07T14:44:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Stanley-M.-Bergman.jpg https://bostonlifesciencestimes.com/2022/07/biocom-california-appoints-miguel-motta-as-vice-president-of-strategic-operations-and-head-of-its-san-diego-office/ 2022-07-07T14:49:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Miguel-Motta.jpg https://bostonlifesciencestimes.com/2022/07/meissa-vaccines-appoints-frank-glavin-chief-executive-officer/ 2022-07-11T14:15:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Frank-Glavin.webp https://bostonlifesciencestimes.com/2022/07/bruker-announces-three-new-ghz-nmr-systems-orders-for-functional-structural-biology-and-clinical-phenomics-research/ 2022-07-11T14:20:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Compact-1.0-GHz-NMR-magnet-Ascend-Evo.jpg https://bostonlifesciencestimes.com/2022/07/h2scan-names-david-meyers-president-and-chief-executive-officer/ 2022-07-11T14:22:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/David-Meyers.jpg https://bostonlifesciencestimes.com/2022/07/samsara-vision-announces-first-u-s-surgeries-of-the-sing-imt-for-age-related-macular-degeneration-as-part-of-the-concerto-study/ 2022-07-11T14:28:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/SING-IMT%E2%84%A2-by-Samsara-Vision.jpg https://bostonlifesciencestimes.com/2022/07/innoviva-to-acquire-la-jolla-pharmaceutical-company/ 2022-07-11T14:41:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/La-Jolla-Pharmaceutical.jpg https://bostonlifesciencestimes.com/2022/07/happify-health-weaves-a-new-path-as-twill-the-intelligent-healing-company/ 2022-07-12T14:10:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Tomer-Ben-Kiki.png https://bostonlifesciencestimes.com/2022/07/ever-pharma-launches-a-digital-training-app-for-the-d-mine-pump/ 2022-07-12T14:12:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/D-mine%C2%AE-Pump.jpg https://bostonlifesciencestimes.com/2022/07/spotlight-therapeutics-appoints-visionary-global-pharma-drug-developer-antoine-yver-m-d-m-sc-as-first-independent-board-member/ 2022-07-12T14:14:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Antoine-Yver-MD-MSc.jpg https://bostonlifesciencestimes.com/2022/07/saphetor-partners-with-ptc-therapeutics-to-advance-awareness-of-clinical-programs-in-rare-diseases/ 2022-07-12T14:15:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Saphetor.png https://bostonlifesciencestimes.com/2022/07/charles-river-associates-cra-global-life-sciences-practice-launches-data-analytics-platform/ 2022-07-12T14:22:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Screenshot-2022-07-12-at-10-21-21-Paul-Maleh-Our-People-Charles-River-Associates.png https://bostonlifesciencestimes.com/2022/07/akanda-to-supply-tetra-bio-pharma-with-pharmaceutical-grade-cannabis-for-fda-trials-of-qixleef-a-potential-multimillion-dollar-prescription-drug/ 2022-07-12T14:26:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/QIXLEEF.jpg https://bostonlifesciencestimes.com/2022/07/jcyte-announces-appointment-of-dr-stewart-craig-as-chief-technology-officer/ 2022-07-12T14:48:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Dr.-Stewart-Craig.jpg https://bostonlifesciencestimes.com/2022/07/colossal-biosciences-and-the-vertebrate-genomes-project-sequence-the-asian-elephant-genome-chromosome-to-chromosome/ 2022-07-12T14:50:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Arima-Hi-C-Assembly-of-the-Asian-Elephant.jpg https://bostonlifesciencestimes.com/2022/07/lysando-ag-strengthens-board-of-directors-by-appointment-of-mr-sang-jung-kim/ 2022-07-12T14:52:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Sang-Jung-Kim.jpg https://bostonlifesciencestimes.com/2022/07/markforged-to-expand-into-mass-production-of-end-use-metal-parts-through-digital-metal-acquisition/ 2022-07-12T14:54:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Shai-Terem.jpg https://bostonlifesciencestimes.com/2022/07/ancora-heart-receives-breakthrough-device-designation-from-fda-for-the-accucinch-ventricular-restoration-system/ 2022-07-12T14:57:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Screenshot-2022-07-12-at-10-56-28-Ancora-Heart-Receives-Breakthrough-Device-Designation-from-FDA-for-the-AccuCinch%C2%AE-Ventricular-Restoration-System.png https://bostonlifesciencestimes.com/2022/07/knopp-biosciences-and-population-health-partners-create-areteia-therapeutics-new-clinical-stage-asthma-company-with-350-million-in-funding/ 2022-07-12T14:59:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Areteia-Therapeutics-Inc..jpg https://bostonlifesciencestimes.com/2022/07/prenuvo-hires-doug-sweeny-as-chief-business-officer-leading-marketing-sales-and-product/ 2022-07-12T15:02:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Doug-Sweeny.jpg https://bostonlifesciencestimes.com/2022/07/startpage-launches-escape-route-to-protect-womens-health-browsing/ 2022-07-12T15:05:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Screenshot-2022-07-12-at-11-04-29-Startpage-Launches-Escape-Route-to-Protect-Womens-Health-Browsing.png https://bostonlifesciencestimes.com/2022/07/u-s-alliance-pharma-acquires-u-k-based-lgcs-drug-development-solutions-dds-business/ 2022-07-13T14:03:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Alliance-Pharma.png https://bostonlifesciencestimes.com/2022/07/protective-life-corporation-names-kathryn-cox-senior-vice-president-and-president-of-protection-division/ 2022-07-13T14:17:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Kathryn-Cox.jpg https://bostonlifesciencestimes.com/2022/07/xilis-announces-series-a-extension-bringing-total-round-to-over-us89-million/ 2022-07-13T14:40:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Xilis-Inc.jpg https://bostonlifesciencestimes.com/2022/07/labcorp-launches-new-test-to-identify-and-confirm-neurodegenerative-disease/ 2022-07-13T14:47:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Labcorp-1.jpg https://bostonlifesciencestimes.com/2022/07/sun-capital-partners-affiliate-acquires-andersen-commercial-plumbing/ 2022-07-13T14:57:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Sun-Capital-Partners.png https://bostonlifesciencestimes.com/2022/07/bytedance-invests-in-the-cryo-em-ai-powered-biotech-startup-shuimu-biosciences/ 2022-07-13T15:34:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Allen-Chunlong-Guo.jpg https://bostonlifesciencestimes.com/2022/07/lazurite-named-a-2022-top-10-surgical-solutions-provider-by-medtech-outlook-magazine/ 2022-07-13T17:25:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Lazurite.jpg https://bostonlifesciencestimes.com/2022/07/health-canada-clears-cuteras-aviclear/ 2022-07-13T17:29:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/AviClear-Console.jpg https://bostonlifesciencestimes.com/2022/07/orthofix-medical-and-limacorporate-announce-partnership-to-provide-solution-for-patients-with-high-hip-dislocation-for-the-us-market/ 2022-07-13T17:38:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Orthofixs-patented-Fitbone.jpg https://bostonlifesciencestimes.com/2022/07/carejourney-appoints-mah-jabeen-soobader-mph-ph-d-as-chief-analytics-officer/ 2022-07-13T17:42:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Mah-Jabeen-Soobader-MPH-Ph.D..jpg https://bostonlifesciencestimes.com/2022/07/lantern-pharma-receives-fda-authorization-to-initiate-its-phase-2-clinical-trial-harmonic-for-lp-300-in-never-smokers-with-non-small-cell-lung-cancer/ 2022-07-14T14:23:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Panna-Sharma.jpeg https://bostonlifesciencestimes.com/2022/07/innoviva-sells-15-economic-stake-in-theravance-respiratory-company-to-royalty-pharma-for-approximately-282-million-plus-full-ownership-of-existing-equity-investments/ 2022-07-14T14:31:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Innoviva.png https://bostonlifesciencestimes.com/2022/07/manifold-bio-raises-40-million-series-a-to-expand-in-vivo-biologics-design-platform/ 2022-07-14T14:34:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Gleb-Kuznetsov-PhD.jpg https://bostonlifesciencestimes.com/2022/07/henley-appoints-rodrigo-mansur-as-us-investment-director/ 2022-07-14T14:50:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Rodrigo-Mansu.jpg https://bostonlifesciencestimes.com/2022/07/exactech-announces-successful-first-surgeries-with-latest-instrumentation-for-its-newton-balanced-knee-technology/ 2022-07-14T14:59:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/The-Newton-Knee.jpg https://bostonlifesciencestimes.com/2022/07/national-study-by-finra-foundation-finds-u-s-adults-financial-capability-has-generally-grown-despite-pandemic-disruption/ 2022-07-14T15:19:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/FINRA-Investor-Education-Foundation.png https://bostonlifesciencestimes.com/2022/07/immune-onc-therapeutics-announces-appointment-of-christopher-whitmore-as-chief-financial-officer-and-provides-clinical-progress-update/ 2022-07-14T15:28:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Screenshot-2022-07-14-at-11-27-29-Team-%E2%80%94-Immune-Onc-Therapeutics.png https://bostonlifesciencestimes.com/2022/07/clarify-health-launches-clarify-access-a-software-solution-to-generate-on-demand-market-access-reports-delivering-robust-payer-insights-and-intelligence-to-pharma-industry/ 2022-07-14T15:38:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Clarify-Access.jpg https://bostonlifesciencestimes.com/2022/07/unitedhealth-group-reports-second-quarter-2022-results/ 2022-07-15T14:33:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/UnitedHealth-Group.jpg https://bostonlifesciencestimes.com/2022/07/enveda-appoints-pharma-veteran-vanitha-sekar-as-chief-business-officer/ 2022-07-15T14:35:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Vanitha-Sekar.jpg https://bostonlifesciencestimes.com/2022/07/endostart-appoints-christopher-rowland-chairman-of-the-companys-board-of-directors/ 2022-07-15T14:48:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Christopher-Rowland.jpg https://bostonlifesciencestimes.com/2022/07/bostons-life-sciences-market-tops-3-million-sf-of-leasing-during-q2/ 2022-07-15T14:52:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Screenshot-2022-07-15-at-10-50-40-Bostons-Life-Sciences-Market-Tops-3-Million-SF-of-Leasing-During-Q2-Boston-Real-Estate-Times.png https://bostonlifesciencestimes.com/2022/07/infosys-to-acquire-life-sciences-consulting-and-technology-leader-base-life-science/ 2022-07-15T15:44:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/infosys.png https://bostonlifesciencestimes.com/2022/07/seaport-circle-to-add-650000-sf-life-sciences-space/ 2022-07-18T14:47:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Screenshot-2022-07-18-at-10-46-03-Seaport-Circle-to-Add-650-000-SF-Life-Sciences-Space-Boston-Real-Estate-Times.png https://bostonlifesciencestimes.com/2022/07/n-lorem-foundation-ceo-publishes-important-perspective-in-nucleic-acid-research/ 2022-07-18T14:50:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Dr.-Stanley-Crooke.jpg https://bostonlifesciencestimes.com/2022/07/blackrock-and-qls-advisors-partner-through-blackrock-systematic-to-invest-in-biomedical-innovation/ 2022-07-18T14:53:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Rich-Kushel.jpg https://bostonlifesciencestimes.com/2022/07/rome-therapeutics-appoints-industry-veteran-jeff-hatfield-as-chair-of-board-of-directors/ 2022-07-18T15:01:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/JEFF-HATFIELD-e1658156465452.jpg https://bostonlifesciencestimes.com/2022/07/alzamend-neuro-receives-positive-pre-ind-response-from-fda-for-al001-treatment-of-bipolar-disorder-major-depressive-disorder-and-post-traumatic-stress-disorder/ 2022-07-18T15:03:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Stephan-Jackman.jpg https://bostonlifesciencestimes.com/2022/07/workers-compensation-executive-chris-watson-appointed-evp-and-chief-operating-officer-of-harvard-medtech/ 2022-07-18T15:05:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Chris-Watson.jpg https://bostonlifesciencestimes.com/2022/07/exactech-launches-significant-update-to-equinoxe-shoulder-preoperative-planning-app/ 2022-07-18T15:09:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Equinoxe%C2%AE-Shoulder-Preoperative-Planning-App.jpg https://bostonlifesciencestimes.com/2022/07/radialis-pet-imager-receives-fda-clearance/ 2022-07-18T15:14:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Radialis.jpg https://bostonlifesciencestimes.com/2022/07/techmer-pm-bolsters-its-quality-management-system-at-illinois-plant-with-an-eye-on-medical-devices/ 2022-07-18T15:30:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Insulin-injector.jpg https://bostonlifesciencestimes.com/2022/07/antenna-group-names-edelmans-eric-schoenberg-chief-operating-officer/ 2022-07-18T15:37:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Eric-Schoenberg.jpg https://bostonlifesciencestimes.com/2022/07/dalrada-names-jose-arrieta-as-chief-strategy-officer-of-dalrada-financial-corporation-and-president-of-dalrada-technologies/ 2022-07-18T15:39:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Jose-Arrieta.jpg https://bostonlifesciencestimes.com/2022/07/symbiosis-hires-jahan-ali-phd-as-vice-president-of-business-development/ 2022-07-19T13:46:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Jahan-Ali-PhD-e1658238390771.png https://bostonlifesciencestimes.com/2022/07/moov-secures-david-arkow-as-head-of-global-sales-to-further-leadership-in-used-semiconductor-equipment-market/ 2022-07-19T13:51:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/David-Arkow.jpg https://bostonlifesciencestimes.com/2022/07/blackstone-and-hudson-pacific-receive-approval-at-planning-committee-to-develop-world-class-studio-facility-in-the-uk/ 2022-07-19T14:01:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Sunset-Waltham-Cross-Studios.jpg https://bostonlifesciencestimes.com/2022/07/labcorp-expands-automated-clinical-trial-kit-production-line-at-european-operations-center/ 2022-07-19T14:03:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Labcorp-2.jpg https://bostonlifesciencestimes.com/2022/07/persephone-biosciences-closes-15m-seed-financing-round/ 2022-07-19T14:07:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Stephanie-Culler.jpg https://bostonlifesciencestimes.com/2022/07/new-study-of-aerin-medicals-rhinaer-shows-positive-clinical-and-quality-of-life-results-following-treatment-for-chronic-rhinitis/ 2022-07-19T14:09:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/RELIEF.jpg https://bostonlifesciencestimes.com/2022/07/paragraf-announces-innovate-uk-biomedical-catalyst-grant-award-to-develop-the-first-proof-of-concept-graphene-based-diagnostic-test-to-immediately-identify-patients-who-need-an-antibiotic-treatm/ 2022-07-19T14:12:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Graphene-based-Diagnostic-Test.jpg https://bostonlifesciencestimes.com/2022/07/fev-tutor-announces-strategic-acquisition-by-alpine-investors/ 2022-07-19T14:13:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Alpine.jpg https://bostonlifesciencestimes.com/2022/07/bighat-biosciences-raises-75-million-in-series-b-funding-to-design-safer-more-effective-antibodies/ 2022-07-20T13:44:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Peyton-Greenside.jpg https://bostonlifesciencestimes.com/2022/07/medical-microinstruments-secures-75m-to-advance-robotic-microsurgery/ 2022-07-20T13:52:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Medical-Microinstruments.jpg https://bostonlifesciencestimes.com/2022/07/guided-therapeutics-receives-institutional-review-board-approval-to-start-clinical-study-for-fda-approval-of-the-luviva-advanced-cervical-scan/ 2022-07-20T13:55:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Guided-Therapeutics-Inc..jpg https://bostonlifesciencestimes.com/2022/07/spinal-elements-announces-first-commercial-cases-utilizing-the-karma-mis-system/ 2022-07-20T14:03:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Spinal-Elements.jpg https://bostonlifesciencestimes.com/2022/07/eikon-therapeutics-announces-lease-for-east-coast-base-of-operations-in-new-york-city/ 2022-07-21T14:52:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Roger-M.-Perlmutter-MD-PhD.png https://bostonlifesciencestimes.com/2022/07/benson-hills-inaugural-esg-report-links-food-science-data-science-and-plant-science-to-drive-modernization-of-the-food-system/ 2022-07-21T14:59:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Benson-Hil.jpg https://bostonlifesciencestimes.com/2022/07/wenzel-spine-announces-first-awake-spinal-fusion-using-varilift-lx/ 2022-07-21T15:31:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Bill-Wilson.webp https://bostonlifesciencestimes.com/2022/07/city-of-hoboken-partners-with-volta-to-expand-ev-charging-infrastructure-at-no-cost-to-city/ 2022-07-21T15:46:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/City-of-Hoboken.jpg https://bostonlifesciencestimes.com/2022/07/sixty-three-percent-of-americans-believe-people-with-mental-health-conditions-treated-differently/ 2022-07-21T16:54:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/LifeWorks.png https://bostonlifesciencestimes.com/2022/07/pharmacyte-biotech-commences-first-phase-of-two-phase-pig-study/ 2022-07-21T16:56:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Kenneth-L.-Waggoner.jpg https://bostonlifesciencestimes.com/2022/07/accenture-to-acquire-eclipse-automation-to-help-clients-build-factories-of-the-future/ 2022-07-21T16:58:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Accenture.jpg https://bostonlifesciencestimes.com/2022/07/willis-smith-capital-acquires-je-manufacturing/ 2022-07-21T17:07:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Eric-Willis.webp https://bostonlifesciencestimes.com/2022/07/innovaderm-shines-as-key-partner-in-clinical-development-and-study-management-of-newly-fda-approved-psoriasis-drug-tapinarof/ 2022-07-21T17:14:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Dr.-Robert-Bissonnette.jpg https://bostonlifesciencestimes.com/2022/07/sila-realty-trust-inc-completes-acquisition-of-tgh-rehabilitation-hospital-for-51-2-million/ 2022-07-21T17:29:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Michael-A.-Seton.jpg https://bostonlifesciencestimes.com/2022/07/frederick-health-leads-the-way-to-faster-delivery-of-precision-medicine-with-meditechs-expanse-genomics/ 2022-07-21T17:36:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Screenshot-2022-07-21-at-13-34-11-Frederick-Health-leads-the-way-to-faster-delivery-of-precision-medicine-with-MEDITECHs-Expanse-Genomics-e1658424943778.png https://bostonlifesciencestimes.com/2022/07/dg-solutions-names-industry-veteran-ghiaseddin-president/ 2022-07-21T17:40:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Pooya-Ghiaseddin.jpg https://bostonlifesciencestimes.com/2022/07/skyflow-hires-tammy-sexton-as-chief-revenue-officer-to-double-down-on-global-growth/ 2022-07-21T17:44:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Tammy-Sexton.jpg https://bostonlifesciencestimes.com/2022/07/feinstein-summer-concert-raises-3-6m-to-advance-medical-research/ 2022-07-22T14:56:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Enrique-Iglesias.jpg https://bostonlifesciencestimes.com/2022/07/vertex-advances-vx-548-in-acute-and-neuropathic-pain/ 2022-07-22T15:03:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Vertex-Pharmaceuticals.png https://bostonlifesciencestimes.com/2022/07/aurinia-announces-positive-chmp-opinion-for-lupkynis-voclosporin-for-the-treatment-of-adults-with-active-lupus-nephritis-in-europe/ 2022-07-22T15:06:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Peter-Greenleaf.jpg https://bostonlifesciencestimes.com/2022/07/european-quantum-computing-leader-iqm-raises-e128m-led-by-world-fund-to-help-combat-the-climate-crisis/ 2022-07-22T15:11:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/IQM-Quantum-Computer.jpg https://bostonlifesciencestimes.com/2022/07/newamsterdam-pharma-holding-b-v-and-frazier-lifesciences-acquisition-corporation-announce-merger-agreement-to-create-publicly-listed-company/ 2022-07-25T14:07:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/NewAmsterdam-Pharma.jpg https://bostonlifesciencestimes.com/2022/07/flare-therapeutics-appoints-amit-rakhit-m-d-as-president-and-chief-executive-officer/ 2022-07-25T14:12:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Flare-Therapeutics.jpg https://bostonlifesciencestimes.com/2022/07/generate-biomedicines-bolsters-leadership-team-with-the-addition-of-jason-silvers-m-d-j-d-as-chief-financial-officer/ 2022-07-25T14:28:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Jason-Silvers-M.D.-J.D..jpg https://bostonlifesciencestimes.com/2022/07/acufocus-announces-fda-approval-for-the-ic-8-apthera-intraocular-lens-the-first-and-only-small-aperture-lens-for-cataract-surgery/ 2022-07-25T14:38:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/IC-8%C2%AE-Apthera.jpg https://bostonlifesciencestimes.com/2022/07/rhinostics-launches-the-veristic-to-redefine-small-volume-blood-collection/ 2022-07-25T14:41:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/The-VERIstic%E2%84%A2.jpg https://bostonlifesciencestimes.com/2022/07/mason-expands-executive-bench-with-cfo-and-vp-of-operations-as-business-accelerates/ 2022-07-25T14:49:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Mason-CFO-Phil-Moon.jpg https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Mason-VP-of-Operations-Bernard-Richardson.jpg https://bostonlifesciencestimes.com/2022/07/enveric-biosciences-announces-8-million-registered-direct-offering-and-private-placement-priced-at-a-premium-to-market-under-nasdaq-rules/ 2022-07-25T14:51:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Enveric-Biosciences.jpg https://bostonlifesciencestimes.com/2022/07/fresenius-kabi-expands-ready-to-administer-portfolio-with-glycopyrrolate-injection-usp-simplist-prefilled-syringe/ 2022-07-25T15:17:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Fresenius-Kabi-Glycopyrrolate-Injection.jpg https://bostonlifesciencestimes.com/2022/07/circle-pharma-appoints-paul-park-mba-as-its-chief-business-officer/ 2022-07-26T14:07:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Paul-Park.jpg https://bostonlifesciencestimes.com/2022/07/seagen-and-astellas-announce-positive-topline-results-for-padcev-enfortumab-vedotin-ejfv-with-keytruda-pembrolizumab-as-first-line-treatment-for-advanced-urothelial-cancer/ 2022-07-26T14:08:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Seagen.jpg https://bostonlifesciencestimes.com/2022/07/anzu-partners-promotes-dr-jimmy-kan-to-partner/ 2022-07-26T14:14:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Jimmy-Kan-Ph.D..jpg https://bostonlifesciencestimes.com/2022/07/scribe-therapeutics-announces-expansion-of-san-francisco-bay-area-headquarters-3-key-senior-hires/ 2022-07-26T14:20:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Scribe-Therapeutics.jpg https://bostonlifesciencestimes.com/2022/07/waters-collaborates-with-leading-researchers-and-industry-partners-to-advance-the-science-of-alternative-proteins/ 2022-07-26T14:34:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/University-of-Minnesotas-Plant-Protein-Innovation-Center.jpg https://bostonlifesciencestimes.com/2022/07/ford-hutman-media-appoints-meriel-mccaffery-as-vice-president-head-of-corporate-communications/ 2022-07-26T14:42:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Meriel-McCaffery.jpg https://bostonlifesciencestimes.com/2022/07/iveric-bio-announces-agreement-for-up-to-250-million-in-non-dilutive-debt-financing-with-hercules-capital-and-silicon-valley-bank/ 2022-07-26T14:44:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/David-F.-Carroll.png https://bostonlifesciencestimes.com/2022/07/groupe-adf-acquires-amrikart-ultraprecision-inc-in-quebec/ 2022-07-26T14:48:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Amrikart.jpg https://bostonlifesciencestimes.com/2022/07/orthofix-announces-first-clinical-use-of-virtuos-lyograft-a-first-of-its-kind-shelf-stable-and-complete-autograft-substitute-for-spine-and-orthopedic-procedures/ 2022-07-26T15:00:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Virtuos%E2%84%A2-Lyograft.jpg https://bostonlifesciencestimes.com/2022/07/qosina-adds-the-aseptiquik-stc-series-to-its-line-of-steam-thru-connectors/ 2022-07-26T15:19:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/The-AseptiQuik%C2%AE-STC.jpg https://bostonlifesciencestimes.com/2022/07/generate-biomedicines-expands-leadership-team-with-the-addition-of-chief-medical-officer-alexandra-snyder-m-d/ 2022-07-26T15:33:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Alexandra-Snyder-MD.jpg https://bostonlifesciencestimes.com/2022/07/curi-bio-launches-mantarray-platform-3d-engineered-muscle-tissues-for-discovery-of-new-therapeutics/ 2022-07-27T14:11:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Mantarray.jpg https://bostonlifesciencestimes.com/2022/07/asahi-kasei-bioprocess-to-showcase-award-winning-motiv-buffer-management-technology-for-pharmaceutical-manufacturing-at-achema-2022/ 2022-07-27T14:13:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Asahi-Kasei-Bioprocess-America.jpg https://bostonlifesciencestimes.com/2022/07/pci-pharma-services-announces-multi-million-dollar-expansion-to-uk-manufacturing-facility-to-meet-growing-demand-for-global-high-potent-manufacturing-services-supporting-oncology-treatments/ 2022-07-27T14:22:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/PCI-Pharma.jpg https://bostonlifesciencestimes.com/2022/07/linus-health-launches-first-ipad-based-brain-health-platform-for-early-detection-of-alzheimers-and-other-dementias-in-primary-care/ 2022-07-27T14:34:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/David-Bates-PhD.jpg https://bostonlifesciencestimes.com/2022/07/biomind-labs-appoints-former-fda-director-dr-thomas-laughren-as-medical-advisor-for-clinical-trials/ 2022-07-27T14:55:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Biomind-Labs.jpg https://bostonlifesciencestimes.com/2022/07/successful-completion-of-series-a-eur-10-million-investment-for-medtech-startup-precipoint/ 2022-07-27T15:03:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/PreciPoint.png https://bostonlifesciencestimes.com/2022/07/dexcom-g6-continuous-glucose-monitoring-system-mobile-app-now-available-in-spanish/ 2022-07-27T15:13:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Dexcom.jpg https://bostonlifesciencestimes.com/2022/07/ambu-announces-fda-clearance-of-fifth-generation-single-use-bronchoscope/ 2022-07-27T15:25:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Ambu%C2%AE-aScopeTM-5-Broncho.jpg https://bostonlifesciencestimes.com/2022/08/rubedo-life-sciences-expands-leadership-team-with-ali-siam-as-chief-business-officer-and-ofir-moreno-ph-d-as-svp-of-drug-discovery/ 2022-08-01T14:09:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Ali-Siam.jpg https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Ofir-Moreno-Ph.D..jpg https://bostonlifesciencestimes.com/2022/08/xeris-commercialization-partner-for-ogluo-tetris-pharma-ltd-to-be-acquired-by-arecor-therapeutics/ 2022-08-01T14:12:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Paul-R.-Edick-e1659363128248.jpg https://bostonlifesciencestimes.com/2022/08/smartlabs-announces-plans-to-expand-high-performance-laboratory-facilities-in-philadelphia/ 2022-08-01T14:16:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Philadelphia-PA.jpg https://bostonlifesciencestimes.com/2022/08/new-cryo-plasma-focused-ion-beam-to-streamline-cellular-cryo-electron-tomography-research/ 2022-08-01T14:19:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Thermo-Scientific-Arctis-Cryo-Plasma-Focused-Ion-Beam.jpg https://bostonlifesciencestimes.com/2022/08/differentiated-therapeutics-raises-5-million-seed-round/ 2022-08-01T15:12:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Differentiated-Therapeutics.jpg https://bostonlifesciencestimes.com/2022/08/new-ceo-wright-l-lassiter-iii-begins-at-commonspirit/ 2022-08-01T15:40:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Wright-L.-Lassiter-III.jpg https://bostonlifesciencestimes.com/2022/08/curia-appoints-niall-condon-to-lead-manufacturing/ 2022-08-02T14:13:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Niall-Condon.jpg https://bostonlifesciencestimes.com/2022/08/stilla-technologies-solidifies-leadership-in-emea-expands-footprint-in-apac/ 2022-08-02T14:16:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Yvan-Sergeant.jpg https://bostonlifesciencestimes.com/2022/08/agilent-acquires-polymer-standards-service-broadening-offerings-for-gpc-sec-polymer-analysis/ 2022-08-02T14:20:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Agilent-Technologies-Inc.jpg https://bostonlifesciencestimes.com/2022/08/wolters-kluwer-supports-second-mercy-ships-floating-hospital-to-enhance-use-of-evidence-based-medicine/ 2022-08-02T14:38:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Wolters-Kluwer-Health.jpg https://bostonlifesciencestimes.com/2022/08/orca-bio-announces-the-precision-t-phase-3-study-is-open-and-enrolling-patients-at-transplant-centers-across-the-u-s/ 2022-08-02T14:42:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Ivan-Dimov-Ph.D..png https://bostonlifesciencestimes.com/2022/08/idrx-launches-with-122-million-series-a-financing-to-treat-cancer-with-purpose-built-precision-combination-therapies/ 2022-08-02T14:57:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/IDRx.jpg https://bostonlifesciencestimes.com/2022/08/wilhelm-von-haller-is-chief-financial-officer-of-lysando-ag/ 2022-08-02T15:01:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Wilhelm-von-Haller.jpg https://bostonlifesciencestimes.com/2022/08/intervenn-biosciences-announces-start-of-enrollment-in-colonoscopy-study/ 2022-08-02T15:28:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/InterVenn-Biosciences.jpg https://bostonlifesciencestimes.com/2022/08/jll-secures-585-million-financing-for-mixed-use-development-allston-labworks-in-boston/ 2022-08-02T15:40:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Allston-LabWorks.webp https://bostonlifesciencestimes.com/2022/08/model-n-and-pfizer-innovate-drug-price-transparency-reporting/ 2022-08-03T14:12:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Model-N.jpg https://bostonlifesciencestimes.com/2022/08/data-showing-mymd-pharmaceuticals-mymd-1-may-extend-life-and-improve-health-published-in-the-journal-of-gerontology-biological-sciences/ 2022-08-03T14:17:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/MYMD-1%C2%AE.jpg https://bostonlifesciencestimes.com/2022/08/grammy-award-winner-tiesto-to-perform-at-klick-muse/ 2022-08-03T14:21:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Screenshot-2022-08-03-at-10-20-21-Tie%CC%88stos-%40tiesto-profile-on-Instagram-%E2%80%A2-108-posts.png https://bostonlifesciencestimes.com/2022/08/automated-dried-spot-sampling-and-analysis-system-redefines-workflow/ 2022-08-03T14:23:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Thermo-Scientific-Transcend-DSX-1.jpg https://bostonlifesciencestimes.com/2022/08/thermo-fisher-scientific-and-structura-biotechnology-collaborate-to-offer-a-solution-for-real-time-cryo-em-data-analysis/ 2022-08-03T14:24:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Thermo-Fisher.jpg https://bostonlifesciencestimes.com/2022/08/eureka-therapeutics-announces-publication-of-crystal-structure-of-tcr-mimic-redirected-t-cells-targeting-alpha-fetoprotein-afp-for-liver-cancer/ 2022-08-03T14:31:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/TCRm.jpg https://bostonlifesciencestimes.com/2022/08/alnylam-reports-positive-topline-results-from-apollo-b-phase-3-study-of-patisiran-in-patients-with-attr-amyloidosis-with-cardiomyopathy/ 2022-08-03T14:52:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Alnylam-Ranks.jpg https://bostonlifesciencestimes.com/2022/08/thermo-fisher-scientific-introduces-highly-sensitive-research-assays-for-measurable-residual-disease-detection-in-myeloid-malignancies/ 2022-08-04T14:41:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Ion-Torrent-Oncomine-Myeloid-MRD-Assays.jpg https://bostonlifesciencestimes.com/2022/08/gilead-sciences-to-acquire-mirobio/ 2022-08-04T14:43:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Eliot-Charles.png https://bostonlifesciencestimes.com/2022/08/globallogic-announces-appointment-of-new-president-and-ceo/ 2022-08-04T14:45:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Nitesh-Banga.jpg https://bostonlifesciencestimes.com/2022/08/somalytics-readies-for-growth-signs-lease-for-headquarters-in-seattle/ 2022-08-04T14:47:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Somalytics.png https://bostonlifesciencestimes.com/2022/08/vacmobile-joins-georgia-techs-advanced-technology-development-centers-accelerate-startup-portfolio/ 2022-08-04T14:51:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Jennifer-Sparks.jpg https://bostonlifesciencestimes.com/2022/08/sakuu-opens-new-battery-printing-and-engineering-facility-in-silicon-valley/ 2022-08-04T14:53:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Sakuu.jpg https://bostonlifesciencestimes.com/2022/08/applied-dna-announces-pricing-of-12-million-upsized-public-offering-priced-at-a-premium-to-market-under-nasdaq-rules/ 2022-08-04T14:58:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/James-A.-Hayward-Ph.D.-Sc.D..jpg https://bostonlifesciencestimes.com/2022/08/fda-grants-extension-of-shelf-life-expiration-date-for-genbody-covid-19-ag-test/ 2022-08-04T15:11:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/GenBody-America-LLC-scaled.jpg https://bostonlifesciencestimes.com/2022/08/experienced-finance-and-operations-executive-lisa-kelley-joins-quanergy-board-of-directors/ 2022-08-04T15:15:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Lisa-Kelley.jpg https://bostonlifesciencestimes.com/2022/08/gsk-and-iqvia-launch-vaccine-track-a-data-trend-platform-to-help-improve-adult-vaccination-in-communities-nationwide/ 2022-08-08T14:55:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Vaccine-Track-insights.jpg https://bostonlifesciencestimes.com/2022/08/thermo-fisher-scientific-launches-enhanced-applied-biosystems-hiv-1-genotyping-kit/ 2022-08-08T14:59:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Thermo-Fisher.jpg https://bostonlifesciencestimes.com/2022/08/persephone-biosciences-announces-first-participant-enrolled-in-proprietary-my-baby-biome-study-of-infant-gut-health/ 2022-08-08T15:02:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Persephone-Biosciences-Inc..jpg https://bostonlifesciencestimes.com/2022/08/eirsystems-announces-close-of-seed-financing-round-to-advance-software-for-preventing-prescription-abuse/ 2022-08-08T15:04:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/EirSystems.jpg https://bostonlifesciencestimes.com/2022/08/exactech-connects-surgeons-and-patients-on-another-level-with-high-nps-and-new-message-streams/ 2022-08-08T15:08:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Exactech.jpg https://bostonlifesciencestimes.com/2022/08/truarc-partners-acquires-molded-devices/ 2022-08-08T15:21:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Screenshot-2022-08-08-at-11-20-48-Meet-the-Team-Leading-Transformational-Growth-TruArc-Partners.png https://bostonlifesciencestimes.com/2022/08/nautilus-inc-announces-appointment-of-new-board-chair-anne-saunders/ 2022-08-08T15:43:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Anne-Saunders.jpg https://bostonlifesciencestimes.com/2022/08/upstream-bio-announces-dosing-of-first-patient-in-a-phase-1b-clinical-trial-of-upb-101-in-asthma/ 2022-08-09T17:11:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Sam-Truex.png https://bostonlifesciencestimes.com/2022/08/beigene-announces-positive-global-phase-3-trial-results-for-pd-1-inhibitor-tislelizumab-in-first-line-unresectable-hepatocellular-cancer/ 2022-08-09T17:14:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Mark-Lanasa-M.D.-Ph.D..jpg https://bostonlifesciencestimes.com/2022/08/childrens-hospital-los-angeles-finds-differences-in-how-doctors-caregivers-and-patients-report-side-effects-of-cancer-therapy/ 2022-08-09T17:28:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/David-R.-Freyer-DO-MS.jpg https://bostonlifesciencestimes.com/2022/08/bioceres-crop-solutions-executed-previously-announced-financing-agreements-for-a-total-amount-of-79-million/ 2022-08-09T17:37:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Bioceres-Crop-Solutions.png https://bostonlifesciencestimes.com/2022/08/arcus-biosciences-appoints-dimitry-nuyten-m-d-ph-d-as-chief-medical-officer/ 2022-08-09T17:41:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Dimitry-Nuyten-M.D.-Ph.D..webp https://bostonlifesciencestimes.com/2022/08/abionic-receives-ivdr-certification-for-its-predictive-ultra-rapid-sepsis-test-allowing-the-management-of-antibiotic-administration/ 2022-08-09T17:43:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/FIVE-MINUTES-TO-SAVE-LIVES.jpg https://bostonlifesciencestimes.com/2022/08/rockley-photonics-signs-supply-agreement-and-receives-first-commercial-purchase-order-for-its-non-invasive-biosensing-wristband/ 2022-08-09T17:45:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Rockley-Photonics.jpg https://bostonlifesciencestimes.com/2022/08/bodyport-receives-fda-clearance-for-the-bodyport-cardiac-scale/ 2022-08-09T17:48:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Bodyport-Cardiac-Scale.jpg https://bostonlifesciencestimes.com/2022/08/transmed7-llc-announces-first-clinical-use-of-speedbird-breast-biopsy-devices-for-commercial-launch/ 2022-08-09T17:54:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Dr.-Edgar-Staren.webp https://bostonlifesciencestimes.com/2022/08/carequest-institute-hires-kaz-rafia-as-chief-health-equity-officer/ 2022-08-09T18:00:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Kaz-Rafia.gif https://bostonlifesciencestimes.com/2022/08/salvo-health-secures-10-5-million-in-seed-funding-to-scale-virtual-health-clinic-for-chronic-conditions/ 2022-08-09T18:01:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Salvo-Health.png https://bostonlifesciencestimes.com/2022/08/manatt-expands-data-strategy-and-health-it-capabilities-in-boston/ 2022-08-10T14:51:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Cynthia-Bero.jpg https://bostonlifesciencestimes.com/2022/08/sfw-capital-completes-strategic-investment-in-sannova-analytical/ 2022-08-10T14:58:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Sannova-Analytical.jpg https://bostonlifesciencestimes.com/2022/08/cure-rare-disease-receives-fda-approval-to-administer-first-in-human-crispr-therapeutic/ 2022-08-10T15:01:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Richard-Horgan.jpg https://bostonlifesciencestimes.com/2022/08/smart-modular-announces-smart-zefr-memory-with-ultra-high-reliability-performance-for-demanding-compute-applications/ 2022-08-10T15:08:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Zefr.jpg https://bostonlifesciencestimes.com/2022/08/rockley-establishes-scientific-advisory-board-of-prominent-scientists-and-medical-experts/ 2022-08-10T15:10:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Rockley.jpg https://bostonlifesciencestimes.com/2022/08/esteemed-healthcare-executive-michael-neeb-named-physiq-special-advisor/ 2022-08-10T15:12:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Michael-T.-Neeb.jpg https://bostonlifesciencestimes.com/2022/08/viecure-partners-with-clarified-precision-medicine-to-accelerate-the-adoption-of-precision-oncology/ 2022-08-10T15:15:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/VieCure.jpg https://bostonlifesciencestimes.com/2022/08/knightscope-nasdaq-kscp-signs-another-hospital-client-contract/ 2022-08-10T15:25:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Knightscope.jpg https://bostonlifesciencestimes.com/2022/08/prellis-biologics-appoints-new-ceo-raises-35-million-in-series-c-funding-to-leverage-human-immune-system-biology-to-de-risk-and-accelerate-therapeutics-drug-discovery-and-development/ 2022-08-10T15:27:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Michael-Nohaile-PhD.jpg https://bostonlifesciencestimes.com/2022/08/u-s-alliance-pharma-expands-early-phase-bioanalytical-services-into-australia/ 2022-08-11T14:54:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Alliance-Pharma.jpg https://bostonlifesciencestimes.com/2022/08/psioxus-therapeutics-appoints-howard-davis-ph-d-as-chief-executive-officer/ 2022-08-11T15:02:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Howard-Davis-Ph.D..webp https://bostonlifesciencestimes.com/2022/08/gl-chemtec-partners-with-edgewater-capital-to-accelerate-growth/ 2022-08-11T15:05:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/GL-CHEMTEC.jpg https://bostonlifesciencestimes.com/2022/08/what-to-expect-at-biomedevice-boston-2022-edition/ 2022-08-11T15:09:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/BIOMEDevice.jpg https://bostonlifesciencestimes.com/2022/08/privately-held-alvogen-announces-favorable-ruling-on-patents-related-to-the-companys-proposed-generic-to-xifaxan-for-ibs-d/ 2022-08-11T15:16:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Alvogen.png https://bostonlifesciencestimes.com/2022/08/partnership-for-safe-medicines-applauds-international-criminal-police-organization-interpol-for-seizure-of-11-million-in-counterfeit-medicines-during-operation-pangea-xv/ 2022-08-11T15:43:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Safe-Medicines.jpg https://bostonlifesciencestimes.com/2022/08/breast-cancer-patients-now-have-new-radiation-treatment-option-that-visualizes-the-heart-and-addresses-co-morbidities/ 2022-08-11T15:46:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Brainlab-ExacTrac-Dynamic%C2%AE.jpg https://bostonlifesciencestimes.com/2022/08/levita-magnetics-secures-26m-to-advance-disruptive-surgical-robotic-system/ 2022-08-11T18:34:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Levita-Magnetics.jpg https://bostonlifesciencestimes.com/2022/08/pharmacyte-biotech-reaches-cooperation-agreement-with-iroquois-capital/ 2022-08-15T14:04:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/PharmaCyte-Biotech.jpg https://bostonlifesciencestimes.com/2022/08/terrapower-announces-750-million-secured-in-fundraise/ 2022-08-15T14:08:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Screenshot-2022-08-15-at-10-07-45-Chris-Levesque-TerraPower.png https://bostonlifesciencestimes.com/2022/08/trodelvy-significantly-improves-overall-survival-in-pre-treated-hr-her2-metastatic-breast-cancer-patients-in-the-tropics-02-study/ 2022-08-15T14:09:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Merdad-Parsey-MD-PhD.jpg https://bostonlifesciencestimes.com/2022/08/monod-bio-closes-25m-seed-financing-to-advance-biosensor-technology-platform/ 2022-08-15T14:16:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Daniel-Adriano-Silva-PhD.webp https://bostonlifesciencestimes.com/2022/08/virios-therapeutics-announces-dosing-of-first-patient-in-imc-2-long-covid-treatment-trial/ 2022-08-15T14:19:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Greg-Duncan.jpg https://bostonlifesciencestimes.com/2022/08/nuvig-therapeutics-expands-leadership-team-with-the-appointment-of-dr-joanne-quan-as-chief-medical-officer/ 2022-08-15T14:24:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Dr.-Joanne-Quan.jpg https://bostonlifesciencestimes.com/2022/08/confluent-medical-technologies-announces-grand-opening-of-costa-rica-expansion/ 2022-08-15T14:30:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Confluent-Medical-Technologies.jpg https://bostonlifesciencestimes.com/2022/08/outset-medical-awarded-va-contract-aimed-at-improving-dialysis-care-for-veterans/ 2022-08-15T14:33:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Leslie-Trigg.jpg https://bostonlifesciencestimes.com/2022/08/seventy-percent-70-of-patients-surveyed-voice-concern-about-tobacco-corporations-ownership-of-lung-disease-treatments/ 2022-08-15T14:37:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/COPD-Foundation.jpg https://bostonlifesciencestimes.com/2022/08/applied-uv-files-trademark-infringement-lawsuit-against-aeroclean-technologies/ 2022-08-15T14:41:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/John-F.-Andrews.png https://bostonlifesciencestimes.com/2022/08/preceptis-medical-receives-fda-clearance-for-expanded-labeling-for-hummingbird-system/ 2022-08-15T14:45:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Steve-Anderson.jpg https://bostonlifesciencestimes.com/2022/08/heart-health-innovator-cleerly-appoints-joseph-jasser-md-as-chief-of-value-based-care/ 2022-08-15T14:52:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Cleerly.png https://bostonlifesciencestimes.com/2022/08/nih-awards-feinstein-institutes-3-8m-to-study-radiation-exposure-and-sepsis/ 2022-08-15T14:53:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Feinstein-Institutes.jpg https://bostonlifesciencestimes.com/2022/08/deepcell-names-human-resources-veteran-kady-cooper-as-head-of-people-to-support-rapid-growth/ 2022-08-16T14:59:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Kady-Cooper.jpg https://bostonlifesciencestimes.com/2022/08/moximed-raises-40-million-to-advance-worlds-first-implantable-shock-absorber-for-knee-osteoarthritis/ 2022-08-16T15:23:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Moximed.jpg https://bostonlifesciencestimes.com/2022/08/lg-chem-and-adm-launch-joint-ventures-announce-intended-location-for-u-s-production-of-lactic-acid-and-polylactic-acid-production/ 2022-08-16T15:28:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/ADMs-North-American-headquarters.jpg https://bostonlifesciencestimes.com/2022/08/gilead-to-acquire-remaining-worldwide-rights-of-trodelvy/ 2022-08-16T15:31:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Trodelvy.webp https://bostonlifesciencestimes.com/2022/08/colossal-to-de-extinct-the-thylacine-also-known-as-the-tasmanian-tiger-an-iconic-australian-marsupial-that-has-been-extinct-since-1936/ 2022-08-16T17:10:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Thylacine.jpg https://bostonlifesciencestimes.com/2022/08/viseon-inc-receives-eu-quality-management-certification-and-ce-mark-under-the-medical-device-regulation-mdr/ 2022-08-16T17:23:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/VISEON-Inc..jpg https://bostonlifesciencestimes.com/2022/08/exactech-announces-commercial-launch-of-novel-total-hip-arthroplasty-system/ 2022-08-16T17:28:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Exactech-1.jpg https://bostonlifesciencestimes.com/2022/08/heartbeam-announces-fda-submission-of-heartbeam-aimi-product/ 2022-08-16T17:40:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/HeartBeam.webp https://bostonlifesciencestimes.com/2022/08/vitalconnect-appoints-amy-covert-as-chief-financial-officer/ 2022-08-16T17:44:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Amy-Covert.jpg https://bostonlifesciencestimes.com/2022/08/transmed7-llc-announces-first-clinical-use-of-heron-soft-tissue-biopsy-devices-for-commercial-launch/ 2022-08-16T17:52:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/TransMed7.jpg https://bostonlifesciencestimes.com/2022/08/dr-b-raises-8-million-for-new-telehealth-service-making-prescription-medications-affordable-accessible-for-anyone/ 2022-08-16T17:59:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Cyrus-Massoumi.webp https://bostonlifesciencestimes.com/2022/08/kriya-appoints-pedro-huertas-m-d-ph-d-as-chief-medical-officer-of-its-rare-disease-division/ 2022-08-17T14:47:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Pedro-Huertas-M.D.-Ph.D..jpg https://bostonlifesciencestimes.com/2022/08/fda-clears-immunocap-blood-tests-for-wheat-and-sesame-allergy/ 2022-08-17T15:00:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Thermo-Fisher.jpg https://bostonlifesciencestimes.com/2022/08/tevogen-bio-appoints-three-prominent-healthcare-leaders-to-its-board-of-directors/ 2022-08-17T15:07:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Tevogen.jpg https://bostonlifesciencestimes.com/2022/08/nanodx-and-skywater-announce-first-commercially-ready-nano-biosensor-to-yield-protein-response/ 2022-08-17T15:11:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/NanoDx.png https://bostonlifesciencestimes.com/2022/08/hca-healthcare-announces-retirement-of-longtime-senior-executive-chuck-hall/ 2022-08-17T15:21:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Chuck-Hall.jpg https://bostonlifesciencestimes.com/2022/08/tebras-complete-operating-system-adopted-by-alturas-pain-and-spine-specialists/ 2022-08-17T15:27:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Tebra.jpg https://bostonlifesciencestimes.com/2022/08/ceva-animal-health-hires-iowa-state-university-students-to-participate-in-swine-veterinary-internship-program/ 2022-08-17T15:35:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Dr.-Edgar-Diaz.jpg https://bostonlifesciencestimes.com/2022/08/charles-river-laboratories-expands-contract-vivarium-space-on-west-coast/ 2022-08-23T13:44:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Charles-River-Laboratories.jpg https://bostonlifesciencestimes.com/2022/08/gate-neurosciences-emerges-from-stealth-with-a-portfolio-of-next-generation-therapies-for-central-nervous-system-diseases/ 2022-08-23T13:53:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Anantha-Shekhar.png https://bostonlifesciencestimes.com/2022/08/pfizer-and-biontech-announce-updated-covid-19-vaccine-data-supporting-efficacy-in-children-6-months-through-4-years-of-age/ 2022-08-23T13:58:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Pfizer.jpg https://bostonlifesciencestimes.com/2022/08/frazier-life-sciences-adds-senior-rd-leader-to-team/ 2022-08-23T14:06:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Annette-Doherty.jpg https://bostonlifesciencestimes.com/2022/08/hyperice-continues-its-relentless-disruption-of-the-recovery-tech-industry-with-introduction-of-normatec-go/ 2022-08-23T14:13:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Ja-Morant.jpg https://bostonlifesciencestimes.com/2022/08/diabetes-technology-leader-and-global-business-executive-doug-lawrence-joins-hygieia-as-ceo/ 2022-08-23T14:17:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Doug-Lawrence.jpg https://bostonlifesciencestimes.com/2022/08/miracor-medical-announces-fda-ide-approval-for-picso-pivotal-study/ 2022-08-23T14:24:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/PiCSO.jpg https://bostonlifesciencestimes.com/2022/08/northwell-implements-new-screening-technology/ 2022-08-23T14:26:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/A-Northwell-Health-security-officer.jpg https://bostonlifesciencestimes.com/2022/08/mobe-appoints-veteran-health-sector-leaders-as-ceo-and-cco/ 2022-08-23T14:31:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/MOBE.jpg https://bostonlifesciencestimes.com/2022/08/american-vanguard-announces-20mm-accelerated-share-repurchase/ 2022-08-23T14:33:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/American-Vanguard.png https://bostonlifesciencestimes.com/2022/08/firststeps-for-kids-announces-matt-mcalear-as-ceo-and-anne-swinney-as-coo/ 2022-08-23T14:36:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Matt-McAlear.jpg https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Anne-Swinney.jpg https://bostonlifesciencestimes.com/2022/08/athenahealth-ranks-no-58-on-fast-companys-fourth-annual-list-of-the-100-best-workplaces-for-innovators/ 2022-08-23T14:41:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/athenahealth.jpg https://bostonlifesciencestimes.com/2022/08/ross-university-school-of-medicine-and-hbcu-bethune-cookman-university-partner-to-expand-access-for-aspiring-underrepresented-medical-students/ 2022-08-23T14:44:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Heidi-Chumley-MD-MBA.webp https://bostonlifesciencestimes.com/2022/08/curbwaste-closes-6-million-seed-round-to-provide-waste-haulers-with-saas-software-solutions/ 2022-08-23T14:48:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/CurbWaste.jpg https://bostonlifesciencestimes.com/2022/08/professional-golfer-aza-munoz-returns-to-lpga-tour-with-new-solution-for-treating-her-hypothyroidism/ 2022-08-24T14:19:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Aza-Munoz.jpg https://bostonlifesciencestimes.com/2022/08/thermo-fisher-scientific-expands-viral-vector-manufacturing-capabilities/ 2022-08-24T14:38:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Thermo-Fisher-Scientific.jpg https://bostonlifesciencestimes.com/2022/08/tessera-therapeutics-expands-leadership-and-board/ 2022-08-24T14:44:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Anne-Virginie-Eggimann-M.Sc_..jpg https://bostonlifesciencestimes.com/2022/08/feinstein-institutes-get-3m-from-lupus-research-alliance-to-study-remission-and-future-therapies/ 2022-08-24T14:47:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Dr.-Betty-Diamond.jpg https://bostonlifesciencestimes.com/2022/08/wellstack-appoints-industry-data-analytics-leader-nilesh-patil-as-chief-growth-and-strategy-officer/ 2022-08-24T14:56:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Nilesh-Patil.jpg https://bostonlifesciencestimes.com/2022/08/hera-biotech-closes-oversubscribed-1-9-million-seed-raise-for-novel-diagnostic-test-for-endometriosis/ 2022-08-24T14:59:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Screenshot-2022-08-24-at-10-58-12-Meet-the-Team.png https://bostonlifesciencestimes.com/2022/08/vektor-medicals-technology-attracts-seasoned-medtech-experts-to-lead-sales-and-quality-functions/ 2022-08-24T15:09:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Tim-Laird-VP-of-Sales.jpg https://bostonlifesciencestimes.com/2022/08/sanotize-announces-24-million-in-series-b-funding-to-advance-its-nitric-oxide-based-therapeutics-including-nasal-spray-for-the-treatment-and-prevention-of-covid-19/ 2022-08-24T15:19:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/SaNOtize.jpeg https://bostonlifesciencestimes.com/2022/08/folx-health-launches-monkeypox-offering-featuring-education-counseling-evaluation-and-referrals-for-treatment/ 2022-08-24T15:27:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/FOLX-Health.jpg https://bostonlifesciencestimes.com/2022/08/pci-pharma-services-opens-new-england-center-of-excellence-to-bring-global-clinical-supply-capabilities-to-new-england/ 2022-08-25T14:08:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Rendering-of-the-new-PCI-facility-in-Bridgewater-MA..jpg https://bostonlifesciencestimes.com/2022/08/cognesy-therapeutics-announces-senior-leadership-team-to-advance-neuroplasticity-drug-discovery-platform-for-neuropsychiatric-disorders/ 2022-08-25T14:13:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Thomas-C.-Wessel-MD-PhD.jpg https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Peter-S.-DiStefano-PhD.jpg https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Danny-Talati-PharmD-MBA.jpg https://bostonlifesciencestimes.com/2022/08/kriya-appoints-curt-herberts-as-president-and-chief-operating-officer/ 2022-08-25T14:21:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Curt-Herberts.jpg https://bostonlifesciencestimes.com/2022/08/new-line-of-electrochemistry-bench-meters-simplify-ph-conductivity-and-dissolved-oxygen-measurement/ 2022-08-25T14:29:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Thermo-Scientific-Orion-Lab-Star-Bench-Meters.jpg https://bostonlifesciencestimes.com/2022/08/latest-data-demonstrates-penumbra-system-and-red-reperfusion-catheters-effective-for-broad-stroke-care/ 2022-08-25T14:48:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Penumbra-Inc.jpg https://bostonlifesciencestimes.com/2022/08/netcapital-funding-portal-powers-1-4-million-capital-raise-by-avadain/ 2022-08-25T15:00:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Netcapital.jpg https://bostonlifesciencestimes.com/2022/08/centerwell-senior-primary-care-to-open-9-senior-focused-care-centers-in-and-around-phoenix/ 2022-08-25T15:02:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/CenterWell-Senior-Primary-Care.jpg https://bostonlifesciencestimes.com/2022/08/pfizer-announces-positive-top-line-data-from-phase-3-trial-of-older-adults-for-its-bivalent-respiratory-syncytial-virus-rsv-vaccine-candidate/ 2022-08-25T15:10:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Pfizer-Building-logo.jpg https://bostonlifesciencestimes.com/2022/08/could-inflation-worsen-school-absenteeism-rates/ 2022-08-25T15:28:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/school.jpg https://bostonlifesciencestimes.com/2022/08/regenacy-pharmaceuticals-announces-completion-of-enrollment-for-phase-2-study-in-diabetic-peripheral-neuropathy-9-3-million-series-b-financing/ 2022-08-25T15:35:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Regenacy-Pharmaceuticals.jpg https://bostonlifesciencestimes.com/2022/08/mantel-launches-carbon-capture-technology-to-reduce-the-worlds-atmospheric-co2-and-help-achieve-net-zero/ 2022-08-25T15:37:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Mantel-founders.jpg https://bostonlifesciencestimes.com/2022/08/nortech-systems-announces-patent-for-flexible-faraday-cage-printed-circuit-board-and-cable/ 2022-08-26T14:33:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Flex-Faraday-Xtreme.jpg https://bostonlifesciencestimes.com/2022/08/the-polypill-reduces-cardiovascular-mortality-by-33-in-patients-treated-after-myocardial-infarction/ 2022-08-26T14:37:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Dr.-Valentin-Fuster.jpg https://bostonlifesciencestimes.com/2022/08/covetrus-names-margie-b-pritchard-general-counsel/ 2022-08-26T15:14:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Covetrus.png https://bostonlifesciencestimes.com/2022/08/turnongreen-announces-sponsorship-of-paretta-autosport-for-indycars-firestone-grand-prix-of-monterey/ 2022-08-26T15:36:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/TurnOnGreen-Inc.jpg https://bostonlifesciencestimes.com/2022/08/bruker-launches-new-nanoelute-2-nano-lc-for-4d-proteomics-advances-fluxomics-applications/ 2022-08-29T14:33:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/nanoElute%C2%AE-2.jpg https://bostonlifesciencestimes.com/2022/08/thermo-fisher-scientific-showcases-latest-innovations-to-improve-biopharmaceutical-and-proteomics-workflows/ 2022-08-29T14:44:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Orbitrap-Ascend-Tribrid-mass-spectrometer.jpg https://bostonlifesciencestimes.com/2022/08/new-data-show-farxiga-significantly-lowers-the-risk-of-cardiovascular-death-in-patients-with-heart-failure/ 2022-08-29T14:47:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/AstraZeneca-India.jpg https://bostonlifesciencestimes.com/2022/08/virtis-health-unveils-ambulatory-infusion-center-in-houston/ 2022-08-29T17:37:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Virtis-Health.jpg https://bostonlifesciencestimes.com/2022/08/massbio-releases-2022-industry-snapshot/ 2022-08-30T14:28:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Joe-Boncore.jpg https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Kendalle-Burlin-OConnell.jpg https://bostonlifesciencestimes.com/2022/08/okyo-pharma-plans-q4-2022-ind-filing-of-ok-101-to-treat-dry-eye-disease-with-subsequent-phase-2-initiation-alongside-peptide-manufacturing-partner-ambiopharm/ 2022-08-30T14:34:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/OKYO-Pharma.jpg https://bostonlifesciencestimes.com/2022/08/medable-simplifies-decentralized-clinical-trials-for-vaccines-expands-global-trial-access-while-cutting-deployment-time-by-50/ 2022-08-30T14:37:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/medable.jpg https://bostonlifesciencestimes.com/2022/08/9-out-of-10-consumers-make-direct-link-between-climate-change-and-rising-energy-bills-schneider-electric-global-study-finds/ 2022-08-30T14:39:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Schneider-Electric-Global-Study.jpg https://bostonlifesciencestimes.com/2022/08/epredia-launches-laser-cassette-printers-designed-to-improve-sample-tracking-and-laboratory-efficiency/ 2022-08-30T14:42:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Laser-Cassette-Printers.jpg https://bostonlifesciencestimes.com/2022/08/thermo-fisher-scientific-launches-ce-ivd-ivdd-next-generation-sequencing-test-and-analysis-software-to-expand-access-to-precision-oncology-biomarker-testing/ 2022-08-30T14:46:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Thermo-Fisher.jpg https://bostonlifesciencestimes.com/2022/08/mirvie-expands-leadership-team-with-appointment-of-alison-cowan-m-d-as-head-of-medical-affairs/ 2022-08-30T14:51:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Alison-Cowan-M.D..jpg https://bostonlifesciencestimes.com/2022/08/oneview-announces-system-wide-patient-experience-collaboration-with-bjc-healthcare/ 2022-08-30T14:56:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/The-BJC-Patient-Engagement-System.jpg https://bostonlifesciencestimes.com/2022/08/long-covid-outpaces-diabetes-in-2022-employer-health-care-costs-nomi-health-research-finds/ 2022-08-30T15:00:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Nomi-Health.jpg https://bostonlifesciencestimes.com/2022/08/linus-health-appoints-seasoned-health-it-and-health-system-executive-john-showalter-md-as-first-chief-product-officer/ 2022-08-30T15:04:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/John-Showalter-MD-e1661871856836.webp https://bostonlifesciencestimes.com/2022/08/covenant-physician-partners-appoints-daniel-gofman-to-chief-development-officer/ 2022-08-30T15:06:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Daniel-Gofman.jpg https://bostonlifesciencestimes.com/2022/08/respected-healthcare-investor-alex-albert-takes-helm-of-healthcare-private-equity-association-as-chairperson/ 2022-08-30T15:09:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Alex-Albert.jpg https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Amy-Christensen.jpg https://bostonlifesciencestimes.com/2022/08/abridge-partners-with-google-cloud-to-power-better-healthcare-delivery-experiences-for-everyone/ 2022-08-30T15:10:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Abridge.jpg https://bostonlifesciencestimes.com/2022/08/healee-lands-2m-to-grow-customizable-telehealth-solution-in-the-u-s/ 2022-08-30T15:20:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Healee.jpg https://bostonlifesciencestimes.com/2022/08/earlysalary-raises-series-d-funding-of-110-million-led-by-tpgs-the-rise-fund-norwest-venture-partners/ 2022-08-30T15:43:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/EarlySalary.png https://bostonlifesciencestimes.com/2022/08/worldwide-clinical-trials-appoints-barry-lederman-as-chief-financial-officer/ 2022-08-31T13:55:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Barry-Lederman.jpg https://bostonlifesciencestimes.com/2022/08/medical-pioneer-masimo-announces-the-full-market-consumer-release-of-the-masimo-w1-the-first-watch-to-offer-accurate-continuous-health-data/ 2022-08-31T13:59:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Masimo-W1%E2%84%A2.jpg https://bostonlifesciencestimes.com/2022/08/energous-and-e-peas-announce-new-wireless-energy-harvesting-evaluation-kit-supporting-iot-industrial-retail-and-medical-applications/ 2022-08-31T14:06:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Energous-Corporation.jpg https://bostonlifesciencestimes.com/2022/08/pearls-second-opinion-gains-regulatory-clearance-in-south-africa/ 2022-08-31T14:11:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Second-Opinion.gif https://bostonlifesciencestimes.com/2022/08/the-first-diagnostic-test-for-long-covid-will-formally-launch-in-europe-in-september/ 2022-08-31T14:19:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/IncellDx-e1661955569125.jpg https://bostonlifesciencestimes.com/2022/08/ameresco-completes-brightfield-solar-project-on-former-brownfield-site-in-illinois/ 2022-08-31T14:27:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Ameresco.jpg https://bostonlifesciencestimes.com/2022/08/tevogen-bio-appoints-esteemed-global-safety-management-expert-victor-sordillo-to-its-corporate-advisory-board/ 2022-08-31T14:32:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Victor-Sordillo.jpg